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ABSTRACT 
The dysfunction of the apical myocardium is observed following chronic exposure to catecholamines, 
or after acutely stressful scenarios, in the syndrome of Takotsubo cardiomyopathy. The physiological 
functions of the β2AR were assessed via measurement of cell shortening; β2AR-cAMP signalling was 
assessed by FRET microscopy, comparing cells from the apical and basal myocardium. The effects of 
pre-stimulation of the β2AR with high levels of endogenous catecholamines were investigated to 
simulate pathological scenarios. The structure of the cellular membranes of cells from different 
myocardial regions was assessed and manipulated to investigate their role in β2AR signalling. An 
improved animal model of the regional pathology in Takotsubo was investigated using 
ovariectomized female rats.  
Apical cardiomyocytes are sensitized to β2AR stimulation, displaying larger increases in inotropy and 
lusitropy in comparison to basal cells. This was not due to differences in cAMP levels induced by 
β2AR within the cell cytosol. Differences were apparent in the amount of cAMP reaching the RII-PKA 
domains (the main arbiters of cellular inotropy and lusitropy). β2AR-cAMP signalling was discovered 
to be more persistent in the apical cardiomyocytes. Basal cardiomyocytes were found to have a 
larger number of caveolae within their membranes, caveolae have been demonstrated to modulate 
β2AR. Following the disruption of caveolar domains via chelation of cholesterol, apical and basal 
responses to β2AR stimulation were equalized; inhibition of phosphodiesterase 4 had the same 
effect. Catecholamine pre-stimulation reduced β2AR responses; adrenaline pre-stimulation exerts a 
more Gi-dependent desensitization than noradrenaline. Female rats are shown to be relatively 
protected from the effects of adrenergic overstimulation and ovariectomized female rats suffer 
acutely high mortality.  
Cells from different regions of the myocardium may control their receptor signalling in different 
ways to produce desirable physiological activity. In settings of pathology this phenomena may leave 
certain regions vulnerable to damage.  
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1.0 INTRODUCTION 
1.1 ROLE OF CATECHOLAMINES IN THE REGULATION OF MYOCARDIAL FUNCTION 
1.1.1THE MYOCARDIUM AND THE CARDIOMYOCYTE 
The four chambered structure of the heart is composed of specialized striated muscle tissue; formed 
from serially coupled cardiomyocytes. Cardiomyocytes amount to 70% of the myocardium by 
volume (Vliegen et al., 1991). These cells are the prime source of contractile power within the heart, 
allowing the production of force for the propulsion of deoxygenated blood around the pulmonary 
circulation (right atria and right ventricle) and oxygenated blood to the other organs of the body (left 
ventricle and left atria). The ventricles are the two largest chambers with the thickest musculature 
and provide most of the propulsive force, the two atria act as primer pumps for the ventricles. The 
atria and ventricles are composed of myocytes which differ slightly in their structure and function 
(Dibb et al., 2009). An exploration of the differences between these cell types is outside of the scope 
of this thesis, as the aspects of physiology and pathology discussed relate primarily to the ventricular 
cardiomyocytes. Given this focus the structure and function of idealized ventricular myocytes will be 
referred to. Human ventricular cardiomyocytes are striated cells of about 50-100μm in length and 
10-30μm in width in mammalian hearts with some variation between different species (Levick, 
2010). They are rod-shaped and anastamose with two other cells (one at each end) via structures 
named connexins. The connexin proteins, which are intrinsic to forming these structures give rise to 
pores which allow cytoplasm to cytoplasm contact between the cells. This allows the influence of 
cytoplasmic factors (such as ions, RNA, cytokines) of cells upon their neighbours. In this way 
myocardial tissue is adapted to rapidly respond to alterations within the cellular and extracellular 
environment. This allows their synchronous contraction upon depolarization, initiated by specially 
adapted pacemaker myocytes within the heart and their ability to increase or decrease cardiac 
contractility and function at the behest of neuro-hormonal factors. As a result both the ‘fight or 
flight’ or ‘rest and digest’ programs of mammalian behaviour can be enacted. 
1.1.2 MYOCARDIAL MUSCLE SHEETS 
The cardiomyocytes form a mesh like array of sheets in 2D (Humphrey and McCulloch, 2003) which 
form a 3D matrix by connecting with adjacent sheets within a collagen and laminin frame work 
(Goldsmith et al., 2004). These sheets merge with each other in an anisotropic fashion, epicardial 
and endocardial layers end with their long axes at 90o to one another (Lunkenheimer, 2006). The 
sheets ascend in a helical fashion from the sub-endocardium from the apex to the base of the heart 
(Streeter, 1979). Ultimately the myocytes of the mid-portion of the ventricular wall end up being 
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aligned in a circular fashion relative to the endo and epi-cardium (Sanchez-Quitana et al., 1990). This 
arrangement is such that upon the linear contraction of the individual myocytes a wringing motion 
elicits from apex to base (the direction of action potential conduction). In systole this causes the 
production of force inward and consequently the increase in pressure and ejection of blood. The 
opposite case arises in diastole with the ventricle relaxing, the drop in pressure results in filling of 
the ventricle.       
1.1.3 EXCITATION-CONTRACTION COUPLING             
The excitation-contraction coupling pathway forms the basis of the linear contraction of individual 
cardiomyocytes. This pathway is a series of ionic fluxes and molecular events which serve to produce 
a shortening of the cell via the effects on contractile filaments within the cells (Bers, 2002). 
 
Figure 1.1 Adapted from Woodcock and Matkovich, 2005 and Roden and George, 1997 an illustration 
of the cardiomyocyte action potential and its component ion fluxes. Their phases of activity are 
indicated. 
Special pacemaker cardiomyocytes initiate a small depolarization of the adjacent cardiomyocytes. 
This causes the fast sodium channels (INa) to open causing an influx into the cells cytoplasm reducing 
the cardiomyocyte membrane potential. This rapid depolarization results in the opening of inward 
chloride channels (ICl) and some potassium (IK) channels which are involved in potassium efflux. This 
causes an early shift toward re-polarization but is prevented from fully returning the cells 
polarization as voltage gated calcium channels (Long-acting, L-Type Ca2+-channels) open causing an 
influx of calcium into the cell. The influx of this calcium as well as that from the Na+/Ca2+ exchanger 
(NCX) operating inwardly causes the initiation of cardiomyocyte contraction. A panel of potassium 
channels (delayed rectifier (IKs), HERG (IKr-) and the rapidly activated inward rectifier, ATP sensitive 
(IKATP)) restore the polarity of the cardiomyocyte. During the opening of L-Type Ca
2+ channels and 
NCX activity a phenomenon known as calcium induced calcium release initiates as the small increase 
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in cytosolic Ca2+ stimulates the opening of ryanodine (RyR) channels within the membrane of the 
sarcoplasmic reticulum (SR). This organelle serves as an intracellular calcium store and opening of 
the ryanodine channels causes an efflux of calcium and a subsequent increase in the cytosolic Ca2+ 
concentration.  Ca2+ binds the myofilament protein troponin-C causing a contraction.  The relaxation 
of the cardiomyocyte only occurs upon the dissociation of calcium from the myofilaments via a 
concentration gradient. This results when Ca2+ is removed from the cytosol by four separate 
processes (Bers, 2002). The sarcoplasmic reticulum Ca2+-ATPase (SERCA2A) which restores the Ca2+ 
to the SR stores, the NCX operating in outward mode as well as the sarcolemmal Ca2+-ATPase 
extruding Ca2+ into the extra-cellular media and the mitochondrial Ca2+-uniporter which passes Ca2+  
into the mitochondria. Mitochondria can act as a cellular store of calcium in this way which allows 
Ca2+ to fufil its role as both a controller of EC-coupling and a signalling molecule (Kirichok, 2004). The 
removal of calcium by the mitochondrial calcium uniporter (mito-Ca2+) is largely inconsequential to 
EC-coupling but small increases in mitochondrial calcium cause the increased production of NADH 
and ATP which usefully matches the increased energy demands by increases in cardiomyocyte 
contractility (Brandes and Bers, 1997). 
 
Figure 1.2 an illustration of the pathways controlling cardiomyocyte excitation-contraction coupling, 
demonstrating the way in which calcium cycling is involved in calcium-induced control of 
myofilament contraction and cardiomyocyte contractility 
1.1.4 ADAPTIVE CONTROL OF THE CARDIAC CYCLE AND CARDIOVASCULAR FUNCTION 
The heart is highly metabolically active as it needs to provide pumping action consistently 
throughout an organism’s lifecycle. In this respect adaptation to the specific energy requirements of 
the environmental situation of the organism has evolved as a method of conserving energy. In 
principle cardiac output is increased at times when it is beneficial for the organism to respire more 
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rapidly and have increased oxygenation of its skeletal muscle (feeding in predators, fighting, fleeing 
predators or danger).  This reactive nature is provided by the competing cardio-stimulatory 
sympathetic nervous system and the cardio-inhibitory parasympathetic nervous system. The 
signalling of these nervous systems is produced by the control of cardiomyocyte EC-coupling either 
enhancing or reducing activity.  
1.1.5 ARCHITECTURE AND FUNCTIONS OF THE SYMPATHETIC AND PARASYMPATHETIC 
NERVOUS SYSTEMS 
The sympathetic (SNS) and parasympathetic (PNS) compose two thirds of the autonomic nervous 
system (the other third being the enteric nervous system). The sympathetic system can be thought 
to be concerned with the response to stress whereas the parasympathetic system promotes 
homeostasis at rest, however this is a simplification and a small amount of sympathetic activity is 
required in the course of normal physiology (Brodal, 2004). Both the SNS and PNS are composed of 
pre-ganglionic and post-ganglionic neurons. The pre-ganglionic neurons of the SNS are short and 
emanate from between the T1 and L2 sections of the spinal cord. These synapse at ganglia with long 
SNS post-ganglionic neurons. Pre-ganglionic neurons of the PNS are long and emanate from S2, S3 
and S4 spinal cord as well as the 3rd, 7th, 9th and 10th cranial nerves. These synapse at ganglia close to 
or within the target organ with short post-ganglionic neurones of the PNS. The vagus nerve 
beginning at the 10thcranial nerve is the PNS nerve of primary importance for the heart but many 
other elements of the PNS innervate the vasculature (Drake et al., 2005). In both the PNS and SNS 
pre-ganglionic neurones release acetylcholine (ACh) across the synapse causing the stimulation of 
nicotinic ACh receptors and the activation of the post-ganglionic neuron. The activities of SNS or PNS 
nerves differ greatly, however SNS post-ganglionic neurones release noradrenaline from vesicles at 
the neural termini and onto the target organ. This is except for the chromaffin cells of the adrenal 
medulla which are effectively modified post-ganglionic SNS neurones. Upon ACh stimulation these 
cells release adrenaline and to a lesser extent noradrenaline directly into the blood stream. In the 
PNS post-ganglionic neurones function by releasing ACh onto their target organ, this stimulates 
muscarinic acetylcholine receptors (differing from synaptic ACh transmission) (Rang et al., 2007). The 
effects of catecholamine release upon adrenal or nervous system (sympatho-adrenal) release on the 
cardiovascular system will be expanded upon extensively in the remainder of this chapter. The effect 
of PNS stimulation on the heart is to cause a decrease in the contractility of the atria and a slowing 
of the conduction of the sino-atrial and atrio-ventricular nodes. This is often in response to 
sympathetic stimulation and serves to reduce heart contraction by reducing pre-load (reducing 
myofilament sensitivity) and slowing heart rate, with the total effect of reducing cardiac output. The 
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effect of PNS stimulation on the vasculature overall is vasodilatory, this gives rise to full perfusion of 
extremities of tissues and reduces central blood pressure.                
1.1.6 THE SYNTHESIS OF THE CATECHOLAMINES 
Synthesis of the catecholamines takes place in the neurons from which they are released or the 
chromaffin cells of the adrenal gland.  Adrenaline, noradrenaline and the related catecholamine 
dopamine are generated by a common pathway in these tissues. The amino acid tyrosine is 
hydroxylated by tyrosine hydroxylase to produce dihydroxyphenylalanine (L-DOPA). This is modified 
to form dopamine by the enzyme amino acid decarboxylase. In the majority of cases the reaction 
terminates at the production of noradrenaline by the action of dopamine-β-hydroxylase within 
neural tissue. In chromaffin cells this noradrenaline can be modified to produce adrenaline via 
methylation of the primary amine by phenylethanolamine-N-methyltransferase (Kanagy, 2005). 
1.2 THE ADRENOCEPTORS  
1.2.1 NINE ADRENOCEPTOR SUB-TYPES AND FUNCTIONS 
The sympatho-adrenal signalling provided by noradrenaline and adrenaline is transduced into 
modifications of cellular physiology by a panel of adrenoceptor subtypes. These receptors are 
components of three G-protein coupled receptor (GPCR) systems which can control cardiac function 
Table 1.1. The GPCR’s bind an array of heterotrimeric G-proteins formed from α, β, γ subunits. There 
are approximately 20 types of G-protein which are defined by differences in their α-subunit 
(Triposkiadis et al., 2009). There are four main types of Gα subunit, these are Gαs, Gαi, Gq/11 and G12/13, 
a Gαi subunit forms a Gi protein for example.      
G-Protein System Effector Pathway Example  
Gs-linked Increases cAMP levels  Beta-adrenoceptors  
Histamine receptors 
Serotonin receptors 
Gi- linked Decreases cAMP levels   Muscarinic receptors 
Adenosine receptors 
Gq/11- linked Activates phospholipase C  (IP3)  Alpha-adrenoceptors 
Endothelin receptors 
Angiotensin receptors 
Table 1.1 G-protein receptor types adapted from Brodde et al., 2006 
There are nine adrenoceptor subtypes in total, comprising 6 alpha (α1A, α1B, α1D, α2A, α2B and α2C) 
and 3 beta-adrenoceptors (β1, β2 and β3). All are members of the G-Protein coupled family of seven 
trans-membrane receptors (Brodde et al., 2006, Guimarães and Moura., 2001).  
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1.2.2 THE Α1 ADRENOCEPTOR FAMILY 
 The α1 adrenoceptors sub-types A, B and D bind Gq/11 proteins, the downstream effect of which is to 
increase cardiac contractility, although this effect is far smaller than the comparative effect via βAR, 
the alpha effect is attributed to Gq/11 control of intracellular calcium stores. This is most likely due to 
the relative expression of α1AR being 10% of βAR in the heart (Simpson et al., 1983). Equally, strong 
α1AAR activity has been demonstrated to be pro-hypertrophic in the rat. Although there is no 
indication if this is the case in humans (Schlüter et al., 1999). Within the vasculature, stimulation of 
α1AR causes constriction of peripheral vessels due to its effects on smooth muscle. Due to this effect 
it also causes a constriction of the bronchi within the lungs. 
1.2.3 THE Α2 FAMILY 
The α2- receptors are linked to Gi which makes them arbiters of seperate signalling pathways in 
comparison to the α1 family. There does not appear to be any evidence that α2AR is present within 
the heart at the protein level (Bylund et al, 1998), although there is some evidence that it may play a 
role in pre-synaptic noradrenaline release in vitro and in vivo (Rump et al., 1995, Minatoguchi et al., 
1995). There is a far greater role for α2AR within the vasculature where it differentially constricts or 
dilates the vasculature on a vessel dependent basis. The α2AAR receptor specifically controls central 
blood pressure whereas α2BAR controls peripheral vascular tone alongside α1AR (Guimarães and 
Moura, 2001).  
1.2.4 THE CARDIOVASCULAR EFFECTS OF THE Β-ADRENERGIC RECEPTORS 
The βAR are the most efficient controllers of excitation-contraction coupling with the 
cardiomyocyte. The β1AR and β2AR sub-types predominantly bind to Gs although under some 
circumstances β2AR can bind Gi in a process known as stimulus trafficking or biased agonism. β3AR 
consistently binds Gi. Both β1AR and β2AR can stimulate increases in cardiac contractility (positive 
inotropy) and rate although the degree to which β2AR does this is controversial and is sub-maximal 
in comparison to β1AR (Motomura et al., 1990; Kaumann et al., 1998). It also appears to be species 
dependent with β2AR effectively controlling lusitropy and inotropy in larger mammals but an unclear 
role in rodents. β3AR is negatively inotropic decreasing cardiac contractility. These findings are rather 
contingent on the preparations, agonists and species of study (Kaumann and Sanders, 1993, 
MacDougall et al., 2012). These differences will be expanded upon in the next section. β1AR effects 
are largely subordinate to β2AR within the vasculature where the β2AR subtype predominates. Both 
cause vasodilatation predominantly by Gs-mediated-cAMP activation of PKA in vascular smooth 
muscle cells which alters the sensitivity of myosin light chain kinase by phosphorylation, preventing 
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the activation of Ca2+-Calmodulin. β2AR-cAMP-PKA activity removes Ca
2+ from the smooth muscle 
cell cytoplasm via increased activity of SERCA2A (by phosphorylating and deactivating the SERCA2A 
inhibitor phospholamban) reducing contractility. In some vessels such as the coronary arteries and 
the cerebral arteries β1AR predominates but the effect is a relaxant one identical to that of β2AR. In 
airway smooth muscle β2AR activation equally, causes dilation of the airways due to the activation of 
Ca2+-dependent K+ channels (MaxiK) (Miura et al., 1992). The MaxiK channel can activated directly by 
the Gαs subunit, this pathway is a significant non-cAMP mediated pathway for smooth muscle 
relaxation induced by βAR stimulation (Tanaka et al., 2003). 
1.3 THE STRUCTURE AND FUNCTION OF THE Β1AR AND Β2AR IN CARDIAC MYOCYTES 
1.3.1 COMPARISON OF THE STRUCTURES OF Β1AR AND Β2AR  
The βAR are possibly the most well studied GPCRs, the 2012 Nobel Prize for chemistry was awarded 
to Brian Kobilka and Robert Leftkowitz for work towards the elucidation of the crystal structure 
(amongst other studies) of βAR (Rasmussen et al., 2011). As previously stated these molecules are 
GPCRs and as such are defined by their seven cell membrane spanning alpha-helices. The genes 
coding for β1AR and β2AR are present on the human chromosomes 10(q24-26) and 5(q31-32) 
respectively, they do not contain introns (Granneman et al., 1993; Brodde et al., 1999). The 800 
GPCRs currently known to science are sub-divided into 6 classes on the basis of their sequence 
homology, the βAR are members of Class A the rhodopsin-like class (Ballesteros and Weinstein, 
1995). The structure of the β2AR was initially resolved by stabilization with an antibody fragment, 
and then a higher resolution structure was obtained by fusing the third intracellular loop with the 
T4-lysozyme (Rasmussen et al., 2007; Cherezov et al., 2007). There is 67% sequence homology 
between the β1AR and β2AR’s trans-membrane regions but the ligand binding regions seem to be 
quite similar. This therefore suggests that the basis of the two sub-types vastly different binding of 
agonists and functional differences must come from regions outside of the binding and membrane 
spanning regions. The extracellular loops 1-3 of β1AR and β2AR are very well conserved; however in 
GPCRs it is the cytoplasmic loops (CL) which are involved in signal specificity (Warne et al., 2008). CL2 
is deemed to be involved in the strength of the GPCRs interaction with G-proteins and CL3 with the 
specificity of binding (Wess et al., 1990; Scarselli et al., 2007). The CL2 region appears to be 
important for βAR function as they are highly conserved between β1AR and β2AR but not with 
rhodopsin (Warne et al., 2008). It is apparent that only two residues within 8Å of the ligand binding 
site are different between the β1AR (Val 1724.56 and Phe 3257.35) and β2AR (Thr 1644.56 and Tyr 
3087.35). The work group which elucidated the structure of the β1AR speculate that further slight 
differences in the EL3 region may change the charge in the vicinity of the binding site (Warne et al., 
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2008). Overall the differences between the avidity of β1AR and β2AR for different agonists may be 
the sum of very small differences within related structures.                  
Figure 1.2 The crystal structure of the Gs- bound β2AR showing the (green) 7 trans-membrane 
structure of the β2AR binding the (yellow) Gαs and the (blue) Gβγ subunits. Taken from Rasmussen et 
al. (2011) 
1.3.2 AGONIST ACTIVATION OF Β1AR AND Β2AR 
The natural agonists of both receptors, noradrenaline and adrenaline, are full agonists of both β1AR 
and β2AR, as is the synthetic agonist isoprenaline. Other synthetic agonists show partial agonism or 
indeed biased agonism at the receptors. Biased agonism is only apparent for adrenaline and 
isoprenaline at the β2AR at supraphysiological levels (Liu et al., 2009). Agonist potency differs 
between the receptors. Isoprenaline is the most potent at both whereas noradrenaline is ~20 fold 
more potent than adrenaline at the β1AR, the opposite is true for the β2AR with adrenaline being 
more ~2 fold more potent (Rang et al., 2007). However, an idealized activation process for these 
molecules can be described. Upon agonist binding a conformational shift within the receptor causes 
the dissociation of GDP from the Gα subunit which then binds GTP. This causes the dissociation of 
the Gα subunit from Gβγ, Gα then binds its target (Gβγ may bind a secondary target). Upon the binding 
of the target protein GTP is hydrolysed within the Gα which returns it to its basal conformation 
allowing it to re-associate with Gβγ and GPCRs. Simplistically, the GS protein is the G-protein involved 
primarily in βAR signalling and its target is adenylate cyclase, an enzyme which catalyses the 
synthesis of the secondary messenger cAMP from ATP. The secondary effects of the Gβγ are not 
integral to the signalling by this molecule for βAR. The Gβγ is more influential for β2AR-Gi signalling 
where the initial target is the reduction of adenyl cyclase activity by the Gαi but Gβγ can modulate 
molecules involved in the control of cellular homeostasis. These pathways are expanded below. 
30 
 
1.3.3 CONTROL OF CARDIAC-EXCITATION-CONTRACTION COUPLING BY Β1AR 
The β1AR binds solely to Gs to exert its effect via the stimulation of cardiomyocyte populations of 
protein kinase A (PKA). This activation causes phosphorylation of downstream effectors which 
control the cardiomyocyte EC-pathway thus increasing contractile force and increasing the speed of 
relaxation. The effect of the βAR on heart rate will be excluded in this discussion as these effects are 
due to the actions of βAR in a relatively specialized subset of cardiomyocytes. β1AR-PKA activity can 
cause the 1) phosphorylation of L-Type Ca2+ channel, which increases its open probability increasing 
the influx of Ca2+ upon depolarization and contributing to the increase of contractile force. 2) 
Phosphorylation of the SERCA2A inhibitor phospholamban, this increases the rate of uptake of Ca2+ 
into SR stores enhancing the efficiency of contraction (positive lusitropy). 3) It phosphorylates the 
myofilament proteins especially troponin I decreasing its calcium sensitivity and enhancing lusitropy 
as dissociation occurs more rapidly. 4) Phospholemman inhibition of the Na+/K+ exchanger is 
removed to enhance responsiveness to depolarization. 5) Phosphorylation of RyR to increase 
calcium sensitivity and in consequence increase the amplitude of calcium-induced calcium release 
(CICR). 6) Phosphorylation of myosin binding protein C by PKA increases contractility. These six 
effects account for the majority of β1AR’s role in EC-coupling. But β1AR signalling also activates 
glycogen phosphorylase kinase enhancing the amount of glucose available for metabolism, which 
will be necessary due to increased cardiac output (Xiao, 2001; Xiao and Lakatta, 1993).          
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Figure 1.3 Proposed roles of βAR sub-types in controlling cardiomyocyte excitation-contraction 
coupling showing the dual binding of β2AR to Gs and Gi proteins 
1.3.4 CONTROL OF CARDIAC-EXCITATION-CONTRACTION COUPLING BY Β2AR 
The stimulation of β2AR in cardiac preparations shows a sub-maximal effect in comparison to 
stimulation of β1AR. This was attributed to the lower expression level of β2AR within the heart. 
However, β2AR is shown to only increase the inward calcium response via L-Type Ca
2+ channels 
(Kuznetsov et al., 1995; Xiao and Lakatta, 1993). This is due to a restricted ability of this receptor 
with respect to phosphorylation targets (Borea et al., 1992; Kaumann et al., 1996; Kuschel et al., 
1999). This situation was shown to break down in heart failure whereby β2AR signalling began to 
become more like β1AR in that it caused the phosphorylation of phospholamban, troponin I and C 
(Kaumann et al., 1999). There is some indication that β2AR may mediate positively lusitropic effects 
(and therefore be able to cause PLB phosphorylation) in dogs (Altschuld et al., 1995) and man, and 
that restricted β2AR signalling is a feature of rodents, cats and sheep (Xiao, 2001, Lemoine and 
Kaumann, 1991; Borea et al., 1992).  A disinterested observer may conclude that this could be 
related to the preparation being studied. Highly novel studies upon single rat cardiomyocytes with 
the β2AR selective agonist zinterol show no effect of β2AR-cAMP response on any element of the EC-
Coupling machinery (MacDougall et al., 2012). Modern real-time imaging of cAMP responses within 
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isolated cardiomyocytes has dispelled notions that the positively inotropic effects of β2AR were via a 
non-cAMP mediated mechanism. In both animal and human cardiomyocytes β2AR has demonstrated 
the ability to bind Gi (Xiao et al., 1999; Kilts et al., 2000). The result of this may be theorized to be 
antagonistic to increases in contractility mediated by the Gs- mediated activities of the βAR. Muscle 
strips from mice transgenically overexpressing the human β2AR show a bell-shaped dose response 
curve in response to adrenaline (but not noradrenaline). Adrenaline appears to be able to dose-
dependently increase the inotropy through a β2AR-Gs mechanism. Apparently β2AR-Gi signalling 
begins to occur at higher levels of adrenaline and this is able to actively inhibit positive inotropy 
mediated by β2AR, reducing contraction to baseline levels (Heubach et al., 2003). These data suggest 
that although coupled to Gs at physiological levels of adrenaline stimulation β2AR can switch to 
coupling Gi, there is a suggestion that high levels of adrenaline stimulation may be required for this 
process to occur. In experiments where two separate parts of a cardiomyocyte were patched (to 
measure L-Type Ca2+ current) with β1AR or β2AR stimulation provided in one pipette, modulation of 
L-Type channels was only observed in one pipette for β2AR but both for β1AR. It seems that only 
β1AR can cause far reaching effects whereas β2AR effects are very localized (Chen-Izu et al., 2000). 
These data corroborated data from frog cardiomyocytes which only express the β2AR (Skeberdis et 
al., 1997) and novel FRET based methods (Nikolaev et al., 2006; Nikolaev et al., 2010).    
1.3.5 THE DIFFERENTIAL PATHOLOGICAL ROLES OF Β 1AR AND Β2AR 
The differences in the pathological characteristics of the two receptor sub-types are attributed to 
the ability of the β2AR to bind Gi it is subsequently able to control a novel set of cell signalling 
molecules. This suggestion was initially put forward by Communal et al. (1999) who demonstrated 
that providing cardiomyocytes with either β1AR or β2AR stimulation resulted in β1AR inducing 
apoptosis whereas β2AR went some way toward preventing it. Ablating the Gi effects by treating the 
cells with pertussis toxin potentiated the number of apoptotic cells. It would appear on this basis 
that β1AR has a cardio-toxic and β2AR has a cardio-protective character. This suggested a mechanism 
for the observation that prolonged βAR signalling promotes apoptosis (Shizakuda and Buttrick, 
2003). Gi stimulation can control apoptosis by activation of phospho-inositide 3 kinase (PI3K) as well 
as mitogen activating pathways (MAPK) promoting cell survival (Xiao, 2001; Chelsey et al., 2000; Zhu 
et al., 2003). The β1AR sub-type also appears to promote cardiomyocyte hypertrophy and calcium 
handling defects resulting in arrhythmia (Schafer et al., 2000; Morisco et al., 2001). The hypertrophic 
signalling of β1AR is due to the activation of CAMKII which is stimulated by the direct effect of Gs (Zhu 
et al., 2003). cAMP from β1AR stimulation may also activate Epac1 and Epac2. These molecules form 
a cAMP response system external to that mediated by PKA. Epac activation by specific agonist 8-CPT 
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is demonstrated to be pro-hypertrophic (Metrich et al., 2008; Pereira et al., 2013). This is suggested 
to be due to the activation of NFAT/calcineurin signalling. A more sinister effect of Epac2 signalling is 
its ability to induce Ca2+ leak from intracellular calcium stores, causing calcium sparks. These events 
have been identified as a source of arrhythmia which is mediated in part by CAMKII, showing an 
element of feedback in this system (Wu et al., 2002; Hothi et al., 2008; Pereira et al., 2013). 
Hypertrophy itself causes an increased risk of arrhythmia due to pathological rearrangement of 
cardiomyocytes; as a consequence these mechanisms increase the risk of arrhythmic death upon 
adrenergic stimulation and in situations of chronic heart failure where SNS activity is enhanced at 
baseline. 
1.3.6 THE ROLE OF THE SARCOMERIC MICRO-DOMAIN IN EC-COUPLING  
The adult cardiomyocyte is a giant bi-nucleated cell; the size of the cells dictates that the conduction 
of action potential and its linkage to the EC-coupling machinery cannot rely upon passive diffusion 
alone. Consequently, a regular repeating network of transverse (t-tubules) and axial tubules (TAT-
system) is present (Linder, 1956; Sperelakis and Rubio, 1971). These 100-300nm diameter 
invaginations of the cell penetrate the interior of the cardiomyocyte to a depth of many microns 
(Franzini-Armstrong, Landmesser and Pilar, 1975). They are essential to the rapid conduction of the 
wave of depolarization into the interior of the cardiomyocyte. The initial stage of cellular contraction 
is the inward current of calcium into the cardiomyocyte via the L-Type Ca2+ channels. This induces 
the CICR via RyR; efficient production of CICR is therefore contingent upon an effective coupling of L-
Type Ca2+ channels and RyR. T-Tubular invaginations provide a structure for the ‘dyad’ couplons 
between L-Type Ca2+ channels and RyR (which are present in the SR distant from the terminating 
plasma membrane). These dyads are only 12nm in diameter (Franzini-Armstrong, Protasi and 
Ramesh, 1999). The concept of the t-tubule as a signalling nexus is supported by the discovery that 
as well as forming dyads, t-tubules are also the site of many ion channels. LTCCs are targeted to 
dyadic membranes, dyads exclude Na+/Ca2+ exchanger and voltage gated Na+ channels, these are 
still located largely within the t-tubule but outside the dyad and separate from each other (Scriven, 
Dan and Moore, 2000). Potassium channels show decreasing amounts of localization within the t-
tubule in the order outward rectifier, slow inward rectifier and late inward rectifier respectively. 
These molecules are however present in the z-groove, which is the element of the repeating 
depressions in the cells surface which contains the t-tubules. Fewer channels appear to be present 
on the crest (outer-part of cell sarcolemma, outside of the t-tubule) (Gu et al., 2002).               
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1.3.7 THE LOCALIZATION OF Β2AR TO THE T-TUBULES 
As modulators of EC-coupling it may be hypothesized that the βAR would be localized to the t-
tubules as this would allow efficient control of the CICR gain at initiation. According to a study using 
immunolabelling and confocal microscopy, adenylate cyclase and Gs appear localized to the t-tubules 
(Laflamme et al., 1999). A combination of scanning ion conductance microscopy (SICM) and FRET 
demonstrated that β1AR was present on both cell crests and in t-tubules as stimulation produced 
cAMP transients in both areas. β2AR produced cAMP only when stimulated in t-tubules (Nikolaev et 
al., 2010). SICM allows regions of cell membranes to be imaged at sub-optical resolutions and the 
highly localized application of agonist. When combined with FRET, which in this case allowed real-
time measurement of cAMP, SICM/FRET gave an indication of the relative localization of cAMP 
following receptor stimulation in defined regions of the cellular membrane. This suggests that β2AR 
was functionally localized to the t-tubule and this may explain the strict control of L-Type Ca2+ 
channels, but not other phosphorylation targets, as the L-Type Ca2+ channel is strictly localized to the 
t-tubule as well (Gorelik et al., 2002). The β2AR-cAMP signal is shown to be localized, rather than 
propagating like the β1AR, which supports earlier findings and the basis of its limited effects on 
contractility and relaxation (Chen-Izu et al., 2000; Nikolaev et al., 2006; Nikolaev et al., 2010). It may 
be that a propagating/ diffusible cAMP signal and localization through cellular micro-domains is 
required for the phosphorylation of many targets. The increased phosphorylation activity upon 
stimulation of β2AR in failing cells (Kaumann et al., 1999) may be explained as the t-tubule system is 
reorganised and becomes less well defined in heart failure (Gorelik et al., 2006). In this way heart 
failure is shown to alter β2AR-cAMP compartmentation (Nikolaev et al., 2010). Interestingly, it 
appears that the ability of β2AR to bind-Gi is not the basis of these phenomena as PTX treatment 
does not affect compartmentation in healthy cells. The control of β2AR-cAMP localization appears to 
be sensitive to the removal of cellular cholesterol or the disruption of PKA binding to micro-domain 
scaffolds known as A-Kinase anchoring proteins (AKAPs) (Nikolaev et al., 2010). In this way it appears 
that t-tubular localization controls the responses of β2AR by allowing a PKA mediated buffering of 
β2AR-cAMP.  
1.4 CAMP COMPARTMENTATION  
The concept of cAMP compartmentation was proposed by the pioneering work of Buxton and 
Brunton (Hayes et al., 1979; Buxton and Brunton, 1983).  It was suggested to explain the finding that 
although both isoprenaline and prostacyclin increase cellular cAMP levels through a Gs-dependent 
mechanism only isoprenaline can enhance cardiac muscle contractility. The non-specific adenylate 
cyclase agonist forskolin was able to induce considerably more cAMP production than isoprenaline 
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but this produced increases in contractility which were less than those generated by isoprenaline. 
This was a paradigm shift as it moved the basis of the specificity of hormone signalling from one 
based upon the intrinsic properties of receptors, to one involving cell structure. This effect has been 
shown to be due to the influence of isoprenaline (via βAR) being specifically on pools of the 
membrane linked PKA-regulatory domain II (PKA-RII), as opposed to prostacyclin which stimulates 
the cytosolic PKA –RI domains (DiBenedetto et al., 2008). This micro-domain theory has been well 
explored and the importance of phosphodiesterases in rapidly removing cAMP and AKAPs in 
structuring the correct PKA domain extensively described (Fischmeister et al., 2006). The enhanced 
control of the β2AR by both intra-molecular properties and external factors adds an extra layer of 
complexity to the situation. 
1.4.1 THE ROLE OF PHOSPHODIESTERASES IN SHAPING CARDIOMYOCYTE CAMP 
COMPARTMENTATION 
Cyclic adenosine monophosphate (cAMP) is a small diffusible molecule; unrestricted cAMP could 
diffuse at 700μm/s through idealized cytoplasm, meaning that in a fraction of a second cAMP from a 
single area of the cell could permeate the entire cell. The signalling would therefore have no 
specificity (Heijman et al., 2011; Oliveira et al., 2010). The removal and therefore control of cAMP 
within the region, where cAMP signalling is required, is a major facet of cAMP compartmentation. 
There are 11 phosphodiesterase families, which are the product of 21 genes; these are divided into 
sub-types which are produced by alternately splicing mRNA. The effect of these enzymes is to 
hydrolyse cAMP or cGMP into 5’-ATP or 5’-GTP, causing the extinction of their signalling function. 
PDE’s are either dual or single specificity and their functions are summarized in Table 2.      
cAMP/cGMP dual- specificity PDE1, PDE2, PDE3, PDE10, and PDE11 
cAMP only PDE4, PDE7, and PDE8 
cGMP only PDE5, PDE6, and PDE9 
Table 2. The Specificities of PDE families 
Of the 11 PDE families only 6, 10 and 11 are not expressed in the heart (Francis, Blount and Corbin 
2011). PDE2 does not appear to be responsible for more than 1% of the cAMP hydrolysis activity 
neonatal rat cardiomyocytes although its inhibition greatly enhances physiologic activity of the βAR 
(Mongillo et al., 2006). PDE2, 3 and 4 appear to be the PDE families most intimately involved with 
cardiac cAMP compartmentation. There are species differences in the functional role of the different 
PDE families, PDE4 provides 60% of cAMP hydrolysis in mouse and seems to have more of a role in 
rat (Georget et al., 2003; Xiang et al., 2005; Leroy et al. 2008). However in human cardiac tissue 
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PDE3 appears to be an equally important component (Hambleton et al., 2005; Richter et al., 2011; 
Movesian et al., 1991). PDE3 and 4 are reported to control 90% of cAMP hydrolysis capacity in 
neonatal rat cardiomyocytes (Mongillo et al., 2004). Equally, in other publications this is described to 
be subtype specific for the control of βAR with PDE4 alone controlling β1AR activity in the rat and 
β2AR being controlled by PDE2<PDE3<PDE4 in ascending order of contribution. This is suggested to 
be a mechanism underlying the tighter regulation of β2AR observed previously (Nikolaev et al., 
2006). Understanding of the role of PDE families’ control of cAMP compartmentation has been 
greatly enhanced by novel FRET techniques as demonstrated in Nikolaev et al. (2006) and by 
Stangherlin et al. (2011).   
1.4.1.1 PDE2 FAMILY 
Although apparently a minor component of cardiomyocyte cAMP hydrolysis capacity, PDE2 is an 
important cellular cAMP regulator. It is intimately involved with regulation/termination of L-Type 
Ca2+ channel phosphorylation (Vandecasteele et al., 2001). PDE2 are membrane localized molecules 
found in plasma membrane, SR and Golgi fractions (Lugnier, 2006). PDE2 can hydrolyse cGMP and 
cAMP catalysis at equal rates but binding of cGMP to the PDE2 GAF domain increases the rate of 
hydrolysis of cAMP 6 times (Martins, Mumby and Beavo, 1982). This means that production of cAMP 
after βAR stimulation for example can be blunted by cGMP pathways (Mongillo et al., 2006). Indeed 
production of cGMP after stimulation of cells with NO donors produces exactly this effect when 
measured by a highly novel FRET based technique (Stangherlin et al., 2011). As β3AR is proposed to 
have the ability to induce NO production, the PDE2 provides a possible integration or fail-safe in βAR 
signalling. Through PDE2, β3AR may exert an influence upon β1AR and β2AR, constraining their 
signalling (Stangherlin et al., 2011). 
 1.4.1.2 PDE3 FAMILY 
PDE3 has the same affinity for cGMP and cAMP but hydrolyzes cGMP at a slower rate; as a 
consequence increases in cGMP enhance cAMP responses (Luginer, 2006; Maurice, 2005). PDE3 
seems to largely be present in the soluble fraction where it may associate with PKA-RI (Weishaar, 
Kobylarz –Singer and Kaplan, 1983); giving rise to a spatially irregular localization (Mongillo et al., 
2004). PDE3 appears to fufill an opposing role to PDE2. Tissue specific alterations in their expression 
levels will alter the effect of cGMP pathways on the control of signalling by receptors such as the 
βAR. In human tissue inhibition of PDE3 raises the level of PLB phosphorylation without βAR 
stimulation, suggesting PDE3 is constitutively active and dampens PKA mediated PLB 
phosphorylation in the course of normal physiology in man. However, the same treatment has no 
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effect in rat and guinea pig (Weishaar, Kobylarz –Singer and Kaplan, 1983). PDE3 appears to have 
phosphorylation site for both PKA and PKB, meaning that its activity can be modulated as it is 
required in a feedback mechanism (Perino et al., 2011).  
1.4.1.3 PDE4 FAMILY 
Perhaps due to the importance of this family for cAMP control within common laboratory animal 
models, more is known about the PDE4 family and its sub-types. Much of this fundamental 
investigation has been performed in the HEK293 cell line, suggesting the importance of PDE4 in this 
cell type, but investigations may not accurately reflect the scenario in the cardiomyocyte. It appears 
that different PDE4 subtypes have different cellular localizations and tissue distributions. PDE4A5 
and PDE4D4 seem to be targeted to the plasma membranes possibly as a result of Lyn/Fyn Src 
homology domains at their N-termini (Beard et al., 1999; Beard et al., 2002; O’Connell et al., 1996; 
McPhee et al., 1999). Lyn kinase anchoring domains appear to be involved in targeting peptides to 
caveolar membranes which will be expanded upon later. PDE4D appears to recruit PKA and PDE4A 
recruits β-arrestins. The PDE4B and PDE4D subtypes appear to be spatially localized within neonatal 
cardiomyocytes giving rise to a striated fluorescence (Mongillo et al., 2004).   Removal of PDE4 
activity enhances the phosphorylation of PLB, L-Type Ca2+ channels and RyR demonstrating its 
importance in the control of βAR signalling (Leroy et al., 2008; Verde et al., 1999; Lehnart et al., 
2005). Lehnart et al. (2005) implicate the PDE4 as being intrinsic to preventing PKA mediated 
phosphorylation of β2AR and its subsequent stimulus trafficking to bind the Gi protein. 
Catecholamine overstimulation especially via β1AR is implicated in causing myocardial damage or 
exacerbating it due to the SNS over-activation observed in in vivo models of failure. Any ablation of 
the PDE4 seems to exacerbate heart failure, demonstrating the PDE4’s integral role in protecting 
cellular homeostasis. In animal models PDE4D3 knock-out mice have hypertrophy consistent with 
βAR overstimulation and heart failure. They display hyperphosphorylation of RyR which is ‘leaky’ and 
increases the prevalence of arrhythmia and sudden death in these mice (Lehnart et al., 2005; Richter 
et al., 2008). A complex series of events controls the PDE4 mediated control of β1AR and β2AR. β1AR 
is in a preformed complex with PDE4D8. Agonist binding causes dissociation of PDE4D8 from the 
β1AR leading to enhanced cAMP signalling. However, β2AR does not seem to be complexed with a 
PDE4D without stimulation. Upon agonist binding PDE4D5 is recruited together with an arrestin 
causing rapid extinction of cAMP in the domain and desensitization of the receptor (Richter et al., 
2008). Using a more advanced FRET technique DeArcangelis et al. (2009) demonstrated that to a 
very small extent PDE4D8 and PDE4D9 associate with β2AR when it is inactive. Upon activation 
PDE4D5 and PDE4D8 avidly associate with β2AR in an arrestin dependent mechanism. This 
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demonstrates that the β2AR is intrinsically very well controlled by PDE4D. More intriguingly an 
arrestin dependent mechanism seems to exist that switches PDE4D8 binding from β1AR to β2AR 
when they are activated together. This mechanism should allow β1AR to prevent the activation of 
β2AR, possibly preventing its PKA mediated phosphorylation and binding to Gi, allowing β1AR 
signalling to dominate. 
 
Figure 1.4 Roles of phosphodiesterase sub-types in the control of βAR by cAMP compartmentation. 
Phosphodiesterase 4 subtypes are shown to variably associate with βAR subtypes when unbound. 
Upon agonist binding there are βAR sub-type dependent variations in PDE recruitment and binding. 
1.4.2 THE ROLE OF AKAP IN CONTROLLING ΒAR SIGNALLING AND PDE ACTIVITY IN THE 
CARDIOVASCULAR SYSTEM               
The A-Kinase anchoring proteins (AKAPs) are a family of structurally unrelated proteins unified by 
their ability to bind PKA and anchor it to specific regions of the cell (Lohmann, Walter and DeCamilli, 
1986). They dock PKAs via the R- Regulatory subunit which binds via a hydrophobic ridge and a 
conserved α-helix present on the AKAP (Newlon et al., 1999; Kinderman et al., 2006). PKA-RI and 
PKA-RII are localized in different parts of the cell and AKAPs can localize PKA to multiple specific 
regions (Herberg et al., 2000; DiBennedetto et al., 2008). AKAP stabilizes interactions with all 
39 
 
elements of the EC-coupling pathway that PKA (and βAR) controls (Jarnaess and Tasken, 2007). 
AKAP7 stabilizes PKA in domains with L-Type Ca2+ channels (Fraser et al., 1998). Yotiao also known as 
AKAP9 controls the PKA mediated control of slow delayed rectified K+ channel (Marx et al, 2002). 
The muscle selective mAKAP (aka AKAP6) tethers PKA to RyR (Marx et al., 2000). AKAP7 tethers PKA 
to PLB and consequently regulates SR calcium uptake, knockdown significantly slows the speed of 
reuptake (Lygren et al., 2007). There is some evidence that AKAPs also function as a scaffold for 
PDE4 function. PDE4D3 which regulates IKs and consequently action potential duration binds Yotiao 
and mAKAP, the suggestion is that this regulation is due to proximity produced by AKAP binding 
(Marx et al., 2002). PDE4D3 is also part of the assembly including RyR, PKA and mAKAP and that this 
allows successful control of Ca2+ (Marx et al., 2000). PDE4B and PDE4D associate with L-Type Ca2+ 
channels in an assembly with AKAP7 (Lehnart et al., 2005; Lygren et al., 2008). 
1.4.3 THE ROLE OF CAVEOLAR COMPARTMENTATION IN THE CONTROL OF Β1AR AND 
Β2AR        
Caveolae are specialized lipid rafts which are enriched in cholesterol and structural proteins; these 
are of two types’, cavins and caveolins (Parton and Simons, 2007). Caveolins are the most well 
studied and are 18-22kDa membrane proteins which serve to induce a curvature of the membrane 
and the flask shape of the caveolae. Caveolae are implicated in endocytosis, transcytosis and as 
being signalosomes (Kurzchalia & Parton, 1999; Lisanti et al., 1995; Harvey and Calaghan, 2012). 
There are three caveolins, Cav-1, 2 and 3. Cav1 and 2 are expressed widely amongst all tissues 
whereas Cav3 is a muscle specific molecule (Parton and Way, 1995). Cav3 is the most crucial for the 
function of cardiomyocyte caveolae. It has been shown to be present in cell crests and within t-
tubular domains (Wong et al., 2013), although initial structural studies demonstrated that true 
caveolae did not appear to be present in the domains of t-tubules directly opposing junctional SR 
(Levin et al., 1980). However, Cav3 itself is present throughout the t-tubular membrane and is an 
arbiter of EC coupling supporting t-tubular interactions with RyR (Scriven et al., 2005; Calaghan and 
White, 2006). More recent super-resolution microscopy studies have suggested these points are not 
mutually exclusive as a coat of Cav3 is present upon the t-tubular membrane but caveolae shaped 
domains are not present in t-tubules except for at the openings facing the extra-cellular medium 
(Wong et al., 2013).  Caveolae appear to concentrate G-proteins and members of G-protein 
signalling pathways (Head et al., 2005). The degree to which they do this appears to be controversial. 
Studies have reported a role for caveolae in controlling the α1AR; and their role in the control of 
caveolar K+ channels and cellular hypertrophy (Morris et al., 2006; Alday et al., 2010 and Fujita et al., 
2001). The β1AR is shown to be present in both caveolar and non-caveolar membrane fractions 
(Head et al., 2005). However, all components of β2AR signaling (β2AR, Gαs, Gαi, AC5/6, L-Type Ca
2+ 
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channels and PKA-RII) are reported present in caveolae (Balijepalli et al., 2006) but another study by 
Head et al. (2005) reports Gαi to immuno-precipitate with an extra-caveolar fraction. Only 
muscarinic, prostanoid receptors and AC4/7 are consistently reported as being absent from caveolar 
fractions (Head et al., 2005; Agarwal et al., 2011). It is important to note that some Cav3 is present 
outside the detergent insoluble, buoyant membrane fractions in cardiomyocytes which may perform 
further cellular functions (Head et al., 2005). This population of Cav3 is denoted as extra-caveolar 
Cav3.  
1.4.3.1 ROLE OF CAVEOLAE AND CAV3 IN THE MODULATION OF Β1AR FUNCTION 
The far reaching effects of β1AR signalling are posited to be as a result of its less heavily regulated 
signalling by localization and phosphodiesterases. It would seem that lack of caveolar localization 
may contribute to this, but a subset of β1ARs resides within this domain (Head et al., 2005). The 
effect of cholesterol depletion by MβCD (and caveolar disruption) upon β1AR’s interaction with ICa 
was assessed in comparison to prostaglandin 2 and 4 receptor signalling (EP2/4) by Agarwal et al. 
(2011). Maximal β1AR stimulation appeared unaffected by caveolar disruption which was not 
unexpected due to the β1AR’s distribution. However, at sub-maximal stimulation cholesterol 
depletion potentiated the β1AR’s effects apparently due to the increased influence of cAMP upon 
PKA compartments. This suggested that caveolae function as a desensitizer of this system rather 
than true compartmentation. EP2/4 signalling was not affected by cholesterol depletion. Importantly 
the presence of cAMP signalling was detected in cytosolic regions by a non-localized FRET sensor 
(defined in the paper as the EPAC2 sensor) for both receptor systems (unaffected by cholesterol 
depletion).                       
1.4.3.2 ROLE OF CAVEOLAE AND CAV3 IN THE MODULATION OF Β2AR FUNCTION 
The compartmentation of β2AR function by caveolar domains has been studied frequently due to the 
strict localization of this receptor system (Head et al., 2005; Balijepalli et al, 2006). However, much 
of this work has been performed in rodent neonatal cardiomyocytes which presents some problems 
when extrapolating findings to adult human cardiomyocyte physiology (Rybin et al., 2003). The 
signalling of β2AR causes greater phosphorylation of downstream effectors in neonatal 
cardiomyocytes so the compartmentation of β2AR may be hypothesised to be more stringent in 
adult rodent cardiomyocytes. Two studies showed that the stringent localization of β2AR in caveolae 
resulted in an inability to control the phosphorylation of PLB. Removal of cholesterol resulted in 
β2AR-mediated phosphorylation of PLB, β2AR did not affect L-Type Ca
2+ channel signalling even after 
cholesterol depletion (Calaghan and White, 2006; MacDougall et al., 2012). The depletion of cellular 
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cholesterol increased the inotropic response of the adult cardiomyocytes due to the enhance uptake 
of Ca2+ into the cell SR. The former study (Calaghan and White, 2006) used a combination of 
salbutamol and atenelol whereas the more recent study utilized zinterol and CGP20712A 
(MacDougall et al., 2012). It may be suggested that the latter combination may be providing a more 
selective stimulation of β2AR with less off target stimulation of β1AR. TnI is observed to be 
phosphorylated when stimulating with salbutamol but not zinterol (when cholesterol is depleted). 
However, zinterol is a partial agonist so even at the dose used (10μM) stimulation of β2AR may not 
be maximal. The increased β2AR response in both cases can be attributed to a globalization of cAMP 
response with an increased influence of cAMP on PKA compartments (Calaghan, Kozera and White, 
2008; MacDougall et al., 2012). MβCD causes the relocalization of β2AR-cAMP activity from a t-
tubule specific domain to being present throughout the cell membrane and to propagate from the 
site of sub-cellular β2AR stimulation (Nikolaev et al., 2010). The caveolar control of adult 
cardiomyocytes β2AR-cAMP by modulating the cellular Ca
2+ re-uptake is in contrast to the situation 
in neonatal cardiomyocytes where localization of L-Type Ca2+ channels seems to be a pre-requisite 
for β2AR mediated control although this study removed the effect of Gi so may not represent the 
physiological scenario (Balijepalli et al., 2006). The ability of caveolae to control the function of β2AR 
is attributed to multifarious mechanisms.           
1.4.3.3 SUGGESTED CAVEOLAR MECHANISMS FOR MODULATING Β2AR FUNCTION 
The effect of Cav3 itself has been deemed to be inhibitory for molecules it binds to, it was suggested 
by Sargiacomo (1995) to be the regulator of macromolecular complexes. Cav3 has been shown to 
inhibit the function of PKA (Razani, Rubin and Lisanti, 1999), AC, and G proteins (Li et al., 1995). 
Pontier et al. (2008) point to β2AR association with extra-caveolar pools of AC5/6 or Gαs when 
cholesterol is depleted as being the basis of increased activity. There is equally a suggestion that 
caveolar domains allow the effective recruitment of PDE 3 and 4 which provides stringent extinction 
of evoked cAMP responses after β2AR stimulation (Soto et al., 2009; Rochais et al., 2006). In a similar 
mechanism the PKA buffering proposed by Nikolaev et al. (2010) may provide a union of these two 
processes as cAMP (and β2AR) cannot escape the micro-domain and stimulate distant pools of AC to 
produce far reaching cAMP responses and PKA activation. Subsequently cAMP is more effectively 
hydrolysed by PDE. Protein phosphatases (PP) which rapidly remove the phosphorylation of targets 
phosphorylated by PKA are implicated as these are targeted to caveolae (Kuschel et al., 1999; Chen-
Izu et al., 2000; MacDougall et al., 2012). These enzymes could rely on the macromolecular 
assemblies based on caveolae to have their effects; this PP activity was shown to be specifically 
caveolae dependent whereas phosphodiesterase activity was not by MacDougall et al. (2012). The 
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β2AR receptor is rapidly desensitized and internalized upon stimulation; β-adrenergic receptor kinase 
also known as G-protein receptor kinases (βARK/GRK) peptides, are involved in this process (Ostrom 
et al., 2001; Soto et al., 2009). Caveolar compartmentation is speculated to be required in these 
processes and interference with this may lead to increased activation of β2AR. However, GRK is 
shown in one study to be present outside of the caveolae domains (Rybin et al., 2000). High-
resolution real-time Förster Resonance Energy Transfer (FRET) based data has supported this 
suggestion (Soto et al., 2009; Violin et al., 2008).The internalization and phosphorylation of β2AR by 
GRK2 and PKA are essential steps for the stimulus trafficking of this molecule to binding Gi. Caveolar 
localization is suggested to be essential for Gi binding and subsequently the control of β2AR function 
(Rybin 2003; Xiao et al., 1999; Kuschel et al., 1999). It is however noteworthy that Gi has been 
reported to be localized mainly to extra-caveolar fractions (Head et al., 2005). PTX pre-treatment 
equally appears to have no effect on the sub-cellular localization of β2AR-cAMP and its localization to 
t-tubules (Nikolaev et al., 2010). This is also the case for PDE4 inhibition which merely serves to 
amplify the t-tubular β2AR-cAMP response. Consequently, the authors attribute cAMP localization to 
be due to interplay of physical localization of the β2AR to t-tubules and a localization of the β2AR-
cAMP response by ‘PKA-RII buffering’.       
 
 
Figure 1.5 Schematic of the role of caveolae in cellular physiology as signalsomes, including 
scaffolding by Cav3 and cholesterol. 
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1.4.4 THE BIASED AGONISM AND ‘STIMULUS TRAFFICKING’ OF Β2AR  
The historic theory of GPCR action was that specific agonists would bind one type of receptor, 
activating one type of G-protein and initiating a well defined cascade of effector activity causing a 
specific physiological outcome. In recent decades this hypothesised ‘linear’ efficacy has been shown 
to be untrue for many GPCRs (Reiter et al., 2012). It appears that agonist signalling via GPCRs is 
‘biased’ toward particular multiple G-protein or β-arrestin based signalling pathways. This pluri-
dimensional efficacy takes place as a particular agonist may preferentially fully activate one or 
multiple signalling pathways via the same receptor. Using the β2AR as an example this property can 
be demonstrated by multiple agonists. Noradrenaline is a full agonist but can only fully activate the 
β2AR-Gs signalling pathway (Heubach et al., 2003; Wang et al., 2008). Clenbuterol, equally, is a full 
agonist of the β2AR but solely activates the β2AR-Gi pathway (Siedlecka et al., 2008). True biased 
agonist properties have been demonstrated by adrenaline and isoprenaline which are full agonists of 
both Gs and Gi pathways via the β2AR (Heubach et al., 2003; Wang et al., 2008; Liu et al., 2009). Two 
overlapping mechanisms exist to produce biased agonism through receptors. One is based directly 
upon the conformational shift induced by the agonist binding to the receptor. The shift induced 
determines which downstream effector can be bound, by allowing the presentation of a binding 
domain. More commonly an induced version of biased agonism, ligand-induced biased agonism, is 
observed. This is a modified form of direct biased agonism whereby both conformational shift and 
the ability to recruit secondary ligands defines the bias of an agonist (Kenakin, 2007).  For the β2AR 
this appears to rely upon the phosphorylation of the receptor by PKA (Dakka, Lutterell and 
Leftkowitz, 1997) or GRK2 (Liu et al., 2009) (GRK5 in human (Spirelli et al., 1995)). In this case the 
conformational shift in the receptor appears to have to be sufficient that activated pathways can 
alter the receptor and reveal further allosteric sites (Drake et al., 2008). These phosphorylations are 
essential for adrenaline’s biased agonism, whereas after noradrenaline binding, which does not 
cause Gi signalling, these phosphorylations are not present (Wang et al., 2008). PKA mediated 
phosphorylation occurs for both noradrenaline and adrenaline at low agonist concentrations but 
GRK2 phosphorylation only occurs at higher concentrations of adrenaline. This means that biased 
agonism, as for classical theories of receptor pharmacology, follows the law of mass action and is 
dose dependent. It must be noted that much of this work was done in HEK293 or neonatal 
cardiomyocytes and thus the situation in adult cardiomyocytes may differ. Biased agonism allows 
subtle control of multiple pathways by single agonists and also provides a mechanism for prevention 
of overstimulation. The internalization of β2AR upon stimulation is equally important. Both β1AR and 
β2AR can be internalized by β-arrestin mediated processes, after phosphorylation by GRK2. 
Phosphorylated receptors can then be targeted to the endosome and degraded as a method of pure 
44 
 
receptor desensitization (Shenoy et al., 2008). β2AR however can be rapidly returned to the cell 
membrane (re-sensitization). It appears that the dual phosphorylation of the receptor by PKA and 
GRK is essential for rapid internalization and re-sensitization. GRK induces arrestin recruitment 
dependent upon a complex with AKAP79 and PKA (Baille et al., 2003; Xin et al., 2008). Liu et al. 
(2009) showed that adrenaline induces rapid internalization and re-sensitization whereas 
noradrenaline just induces internalization. This is postulated to be a further regulator of the β2AR’s 
Gi binding, as Gi is believed to be localized separately to β2AR within the cell (Head et al., 2005). The 
importance of this process has led to the term ‘stimulus trafficking’ becoming somewhat 
synonymous with biased agonism. Many of the elements of the cell machinery essential for the 
stimulus trafficking of β2AR are classical elements explored as agents of desensitization. It may be 
suggested that what is deemed as being desensitization of receptor pharmacology in many cases 
may in fact be a partial form of biased agonism. This allows the switching of receptor function from 
being positively inotropic to being negatively inotropic in the case of the β2AR.                      
1.4.4.1 THE DOWNSTREAM EFFECTORS OF Β2AR-G I SIGNALLING  
Compared to the somewhat limited signalling of β2AR-Gs, β2AR-Gi can exert an influence upon a wide 
variety of cell signalling systems. Antagonism of cAMP signalling and the function of the Gαs subunit 
appear to be a relatively small component of its effects although the activity of Gi recruits PDE4 to 
the β2AR complex causing a reduction in β2AR-Gs signalling. β2AR-Gi   and NCX appeared to interact  
within cardiomyocytes where NCX was selectively over expressed, β2AR-Gi appeared to be 
responsible for some of NCX’s negatively inotropic effects (Sato et al., 2004). Koch et al. (1993) 
demonstrated that the βγ subunit of Gi activates downstream effectors specifically MAPKs. The 
pathway of β2AR-Gi cellular effects suggested by Daaka, Lutterell and Leftkowitz is the stimulation of 
MAPK via the Src/Ras pathway (Daaka, Lutterell and Leftkowitz, 1997). Pertussis toxins efficacy in 
preventing the β2AR-Gi response via its restriction of Gi subunit dissociation shows the importance of 
this process. MAPK activity can actively oppose Gαs activation and inhibit PKA-mediated PKA 
phosphorylation of PLB (Crespo et al., 1995). MAPK can reduce cardiomyocyte contractility and may, 
as a result, provide a protective mechanism upon sympathetic overstimulation. MAPKs are stress 
activated proteins. A similar group of effectors known as extracellular regulated kinases (ERKs) are 
also observed to be cell survival signals (Johnson and Lapadat, 2002). Communal et al. (2000) 
demonstrated the importance of MAPK mechanism in protecting cardiomyocytes from 
noradrenaline-induced apoptosis. This is interesting in the light of work from the same group 
demonstrating the opposing effects of β1AR and β2AR on apoptosis and the ability of Gi mechanisms 
to ameliorate β1AR induced apoptosis. A β2AR-Gi-mediated anti-apoptotic mechanism is suggested to 
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be via ERK and AKT phosphorylation (Chesley et al., 2000; Shizukuda & Buttrick, 2002). The ability of 
β2AR to stimulus traffic to Gi may present a physiologically important mechanism to offset the 
toxicity of sustained β1AR signalling. The activation of p38 MAPK is shown to be negatively inotropic 
in adult cardiomyocytes, conversely inhibition of p38 MAPK with SB203580 causes a strong but 
reversible increase in cardiomyocyte inotropy (Liao et al., 2001).                                 
 1.4.4.2 THREE INTERRELATED META-MECHANISMS OF Β2AR CONTROL 
Structurally the β2AR can bind many regulatory factors, displays higher avidity for the biased agonist 
adrenaline and undergoes phosphorylation which causes rapid quenching of its cAMP production 
and stimulus trafficking to Gi. Extrinsically the β2AR is controlled at the molecular level via its rapid 
recruitment of phosphodiesterases but also by the receptor’s recruitment to caveolae and t-tubular 
domains. This plays a role in the spatial restriction of cAMP responses preventing the PKA mediated 
phosphorylation of targets outside of the β2AR domain. Overall this leaves the β2AR heavily 
controlled and localized within cells ready to counter-balance β1AR signalling at excessive levels of 
activation.    
1.5 THE TOXICITY OF ΒAR (Β1AR) SIGNALLING 
Although βAR stimulation exists as the most effective physiological means of acutely enhancing EC 
coupling within the heart, chronic stimulation and acute over-stimulation can cause damage to 
myocardial tissue. This toxicity is suggested by plasma noradrenaline levels ability to predict the 
relative severity of heart failure, where SNS is usually overactive, possibly as a short-term means of 
offsetting loss of cardiovascular function (Cohn et al. 1984; Packer, 1988). The toxic effect of SNS 
activity is ascribed to the βAR based on the inability of an α1AR blocker to block the pro-apoptotic 
effect of noradrenaline on adult rat cardiomyocytes (Communal et al., 1999). The same study 
demonstrated that this effect can be attributed solely to the β1AR, as described above the β1AR and 
β2AR have very distinct characters relating to apoptosis (Shizukuda and Buttrick, 2002). Although 
opposing inotropy, the β2AR-Gi cascade can be seen as a benign counterbalance to β1AR’s toxicity 
and is possibly cardio-protective in the same manner as β-blocker therapy via opposing SNS activity 
(Bristow, 2000; Domanski et al., 2003). The mechanisms of this toxicity will be explored below.  
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1.5.1 MYOFIBRILLAR DISORGANIZATION, CONTRACTION BAND NECROSIS AND FIBROSIS- 
THE PATHOLOGY OF CATECHOLAMINE INDUCED DAMAGE 
Chronic catecholamine stimulation of myocardial tissue reproducibly produces disorganization of the 
array of cardiomyocytes within the tissue. This has been shown repeatedly in animal models (and 
human disease) where catecholamines or interventions designed to elevate catecholamine levels (i.e 
cocaine) have been applied (Szakacs and Cannon, 1958; Van Vliet, Burchill and Titus, 1966; Fineschi 
et al., 2001). Indeed historically isoprenaline has been applied as an agent to induce ‘infarct-like’ 
damage in the myocardium (Rona et al., 1959). The same morphological abnormalities can be 
induced by overexpression of the β1AR in mice, as well as myocyte death and apoptosis the surviving 
cells show a hypertrophic phenotype (Engelhardt et al., 2004). Cells appear misshapen and fibrosis 
can be observed by staining muscle with Sirius red. Cell loss is notable and occurs in specific bands 
(contraction-band necrosis) and is attributed to mechanical overload due to catecholamine 
overstimulation (Karch and Billingham, 1986). Catecholamines can induce the deposition of C - 
reactive protein and fibrinogen (Zelinka et al., 2007). Overall the loss of contractile units due to 
acute apoptosis and loss of inotropic support (and incomplete repair by fibrosis) caused by 
catecholamine stimulation appears to spark a vicious circle. Cells hypertrophy to compensate for the 
loss of mechanical strength but themselves become overloaded and fail.  
1.5.2 APOPTOSIS INDUCED BY Β1AR STIMULATION 
Catecholamine-induced cardiomyocyte apoptosis was initially attributed to some facet of cAMP/PKA 
signalling. β1AR mediated apoptosis was blocked by the PKA inhibitor H89, and PKA activators 
forskolin and di-butyrl-cAMP-induced apoptosis (Shizukuda and Buttrick, 2002).  Another study 
demonstrated that this may not to be the case and β1AR induces cardiomyocyte apoptosis via the 
enzyme Ca2+/calmodulin-dependent kinase II (CaMKII) independently of PKA/cAMP (Zhu et al. 
2003). Inhibition of PKA by the inhibitor, PKI14-22, or an inactive cAMP analogue, Rp-8-CPT-cAMPS, 
did not prevent β1AR induced apoptosis but blockade of CaMKII did. CaMKII (predominantly CaMKIIσ 
in cardiac tissue) is a mediator of apoptosis for a variety of stimuli which is separate to mediators 
(such as caspases) following extrinsic stimuli (Zhu et al., 2007). CaMKII’s activities enhance the 
release of mitochondrial cytochrome C and other apoptotic signals and causes PKA-independent 
increases in cellular Ca2+ concentrations. This has the effect of pushing cellular physiology toward 
apoptosis. AIP inhibition of L-Type Ca2+ channels prevents activation of CaMKII and β1AR induced 
apoptosis (Zhu et al., 2003). It has been proposed that there are specialized β1AR-CaMKII-L-Type Ca
2+ 
channel (possibly caveolar) domains which may control this process (Best and Kamp, 2011). β1AR is 
suggested to activate CaMKII through direct Gαs interaction removing the requirement for PKA 
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activity. There appear to be both PKA dependent and independent mechanisms of apoptosis. As 
described the β2AR activity is anti-apoptotic but α1AR also seems to have an antiapoptotic effect on 
β1AR activity as it can regulate the expression of the β1-integrin which controls the anti-apoptotic 
ERK1/2 factor (Communal et al., 2003). A separate group drew the same conclusion and suggested 
that the hypertrophic signalling was as a result of ras-raf-MEK-ERK1/2 signalling which is anti-
apoptotic (Amin et al., 2002). A more recent study once again demonstrated a possible role for PKA 
using transgenic mice and a novel inhibitor of PKA (Zhang et al., 2013). The same study 
demonstrated that effectively inhibiting PKA activity prevented CaMKII activation showing a co-
dependence of these two pathways. Intriguingly, the hypertrophic Epac pathways which were also 
activated by β1AR-cAMP were allowed to exert an anti-apoptotic effect when PKI inhibited PKA 
suggesting this is a protective mechanism induced alongside β1AR-PKA signalling. Like α1AR, EPAC 
signalling is apparently both hypertrophic (Metrich et al., 2008) and anti-apoptotic.    
1.5.3 ABERRANT CALCIUM HANDLING INDUCED BY Β1AR STIMULATION 
β1AR extensively alters Ca
2+ handling within the cardiomyocyte. The EC-Coupling pathway is reliant 
on effective cycling of intracellular calcium stores. The effect of β1AR over-stimulation may be to 
gradually increase basal levels of Ca2+ both at diastole and systole; this is initiated by PKA stimulation 
(Zhang et al., 2013). The aberrant phosphorylation of RyR and L-Type Ca2+ channels could contribute 
to these phenomena although this is somewhat controversial (Marx et al., 2000; Eisner and Trafford, 
2002). Without effective synchronization of Ca2+-handling, myocytes will remain in a state of relative 
hyper-contracture or unpaired relaxation and consequently a loss of inotropy will result. β1AR may 
be able to induce a fetal gene program, this may result in a reduction of the expression of SERCA2a 
with a reduction in lusitropy  (Lowes et al., 2002; Abraham et al, 2002). This suggestion is 
corroborated by the finding that SERCA2A expression and mRNA is reduced in biopsies taken from 
patients with high levels of plasma catecholamines and animals overexpressing β1AR (Nef et al, 
2009; Engelhardt et al., 2004). As well as reduced SERCA2A levels the patients also showed a 
somewhat paradoxical reduction in the amount of PLB phosphorylation. The ratio of PLB to SERCA2A 
is increased and there is a large increase in the expression of sarcolipin (a peptide related to PLB and 
with an inhibitory effect on SERCA2A). The sum of these alterations must be a reduction in the re-
uptake of Ca2+ into the SR which prolongs systole and causes reduced cardiac output (Nef et al., 
2009). This may ultimately result in calcium leaking from regions of the cell where it is functionally 
localized (compartments) and cause the activation of signalling pathways in an aberrant fashion. Ca2+ 
is involved in apoptotic pathways with CaMKII and its effects on mitochondrial Ca2+ stores.  
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1.5.4 INDUCTION OF REACTIVE OXYGEN SPECIES 
 Reactive oxygen species are deemed to be important signalling molecules within cellular physiology 
(Finkel, 2000), but are also toxic to cardiac cells (Sawyer et al., 2002; Turner et al., 1998), ROS are 
also involved in hypertrophy and mediate apoptosis upon mechanical stretch (Siwik et al., 1999; 
Pimentel et al., 2001). Remondino et al. (2003) demonstrated that βAR stimulation involved the 
production of reactive oxygen species (ROS). A mechanism for the production of ROS is not clear, 
although there is some suggestion that PKA may activate the F1/F0-ATPase producing ROS via a 
mitochondrial dependent mechanism. In Remondino’s study mimetics of super-oxide dismutase 
(SOD) and catalase (EUK134 and MTMP), which remove ROS from the cell cytosol, reduced 
noradrenaline-stimulated apoptosis. The mitochondrial permeability transition pore was blocked by 
bongkrekic acid and reduced apoptosis. The authors implicated a ROS/JNK pathway as 
overexpression of the inhibitor of JNK increased cell survival. 
1.5.5 LIPOTOXICITY INDUCED BY CATECHOLAMINE STIMULATION 
Stimulation by isoprenaline, adrenaline and noradrenaline have been demonstrated to induce 
lipolysis in adipocytes (Arner et al., 1990) and toxic concentrations of isoprenaline have been shown 
to induce defects in myocardial lipid homeostasis (Jodalen, Lie and Rotevaten, 1982; Bruneval, Yunge 
and Hutter, 1985). This effect is shown to enhance the intracellular levels of toxic metabolites 
ceramide and DAG (Listenberger, Ory and Schaffer, 2001; Park et al., 2008) via a mechanism 
suggested to be PKA dependent by Shao et al. (2013, B). Equally, lipolysis, lipid incorporation and 
oxidation is enhanced by catecholamine infusion (Jocken and Black, 2008) and lipids are rapidly 
incorporated in the hearts of mice given a single dose of isoprenaline increasing the level of DAG 
relative to phosphatidylcholine (Shao et al., 2013, B). These alterations are suggested by the authors 
to depress the electric activity of cardiac tissue with consequences for inotropy. These effects were 
ameliorated by the overexpression of ApoB in a transgenic mouse model. This is a lipid transporter 
which appeared to rescue the cells by rapidly removing lipid deposits and the ApoB transgenic 
animals were not affected by the dose of isoprenaline. Overexpressing another type of fatty acid 
transporter, which disrupts the lipid balance in cardiomyocytes, caused a cardiomyopathy (Chiu et 
al., 2005). In a similar study where the peroxisome proliferator activated receptor (PPARγ) was 
overexpressed, the resulting cardiomyopathy did not affect DAG or ceramide levels. Instead a 
mechanism involving long chain fatty acid coenzyme A was implicated (Son et al., 2010). Further to 
that, overexpression of lipoprotein lipase (Yagyu et al., 2003) and PPARα (Finck et al., 2002) led to 
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cardiac lipid accumulation and cardiomyopathy. The mechanism of isoprenaline-induced heart 
failure appears to also involve membrane instability via a lipotoxic mechanism which can be 
prevented by the herbal extract diosgenin which stabilizes cell membranes (Jayachandran, Vasanthi 
and Rajamanickam, 2009).     
1.6 REGIONALITY OF ΒAR S IGNALLING WITHIN THE MYOCARDIUM 
The sympathetic control of the heart is not evenly distributed at the organ level; there is a greater 
innervation of basal myocardium by sympathetic nerves which stain for the enzyme tyrosine 
hydroxylase (involved in the synthesis of catecholamines). The density of βAR (no differentiation 
between subtypes) is greater at the apical myocardium in dogs (Mori et al., 1993). As explored 
extensively above, SNS activation especially by the βAR is cardiotoxic. A greater density of 
sympathetic nerves at the basal myocardium may be counterbalanced by a greater apical density of 
βAR receptors obtaining sympathetic input from circulating plasma (Kawano et al., 2003; Mori et al., 
1993). It is not clear what benefit this inhomogeneous distribution of receptors provides the heart. 
The regionality of receptor expression is however correlated with an apparent vulnerability of the 
apical ventricular myocardium to damage by catecholamines. The historic method of infusing 
isoprenaline into rodents causes ‘infarct-like’, not evenly spread damage, to the myocardium 
suggests there are some underlying differences in βAR activity within different regions, sensitizing 
the apex (Rona et al., 1959; Brouri et al., 2004). This has ramifications for human disease, the SNS is 
overactive in many forms of heart failure possibly exacerbating cardiac dysfunction, especially where 
the myocardium may already be damaged focally by ischemia due to an infarct (Port and Bristow, 
2001; Wittstein et al., 2005). Catecholamine levels may become pathologically elevated following 
stressful stimuli and this is implicated in a relatively newly described form of heart failure known as 
Takotsubo (stress) cardiomyopathy (Wittstein et al., 2005). Takotsubo cardiomyopathy (TTC) is 
defined by region-specific dysfunction within the left ventricle, usually focused on the apical 
myocardium, resulting in a reduction in cardiac output and symptoms of heart failure. 
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Figure 1.6 Schematic diagram of the differential innervation of the myocardium, which is 
dependent upon anatomical location. The increased density of βAR is demonstrated at the 
myocardial apex and the paucity of innervation, reproduced from Lyon et al. 2008.  
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Figure 1.7 Chronic stimulation of rodents with isoprenaline produces infarct like scars preferentially 
at the apical myocardium, adapted from Rona et al. (1985). 
1.7 TAKOTSUBO CARDIOMYOPATHY 
 This disorder was first described by Sato (1991), and the name Takotsubo (meaning literally 
‘octopus pot’ in Japanese) was given as it neatly describes to ampulla shaped appearance of the left 
ventricle at systole. This is a result of virtual ‘apical ballooning’ caused by the loss of inotropy at the 
apical myocardium. Although case reports of transient ‘cardiomyopathies’ due to iaotrogenic 
delivery of adrenaline were present at the time (Fyffe et al., 1990), since Sato’s seminal case review, 
myriad studies and case reports concerning the clinical presentations of this disorder have been 
published. The most common feature of TTC is that the patient will usually have experienced a major 
physical, emotional or pharmacologic stressor acutely prior to the onset of symptoms. These 
symptoms bear a distinct similarity to MI with matching ECG profiles (ST-segment elevation, T-wave 
inversions) which are indicative of ventricular damage. However, upon angiography the patients are 
discovered to have no culprit coronary occlusions to explain the clinical picture. Equally, TTC 
sufferers are predominantly post-menopausal women, although cases in men are becoming more 
 
Un-Damaged Myocardium 
Apex Apex 
Base Base 
52 
 
widely reported (Nef et al., 2010). The central role of catecholamines in this condition became 
apparent as cases of TTC are widely reported, and the production of TTC following delivery of 
adrenaline in cases of anaphalaxis, or dobutamine as part of functional investigations (Bybee et al., 
2004). TTC patients are discovered to have circulating levels of adrenaline and noradrenaline in their 
plasma far in excess of those with Killip III class MI (Wittstein et al., 2005). There are numerous 
animal models producing Takotsubo like effects either by infusing adrenaline (Paur et al., 2012), 
isoprenaline (Shao et al., 2013 A, B) or using emotional stressors (Ueyama et al., 2002). Apical 
ballooning and left ventricular dysfunction are common features of patients suffering from 
pheochromocytomas. These are tumours of the chromaffin cells of the adrenal glands and result in 
the massive elevation of circulating catecholamines (Takizawa et al., 2007; Sanchez-Recalde et al., 
2006). Another feature of TTC is that it most frequently affects post-menopausal women and in most 
cases is full reversible with no persisting functional defects of the cardiovascular system. As a result 
TTC has sparked much interest within the cardiovascular research community as reversibility of TTC 
may involve a protective mechanism which can be utilized to assist in the treatment of other heart 
failures. Levels of biomarkers reported in TTC patients are more indicative of cardiac failure, rather 
than acute myocardial infarction. There are elevated levels of natriuretic peptides, consistent with 
high levels of myocardial wall stress during the acute phase (Madhavan et al. 2009). Biomarkers 
related to myocardial damage such as creatine kinase and troponin T are not raised to the same 
level as observed in MI secondary to acute coronary occlusion (Madhavan et al., 2009; Fröhlich et al., 
2012). This suggests that the pathological processes involved in TTC are quite distinct from that of 
MI. The pathological mechanism underlying the regional dysfunction, in TTC, remains elusive and is 
the focus of much research activity. The possible mechanistic basis of TTC will be evaluated below.         
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Figure 1.8 Syndrome of Takotsubo cardiomyopathy a) apical myocardium of the left ventricle is 
demonstrated to be hypo-contractile at systole in comparison to the basal myocardium which is 
hyper-contractile. Note the lighter area of the apical vs. basal segement indicating dialation of the 
ventricular chamber. b) At five months following TTC the contractility of the patients heart at systole 
is recovered Adapted from Lyon et al. (2008). 
1.7.1 DEFECTS IN MYOCARDIAL PERFUSION OF THE APEX DUE TO CATECHOLAMINE 
EFFECTS 
TTC has been suggested to be the persisting effects of an aborted myocardial infarction. This will 
have given rise to transient ischemia which is survivable but causes acute symptoms of heart failure. 
However the area affected usually extends beyond one coronary territory. It could however be the 
case that catecholamines induce vasoconstriction in some regions (α1AR stimulated) and this stops 
efficient perfusion of the muscle. There are differences in histopathologic parameters between 
confirmed ischemic myocardial stunning and TTC which suggest that it is not an ischemic process 
(Nef et al. 2010). It could be the case that if many coronary vessels are affected and in the correct 
pattern then apical dysfunction could occur (Abe et al., 2012). Although this case is defined by the 
author as being a mimic of TTC rather than what occurs in all patients. A coronary artery disease was 
noted in only 3 patients out of 30 studied by Kurisu et al. (2009). This suggests that vascular defects 
although present in a number of cases is not central to the catecholamine induced dysfunction in 
TTC; vascular issues may serve as a modifier of the disorder. It may be the case that rather than 
affecting the myocardium by damaging large vessels catecholamines may impair the 
microcirculation. There are conflicting findings regarding the role of perfusion defects in akinetic 
regions of myocardium in TTC patients. Galiuto et al (2010) revealed areas of poorly perfused 
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myocardium by myocardial contrast echocardiography. This was similar to the level of perfusion 
defect seen in sufferers of MI. Adenosine infusion caused a recovery of perfusion in the case of the 
TTC but not the MI sufferers suggesting vasoconstriction was occurring by some process in TTC. 
Notably the perfusion defect seemed to form a small part of a wider akinetic region leading to a 
suggestion that the perfusion defect may be epiphenomenal rather than causative. Studies using PET 
and SPECT have demonstrated that there appear to be metabolic and inflammatory defects in TTC 
patients (Burgdorf et al., 2008; Morel et al., 2008). Other studies have found no perfusion defects in 
TTC patients (Salerno, Lisi and Gori, 2009; Akashi et al., 2004). Catecholamine uptake (123-iodine 
metaiodobenzylguanidine imaging) seems to be impaired, possibly as a result of the SNS over-
activation and/or desensitization (Akashi et al., 2004). 19F-fluorodeoxyglucose uptake is impaired in 
PET studies of TTC patients, so metabolism may be slower in the akinetic reasons leading to an 
energetic imbalance and a loss of inotropy (Elesber et al., 2006).  In some cases of TTC there appears 
to be an apico-basal gradient in pressure within the left ventricle and the hyperkinesis of the basal 
myocardium leads to an acute obstruction of the left ventricular outflow tract (LVOTO) (El-Mahmoud 
et al. 2008). This did not affect the patients’ prognosis.  
1.7.2 DIRECT CATECHOLAMINE TOXICITY 
It has been observed that contraction band necrosis and myofibrillar disorganization are present in 
biopsies from patients with TTC suggesting a role for catecholamine toxicity (Nef et al., 2008).  This 
myocyte loss and myofibrillar degeneration would interfere with myocardial function and the 
production of force. In an aligned study the expression of SLN is shown to be increased in TTC 
patients and amounts of PLB phosphorylation increased suggesting possible catecholamine-induced 
calcium handling defects (Nef et al., 2009).  Lipotoxicity and lipid incorporation are demonstrated to 
occur in rat and mouse models of TTC, indicative of catecholamine toxicity and contributing to 
cardiac dysfunction (Shao et al., 2013 A, B).  
1.7.3 NEGATIVELY INOTROPIC EFFECTS OF Β2AR ACTIVITY FOLLOWING HIGH 
CIRCULATING ADRENALINE LEVELS 
Our group has proposed that a direct effect of adrenaline upon the cardiomyocytes via β2AR could 
explain the regional dysfunction and reversibility of TTC (Lyon et al., 2008). The anatomical 
differences in the innervation of the myocardium and density of βAR may also be paralleled with 
differences in β2AR expression and function. As noradrenaline (emanating from the nerves) is a less 
potent stimulator of β2AR in comparison to adrenaline (supplied by the circulation), there could be 
an increase in the ratio of β2AR in comparison to the β1AR in the less innervated region. 
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Physiologically, this would provide inotropic support due to the paucity of neural innervation but the 
cardio-protective effects would counterbalance the possible toxicity arising from the enhanced β1AR 
density. When faced with supra-physiological concentrations of adrenaline this situation could be 
subverted. The well defined ability of the β2AR to stimulus traffic and bind Gi then results in negative 
inotropy within the apical segment. This is whilst the basal segment is unaffected due to reduced 
β2AR density and becomes hyperkinetic producing the apical ballooning effect observed in TTC. The 
cardio-protective, anti-apoptotic nature of β2AR-Gi ultimately prevents persisting damage of the 
myocardium. When β2AR signalling reverts to β2AR-Gs upon withdrawal of catecholamine and the 
effects of RGS2 normal cardiac function is restored (Lyon et al., 2008). The only detected genetic 
polymorphism in TCM patients to date is the GRK5 L41Q polymorphism, resulting in a constitutively-
active GRK5. This implicates a stimulus-trafficking like mechanism as stimulus trafficking is 
dependent on GRK (Spinelli et al., 2010).  The threshold for Gi coupling may therefore be lower in 
individuals carrying this polymorphism, with stimulus trafficking occurring at lower circulating 
adrenaline concentrations and/or more rapidly.  The lower severity of myocardial damage as 
indexed by cardiac troponin biomarkers is suggestive of a protective mechanism in TTC (Wittstein et 
al., 2005).  
1.7.4 ANIMAL MODELS OF TAKOTSUBO 
Current animal models of TTC exist in mouse, rat and non-human primates. Initial studies were made 
in rats that were taped down in dorsal recumbency to evoke profound emotional stress. Left 
ventriculography showed the presence of apical ballooning or general hypokinesis of the rats left 
ventricle with a reduction in fractional shortening from 50 to 35% (Ueyama et al., 2002).  An infusion 
of amusalulol, a non-selective α and β adrenoceptor blocker, prevented apical dysfunction 
confirming the role of the adrenoceptors. In a later study the same group utilized ovariectomized 
female animals with or without estrogen supplementation demonstrated that oestrogen had a 
similar sympatholytic effect to adrenoceptor blockade (Ueyama et al., 2003). Interestingly, MAPK 
was also implicated in this process (Ueyama et al., 1999). Ueyama et al. (2007) provided a more 
sophisticated follow up to these studies where echocardiography was used to explore the 
ovariectomized and oestrogen supplemented animals however recovery of contractility by 
oestrogen supplementation was absent and only a reduction in acute blood pressure was observed. 
A plethora of genes were activated by the stress including genes related to heart failure, EC-
coupling, lipid transport and mitochondrial homeostasis. A more consistent approach to animal 
models of TTC appears to be the infusion of catecholamines; as explored above catecholamine 
induced myocardial damage is well reported. Khullar et al. (1989) produced a highly original study to 
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assess the effects of what seemed to be a very transient infusion of noradrenaline in Rhesus 
monkeys, this produced necrosis, vacuolization, myofibrillar degeneration and the infiltration of 
leucocytes after two hours. After two days there was some recovery of the tissue but an infarct like 
scar had formed after a few weeks with attendant myofibrillar disarray and increases in membrane 
permeability. This study showed that very transient elevations in plasma catecholamines could 
damage the myocardium of a species very closely related to man. Izumi et al. (2009) infused 
adrenaline at a lower dose than Khullar et al. into cynomologous monkeys and observed apical 
ballooning and activation of genes related to stress induction. The ECG parameters of the animals 
displayed ST-segment elevations akin to those of TTC patients. Myocytolysis was observed, and was 
increased at the apical myocardium, and mRNA levels of positively inotropic molecules such as 
SERCA2 and RyR were specifically down-regulated at the apex.   The apical dysfunction was 
recovered after a month and this recovery was made more rapid with beta-adrenoceptor blockade 
provided by metoprolol. A high degree of mortality was observed with roughly a third of the 
monkeys dying acutely from the adrenaline infusion. A rat model has been produced by giving 
adrenaline by a single intravenous bolus: apical dysfunction is observed by 20 minutes which 
resolves at 60 minutes (Paur et al., 2012). Noradrenaline infusion did not result in apical dysfunction 
showing that possibly catecholamines without the ability to cause biased agonism of the β2AR 
cannot cause TTC-like effects. The hypo-contracture of the apex begins to reverse within the 
experimental time frame. These studies differ in that rats received one bolus of ~60ug/kg adrenaline 
and the monkeys received a total of 10-20μg/kg in two separate doses. This may hint at a species 
difference or suggest an effect of rapid metabolism of adrenaline in the rat.  Primates may be more 
susceptible to catecholamine-induced damage (Izumi et al., 2009). This may also be true for human 
physiology and result in an increased rate of catecholamine induced pathology in man. Apical 
depression appears to be Gi dependent process as groups of ratswhich were pre-treated with PTX 
did not display cardiac dysfunction after acute adrenaline or isoprenaline infusion (Shao et al., 
2013A, Paur et al., 2012). Shao et al. (2013 A, B, C) presented a rat and mouse model of TTC where 
apical dysfunction is induced by intraperitoneal injection of isoprenaline. Histologically both the rats 
and mice displayed myofibrillar disorganization, cell loss and rapid accumulation of lipids, in mouse 
there was a reduction in lipid transporter expression. A transgenic animal which overexpressed the 
ApoB lipid transporter did not display apical ballooning following isoprenaline injection. Mice had to 
be supplied with 10 times the equivalent dose of isoprenaline given to the rat to induce apical 
ballooning which is reminisicent of the species difference between rats and non-human primates, 
suggesting larger animals are less tolerant of acutely high catecholamine levels. Rat studies once 
again hinted at the possible role of β2AR and Gi as blockade of β2AR or ablation of Gi by pertussis 
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toxin prevented apical dysfunction (Shao et al., 2013 A). In the mouse infusion of adenosine which 
prompts a potent vasodilatory effect ameliorated apical ballooning as reported in imaging studies in 
patients (Shao et al. 2013 C; Galiuto et al., 2010).     
1.7.5 THE PREVALENCE OF TAKOTSUBO CARDIOMYOPATHY IN POST-MENOPAUSAL 
WOMEN 
The typical TTC case is apical or mid-ventricular dysfunction in a post menopausal woman. Estrogens 
are known to have sympatholytic actions (Lindheim et al., 1992). Loss of oestrogen-mediated 
protection at menopause may be one explanation for the significantly increased incidence of TTC in 
older, postmenopausal women. A variety of clinical observations and laboratory studies support this 
view and the prevalence of TTC was a feature of early case reports, small cohorts and series reports, 
and was recently confirmed in the large retrospective analysis of ~6800 cases from the US (Gianni et 
al., 2006). In younger women, a number of cases in of TTC in young women with anorexia nervosa, 
associated with low oestrogen levels and amenorrhoea, have been reported (Vollman, Kate and 
Tukkie, 2011). Animal models of TTC and other heart failure syndromes demonstrate that 
ovariectomized animals and oestrogen receptor knockout mice have poorer cardiac outcomes and 
higher responsiveness to adrenergic stimuli than oestrogen competent animals (Ueyama et al., 
2003). The infusion of oestrogens appears to directly influence β1AR expression, with a relative 
increase after ovariectomy, with associated cardiotoxicity, reversed by oestrogen supplementation 
(Thaiworkaiwong get al., 2003). Immobilisation stress in ovariectomised female rats generated a 
TTC-like phenotype, which was reversed by estradiol 17β supplementation (Ueyama et al., 2003). 
Various studies have demonstrated that pressor responses are enhanced in post-menopausal 
women (Lindheim et al., 1992; Sung et al., 1999). Their responses to mental stress are enhanced in 
terms of both cardiovascular response and plasma catecholamine levels, these parameters are 
reduced by oestrogen supplementation (Ceresini et al., 2000 Del Rio et al., 1998). These findings 
suggest that women of this demographic may be more likely to react physiologically, to a given 
stressful stimuli, to an extent substantial enough to evoke the TTC syndrome. Although no reduction 
of TTC cases can be seen in populations of patients receiving hormone replacement therapy, it 
seems that oestrogen supplementation should be explored as a potential acute treatment strategy. 
The positive effects of oestrogen are suggested to be vascular based (Sung et al., 1999) and this is 
thought to be due to the effects of NO on vascular smooth muscle (Morimoto et al., 2004). Although 
this sort of mechanism is not implicated as a main factor in the pathogenesis of TTC, it may be the 
case that at baseline oestrogens presence prevents the catecholamine storm from becoming toxic 
via the removal of necrotic factors, toxic lipids and allows more oxygen to cells allowing the anti-
apoptotic program launched by β2AR to become more effective.   
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1.8 SUMMARY 
The myocardium can be damaged in numerous ways by catecholamine overstimulation. The apical 
myocardium appears to be especially vulnerable to damage during such episodes. This is postulated 
to be the basis of the regional dysfunction, centred on the apical myocardium, seen in the syndrome 
of Takotsubo cardiomyopathy. The main cellular arbiters of catecholamine responses, β1AR and 
β2AR, have rather different characteristics, β1AR being cardiotoxic and β2AR being cardioprotective. 
The architecture of sympathetic control is such that levels of β2AR activity may be increased in this 
region contributing to the vulnerability of the apical myocardium to damage during episodes of high 
sympathetic stimulation.  The β2AR signalling is a stringently controlled; the competing mechanisms 
of β2AR compartmentation may vary between myocardial regions as a mechanism of 
counterbalancing the paucity of sympathetic innervation in this region. These control mechanisms 
may be reduced in the apical myocardium to allow increased activity and inotropic support. During 
high levels of catecholamine this regional modification could be subverted and lead to toxic effects 
or an increased level of biased agonism of β2AR. Both of these mechanisms may have the convergent 
effect of reducing myocardial inotropy and apical ballooning and recovery acutely in syndromes such 
as TTC where very high levels of catecholamines are present for a short period of time.  In scenarios 
where catecholamine stimulation is at a lower level and more persistent, less controlled β2AR 
signalling may synergize with β1AR and cause the toxic effects underlying the apical vulnerability 
observed in catecholamine cardiomyopathies. This would also be an as yet unknown feature of GPCR 
compartmentation, ‘a top-down effect’ in which organs are able to organize receptor signalling to 
produce different effects in different regions of tissues on the basis of mechanical requirements. 
βAR signalling appears to walk a tight rope between the necessity for positive inotropy, ensuring 
sufficient pumping of blood, whilst making sure these pathways are not overstimulated with 
deleterious consequences for heart tissue.  
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1.9 HYPOTHESIS 
I hypothesize that there is anatomical variation in the control of the β2AR within the myocardium 
from apex to base. These differences may be based upon both the expression of the receptor and 
control of downstream signalling. This difference allows increased activity of the β2AR. One of the 
manifestations of this may be Takotsubo cardiomyopathy. Decreased control of the β2AR in the 
apical myocardium may induce increased β2AR-Gi activity. β2AR-Gi is shown to be cardio-depressant 
and thus may have a role in β2AR induced apical dysfunction.    
1.9.1 AIMS                
1) To investigate differences in cardiomyocyte contractile and cAMP response to β2AR 
stimulation between cells isolated from the apical or basal myocardium 
2) To assess the role of sub-cellular micro-domains and phosphodiesterases in restricting the 
cAMP response to β2AR stimulation in cardiomyocytes isolated from the apex and base. 
3) To subject cardiomyocytes to acute catecholamine shock to assess its effects on β2AR 
signalling within isolated cardiomyocytes 
4) Develop an improved animal model of TTC using ovariectomized female rats and explore the 
utility of acute oestrogen treatment in preventing apical dysfunction    
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2. Materials and Methods 
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2. METHODS AND MATERIALS 
2.1 ANIMALS  
All animals were maintained and utilized under conditions fulfilling the criteria of Animals in 
Scientific Procedures Act 1986 (ASPA, 1986). Work performed in Germany conformed to the Local 
Guidelines of Göttingen Medical University.  
2.1.1 SPRAGUE DAWLEY RATS 
Both male and female out-bred, wild type rats (Rattus norvegicus) were obtained from Harlan 
Laboratories (Wyton, UK). This strain is possibly the most widely used outbred strain used in 
research. They were fed standard rat chow, which they had access to ad libitum. Rats were housed 
at a density of 4-6 per cage and maintained on a 12-hour light/dark cycle at 21oC. Males were culled 
for the isolation of adult cardiomyocytes when >250g. Males and females were used for 
echocardiographic procedures between the ages of 8 and 10 weeks (males 250-350g and females 
>190g). 
2.1.1.1 PREPARATION OF OESTROGEN DEFICIENT FEMALE RATS BY OVARIECTOMY   
A subset of female rats was prepared by removal of their ovaries (Appendix, Harlan PDF). These 
procedures were performed by Harlan Laboratories surgeons. The rat was anaesthetized and placed 
in the ventral recumbence; the animal’s dorsal mid-lumbar region was shaved and swabbed with 
antiseptic agents. An incision through the skin was made along the mid-line half way between the 
caudal edge of the rib cage and towards the base of the tail. Incisions through the musculature were 
made a third of the distance between the spinal cord and the ventral midline on both right and left 
sides. The ovary and oviducts were exteriorized, the uterine vasculature was clamped to provide 
haemostasis and both ovaries and part of the oviducts were removed to give a bilateral 
oophrectomy. The remaining uterine material is placed back into the animal the musculature is not 
sutured. Sterile wound clips are used to close the incision in the skin. Harlan provided post-operative 
relief by maintaining the animals in a clean quiet environment with food and water ad libitum. 
Wound healing was monitored for 72 hours and wound clips were removed after a minimum of one 
week. These animals were delivered to the Imperial College animal house following complete 
recovery from the procedure and removal of wound clips. Animals showed no outward signs of 
having been operated upon save for a slight patchiness to the hair on their backs.  
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2.1.2 FVB/N MICE  
Male and female mice of the FVB/N strain were also obtained from Harlan Laboratories (Wyton, UK).  
Male mice of this strain which transgenically, homozygously expressed the cAMP-sensing FRET 
construct Epac-1 (homozygotes) were a gift from Dr. Viacheslav Nikolaev. Mice were fed standard 
chow ad libitum. Females were housed at a density of 5-6; males were housed alone. Both sexes 
were maintained on a 12 hour light/dark cycle at 21oC. They were culled to provide tissue for the 
isolation of cardiomyocytes when they weighed >20g. The transgenic mice were prepared by cloning 
the DNA sequence of the Epac1-camps Sensor into pB-βAKT vector between KpnI and EcoRV 
restriction sites (Nikolaev et al., 2006). This resulted in transgenic animals in which all tissues were 
fluorescent due to expression of the Epac1 sensor. 
2.2 CARDIOMYOCYTE ISOLATION 
Studying isolated cardiomyocytes allows researchers to assess the effects of pathology or 
pharmacological interventions on the fundamental contractile unit of the heart. Isolation removes 
the effects of vasculature, neural input and the interaction of cardiomyocytes with other cell types. 
2.2.1 ISOLATION OF ADULT RAT CARDIOMYOCYTES 
Rats were humanely killed by cervical dislocation after the induction of a brief anaesthesia in an 
atmosphere of 5% isoflurane. Incisions were made across the base of the rib cage and then on either 
side to fully expose the thoracic cavity. The entire contents of the cavity were promptly removed 
and placed in ice cold Krebs-Henseleit (KH) Buffer (119mM NaCl, 4.7mM KCl, 0.94mM MgSO4, 1mM 
CaCl2, 1.2mM KH2PO4, 25mM NaHCO3, 11.5mM glucose; 95% O2, 5% CO2). The tissue was moved to a 
petri-dish where it was placed in clean ice cold KH. The lungs, thyroid and superfluous pericardial fat 
were dissected away from the heart leaving the aorta and atria intact. The heart was cannulated via 
the aorta and clipped onto a Langendorff apparatus and perfusion of the heart with KH at 37oC was 
initiated. Nylon thread was used to ensure that all fluid exiting the cannula was directed through the 
coronary circulation. The presence of calcium in the KH buffer meant that strong, rhythmic beating 
of the heart was established. After 1-1½ minutes, upon full clearance of blood from the coronary 
circulation, the KH buffer was switched to a low calcium (LoCa2+) buffer (12-15µM CaCl2, 120mM 
NaCl, 5.4mM KCl, 5mM MgSO4, 5mM pyruvate, 20mM glucose, 20mM taurine, 10mM HEPES, 5mM 
nitrilotriacetic acid (NTA); 100% O2). The LoCa
2+ medium containing the chelating agent NTA 
removes calcium from the extracellular medium meaning excitation-contraction coupling can no 
longer take place. Rapid cessation of beating confirmed that the LoCa2+ medium had fully removed 
calcium from the heart and that perfusion was effective, this solution was continuously perfused 
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through the heart for 5 minutes. This cessation of contraction appears to protect the cardiomyocytes 
during the isolation. At this point a solution of 1mg/ml Collagenase II and 0.6mg/ml Hyluronidase 
(C+H) in enzyme (Enz) buffer (12-15µM CaCl2, 120mM NaCl, 5.4mM KCl, 5mM MgSO4, 5mM 
pyruvate, 20mM glucose, 20mM taurine, 10mM HEPES,150µM Ca2+) was perfused into the heart  for 
10 minutes. Hyaluronidase has been observed to be effective in improving the isolation of 
cardiomyocytes alongside collagenase and has become part of our laboratory’s isolation protocol. 
After 10 minutes of enzymic degradation the Langendorff perfusion was switched off and the heart 
cut down. The heart was placed in clean C+H and dissected. For comparisons between apical and 
basal cardiomyocytes the right ventricular free wall, atria and mid- third of the left ventricle were 
removed. The remaining top third represented the base and the bottom third represented the apex 
of the heart. These portions were minced and placed in fresh C+H in 50ml falcon tubes. The samples 
were shaken mechanically at 35oC for 5 minutes at which point the supernatant was filtered through 
gauze and fresh C+H replaced in the tube with undigested tissue. These samples were shaken for a 
further 30 minutes at which point the supernatant was strained through gauze. The resulting 
filtrates were centrifuged for 1 minute at 700rpm. This yielded a pellet of isolated cardiomyocytes, 
the supernatants were removed from these samples and the pellets re-suspended in Enz. This 
method yields rod shaped cardiomyocytes which are tolerant of Ca2+, quiescent when un-stimulated 
and can be maintained in cell culture.  This procedure was performed by Mr. Peter O’Gara on the 
majority of occasions. 
Diagram of apex/base division 
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2.2.2 ISOLATION OF ADULT MOUSE CARDIOMYOCYTES 
Similarly to the rats, mice were killed by cervical dislocation after a brief anaesthesia with isoflurane. 
The heart and contents of the thoracic cavity were removed and placed into ice cold HEPES buffer 
(NaCl 113mM, KCl 4.7 mM, KH2PO4 0.6 mM, Na2HPO4 0.6 mM, MgSO4 1.2 mM, NaHCO3 12mM, 
KHCO3 10 mM, HEPES 10 mM and Taurine 30 mM). After the cessation of beating the thymus and 
other adherent tissues were dissected away from the aorta. The aorta was cannulated and the heart 
perfused with the HEPES buffer utilized above at 37oC, after the fluid exiting the heart became clear 
trypsin/liberase solution added to the perfusate (Solution as composition as detailed plus 13μM 
CaCl2, Liberase 0.05mg/ml, 0.3mg/ml Trypsin). Liberase is a more highly purified form of collagenase; 
mouse myocytes isolated with this enzyme appear healthier than those isolated with the collagenase 
utilized for the rat. After a ten minute exposure to these enzymes the heart was cut down from the 
apparatus. The tissue was cut into small pieces, selecting apical and basal segments.  After a further 
5-10 minutes shaking, this material was triturated with a needleless 1ml syringe until all the material 
was broken down. The resulting suspension was centrifuged and the enzyme containing media 
removed, the cells were washed in a blocking buffer (HEPES Buffer plus 1%BSA and 50μM CaCl2). The 
cells were subsequently washed and maintained in myocyte culture medium (MEM no L-glutamine, 
BSA 0.1%,  penicillin/streptomycin 1%, L-glutamine 2mM, BDM 10 mM and ITS-Supplement 1x ). 
2.3 FÖRSTER RESONANCE ENERGY TRANSFER (FRET) SENSOR MEASUREMENT OF CAMP 
The phenomenon of Förster resonance was initially postulated by Förster in 1948. He suggested that 
two fluorophores with partially overlapping excitation and transmission energies would undergo 
resonance to a degree determined by their proximity. This would be via a non-radiative transfer of 
energy (FRET) from the higher energy fluorophore to the lower depending upon the sixth power 
relationship of the Förster radius (r6). The utility of this phenomenon was only gradually realized 
over the next half a century: a paper by Stryer in 1967 (Stryer and Haugaland, 1967) demonstrated 
that in functionalized molecules with fluorophores, FRET could act as a molecular ruler. It was only 
with the advent of the molecular biology revolution that controlled overexpression of sub-units of 
PKA allowed Tsien’s group to create a FRET functionalized PKA (Adams et al., 1991). This molecule 
was dubbed FlIChR (‘flicker’) as the construct was composed of Fluorescin, the PKA catalytic 
holoenzyme and Rhodamine.  Microinjection of cells with FlIChR allowed real-time imaging of cAMP 
transients. The exquisite sensitivity of FRET to proximity meant that conformational shifts caused by 
binding of cAMP to the PKA holoenzyme meant observable shifts in fluorescence ratios could be 
semi-quantitatively related to cAMP concentrations. The next stage in the development of FRET 
modalities was the discovery and subsequent development of green fluorescent protein and its 
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derivatives as scientific tools. Genetically-encoded fusion peptides, comprising of GFP and BFP with a 
sensor domain were developed. The fused sensor domain which perturbs or produces FRET between 
the fluorophores upon the biological interaction of interest became a familiar approach. Slight 
improvements have been produced in recent years with modified fluorophores which eliminate 
some unwanted properties such as dimerization. 
2.3.1 MEASUREMENT OF CAMP BY FRET USING EPAC MODIFIED FRET SENSORS 
Manuela Zaccolo and colleagues produced cAMP sensors based upon the regulatory domain of PKA-
RII labelled with CFP and the PKA catalytic domain, labelled with YFP (Zaccolo and Pozzan, 2002). 
This gave localized sensors which provide a method of measuring cAMP within domains where 
different populations of PKA are present and where cAMP will have different outcomes for cellular 
physiology. In 2004 Viacheslav Nikolaev and members of the Lohse group developed new FRET 
sensors for cAMP based upon the cyclic nucleotide binding domain of Epac, rather than PKA 
(Nikolaev et al., 2004). They fused the cAMP binding domain (CNBD) of Epac to CFP and YFP in a 
single molecule which could be expressed in primary cell types after adenoviral transfection. This 
molecule gives highly sensitive detection of cAMP and is robustly expressed (with efficient folding) 
by primary cell types in culture. DNA encoding this sensor was successfully transferred into mouse 
embryo to produce animals transgenically expressing this construct removing the need for 
maintenance of cells in culture for periods of transfection. 
 
Figure 2.1 FRET sensor responses using sensors based upon the cyclic-nucleotide binding domain of 
Epac, demonstrating the reduction of Forster resonance following the conformational shift induced 
by the binding of cAMP 
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Epac1 Sensor 
This is the sensor expressed in transgenic mice; it is based on the Epac1 sub-type fused between CFP 
and YFP.  
 
Figure 2.1.1 Images demonstrating the construction of the Epac1 sensor from the cyclic nucleotide 
binding domain (CNBD) of Epac1, which is between cyan (CFP) and yellow fluorescent protein (YFP). 
Mouse cardiomyocytes give rise to both yellow (left) and blue (right) fluorescence when excited at 
488nm. This appears as a faint green fluorescence in the unfiltered image (centre). 
cEpac2 
The cEpac2 sensor is based on the Epac2 subtype fused to CFP and YFP and original sensor used to 
transfect rat cells via adenoviral transfection. This variant can freely diffuse in the bulk cytosol of the 
cell. 
 
Figure 2.1.2 Image demonstrating the construction of the cEpac2 sensor, which is based upon the 
CNBD of EPAC2. This sensor gives rise to fluorescence throughout the cell cytosol as shown in the 
image on the right.   
 
EPAC1 
EPAC2 
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RII-epac - Localized 
RII-epac consists of the Epac cAMP binding domain fused to CFP –YFP and the regulatory subunit of 
PKA-RII. This causes the sensor to become localized in the cellular components associated with the 
particulate fraction of cellular PKA as the RII subunit binds to A-Kinase Anchoring Protein. The RII 
compartment contains the PKA responsible for modulating cellular contraction, thus cAMP reaching 
this sensor would be able to influence contractility. 
 
Figure 2.1.3 The RII_Epac sensor, is based upon the CNBD of EPAC1 but fused with the RIIβ AKAP 
docking domain to its N-terminus. This sensor gives rise to a striated pattern of fluorescence.    
pmEpac2 - Localized 
This construct is based upon Epac2 and is N-terminally fused to the SH4 motif of Lyn kinase 
(MGCINSKRKD) this peptide localizes to the caveolin-rich domains of cardiomyocytes (Zacharias et 
al., 2002). Consequently, the relative production of cAMP in these regions can be monitored. 
 
Figure 2.1.4 The pmEpac2 sensor, which is based upon the CNBD of EPAC2, but is fused with the SH4 
motif of Lyn Kinase peptide.  
RII_EPAC 
EPAC
2 
MGCINSKRKD 
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2.3.2 CULTURE OF RAT CARDIOMYOCYTES FOR FRET MICROSCOPY 
Once cells were isolated they were placed on laminin-coated 25mm coverslips. After a period of 
adhesion, dead and non-adherent cells were washed off and the slip was cultured in M199 media 
with the following additions (0.5mg/ml BSA, 0.66mg/ml creatine, 0.66mg/ml taurine, 0.32mg/ml 
carnitine at 37oC and 5%CO2). An adenovirus expressing the FRET construct of interest is introduced 
into the culture medium at a concentration providing a multiplicity of infection of more than 300 
(MOI 300), meaning that each cell was  infected by on average 300 virus particles. Cells were 
cultured for 48 hours in this way and utilized before 60 hours had elapsed. Coverslips were removed 
from the culture media for use, washed with a buffer solution containing 144mM  NaCl, 5.4mM KCl, 
1mM MgCl2, 2mM CaCl2 and 10mM HEPES, pH=7.3, and clipped into a 200µl 25mm coverslip holder 
containing the same solution. Sub-sets of cells were pre-stimulated with either adrenaline or 
noradrenaline (100nM-1µM) for set times. One set had their cellular cholesterol depleted by 
exposure to methyl-β cyclodextrin (MβCD) (1-2mM, 1 hour). Treatment with pertussis toxin 
(1.5µg/ml, 3 hours 37oC) was employed to remove the effects of Gi when necessary.  
2.3.4 ADENOVIRAL TRANSFECTION TO MODULATE CELLULAR CAV3 LEVELS 
Some cells were co-transfected with viruses expressing the cEPAC2-FRET sensor and vectors 
expressing either the cav3 or cav3DN peptides (MOI100-200) for 48 hours. Cav3 is the predominant 
scaffolding peptide in mammalian cardiac caveolae; the adenovirus encodes a human myc-tagged 
variant. The Cav3DN peptide is a mutant form of human Cav3 with a deletion of 9 nucleotides (186-
194) in the TFT-motif and has been reported to cause muscular dystrophy. This produces a peptide 
which cannot stabilize caveolae and displaces wild-type cav3 resulting in a reduction of the number 
of cellular caveolae (Koga et al., 2003). These viruses were a kind gift from Dr. Viacheslav Nikolaev. 
 2.3.5 FRET MICROSCOPY SYSTEM SCHEMA 
Our FRET microscopy system consisted of an ORCA-ER CCD camera (Hamamatsu Photonics, Welwyn 
Garden City, UK) attached to an inverted microscope (Nikon TE2000) equipped with 30WDia halogen 
lamp illuminator pillar. The system had an EX436/20 excitation filter combined with DM455 dichroic 
mirror. The fluorescence emanating from the cell was split into YFP and CFP channels using a Dual 
View (Optical Insights, equipped with 535/40 and 480/30 emission filters) beam splitter. Images 
recorded onto a PC were used to quantify the relative ratio of YFP to CFP and hence monitor FRET 
output. Analysis was performed using Micro-Manager Software; subsequently bleed through from 
the CFP channel into the YFP channel was corrected for. Bleed-through was calculated by 
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establishing the relative intensity of the fluorescence in the yellow channel when imaging CFP 
expressing HEK293 cells.  
Solutions were applied to cells directly via a gravity-driven perfusion system. Reagents and all FRET 
microscopy studies were performed utilizing a HEPES based FRET buffer (NaCl 144mM, HEPES 
10mM, MgCl2 1mM, KCl 5mM – pH7.4).  The solution inlet was produced by shaping a glass capillary, 
1mm outside diameter (O.D); this was mounted on a micro-manipulator allowing the operator to 
manoeuvre the inlet into close to the cell of interest. Cells were perfused at roughly 1ml/min so the 
bath volume (200μl) was changed roughly five times a minute. The bath solution was evacuated 
using a peristaltic pump as desired.  
 
Figure 2.2 Schematic of the FRET Microscopy system including the micro-perfusion system 
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2.3.6 WHOLE CELL FRET PROTOCOLS    
There a number of protocols have been established to investigate different aspects of βAR signaling 
and the physiology of cAMP within cardiomyocytes.  
Protocol 1: Establishing amplitude of FRET shift caused by cAMP production 
This experimental protocol measured the effect of a given intervention on cellular cAMP levels 
relative to the full activation of all adenylate cyclase (activated by the forskolin analogue NKH477).  
Consequently, this protocol gave us information on the way in which a treatment affects cAMP 
concentrations in specific cellular compartments. As an example, an experiment to determine β2AR 
activity is detailed as follows. Isoprenaline was perfused on to the cells in the presence of the β1AR 
blocker CGP20712A, following the plateau of the FRET response, NKH477 was perfused onto the 
cells to establish the maximal FRET response. The final step allowed a corrected measure of the β2AR 
activity. The modified protocols (employed in different scenarios of pre-treatment or βAR) are 
discussed in more detail in the individual chapters. 
 Protocol 2: Establishing the persistence of cAMP increases 
This protocol enables one to establish the amount of time that a cAMP signal will persist after 
stimulation. cAMP does not spontaneously degrade thus the rate of FRET signal removal which 
relates to the rate of cAMP degradation is a function of cellular phosphodiesterase activity. 
Isoprenaline was perfused onto the cell and rapidly washed off with either βAR blockers or FRET 
solution. The time course and reagents employed are discussed in more detail in Chapter 4.  
Protocol 3: Establishing the β1AR and β2AR contribution to isoprenaline induced cAMP production 
Isoprenaline stimulates both β1AR and β2AR. If specific blockers of the receptors are perfused onto 
the cell following isoprenaline stimulation, the action of cellular phosphodiesterases will remove the 
cAMP produced by the action of that particular receptor sub-type. Thus perfusion of CGP20712A to 
block β1AR and ICI118, 551 to block β2AR revealed the relative contribution of the different subtypes 
to the cardiomyocyte βAR response, as phosphodiesterase activity removes the cAMP produced. The 
time course and reagents employed are discussed in more detail in Chapter 3.        
 
 
 
71 
 
Protocol 4: Establishing Concentration/Response Relationship 
Cells transfected with cAMP-detecting FRET constructs were exposed to cumulatively increasing 
concentrations of isoprenaline in the presence of the specific β1AR blocker CGP20712A, via the 
perfusion system. This allowed assessment of the relationship between concentration (relative β2AR 
stimulation) and the cellular cAMP response. The protocol is discussed in more detail in Chapter 3.  
2.4 SCANNING ION CONDUCTANCE MICROSCOPY (SICM) – SICM/FRET 
Patch clamping is a venerable technique which has been used to study cellular electrophysiology for 
many years. The principle is that disruptions in conductance between electrodes (usually) one in the 
cell bath and one contained within a glass pipette can be interpreted as changes in cellular 
physiology or the functioning of ion channels. Due to the differences in the electrodes polarity an ion 
current travels between the two. In 1989, Paul Hansma (Hansma et al., 1989) realized that this 
current would be disrupted by the proximity of physical structures. Thus he created a system which 
could record the disruptions of the systems ion current when the pipette was tracked across the 
cells surface. The particularly notable aspect of this imaging modality is that by automating the 
control of pipette so that conductance never drops below a defined value the pipette does not come 
into contact with cellular structures making SICM a non-contact imaging modality. The level to which 
the pipette is able to drop at a given point is graphed by software and a 3D image of surface 
topography is built up. As the resolution of this modality is only limited by the radius of the nano-
pipette employed. This technique is able to resolve structures in living cells which could only 
traditionally be visualized with scanning electron microscopy, after fixation and staining with heavy 
metal dyes. Despite this potential the technique was largely forgotten until around 1997 when Yuri 
Korchev began to investigate its potential in looking at biological samples. A further adaptation 
(Novak et al., 2008) was made with the addition of a piezo controller to allow control of the pipette 
in the z direction, so called hopping mode. This allows the pipette to avoid very large thin structures 
in the z-axis which are present in biological samples which are often irregular in nature. This 
provided better resolution of structures and protected the pipette from damage or blockage due to 
interaction with the sample. Ultimately SICM is most useful when used as a platform for functional 
studies of biological samples. The SICM pipette allows one to resolve cellular topography and apply 
substances, via pressure or ionphoresis, to areas of interest. If the cell has been transfected with a 
FRET construct then the effect of local application of pharmacological agents to cellular structures of 
interest can be interrogated. This modality (SICM/FRET) provides a completely original way of 
looking at GPCR pharmacology and cAMP compartmentation. FRET images can be divided into 
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separate zones upon analysis and the relative confinement of cAMP signals can be assessed in the x-
direction.           
2.4.1 SICM/FRET SYSTEM 
The SICM probe was a boro-silicate glass pipette; this was machined from a glass capillary (1mm 
outer diameter) tube by a laser puller (Sutter, P2000, Royston, UK) apparatus. The resistance of 
these pipettes was between 80-100MΩ. The pipette was filled with FRET buffer (bath medium) and 
air bubbles are eliminated by agitation. The pipette was placed inside a pipette holder and an 
electrode placed inside. When the holder was placed inside the piezo stage apparatus it was brought 
into solution and an ion current was established between the pipette and the electrode in the bath. 
The ion current was relayed to PC via an amplifier. The PC was able to control a module which 
ensured the pipette conductance did not drop below a certain level (‘feedback’). The same PC also 
controlled both the rastering of the sample in the X/Y directions and the movement of the bath in 
the z-direction for hopping mode via communication with a piezo-actuator stage. The software 
(IonView, IonScope, UK) which allowed control of these modules also acquired data and many 
aspects concerning the motion such as pipette hopping parameters and the desired image 
resolution.     
2.4.2 SICM/FRET PROTOCOL 
Cardiomyocytes isolated from rats were transfected with the cEpac2 FRET sensor, in a laminin-
coated Matek dish (Matek Corporation, US). These were scanned using the SICM as described above 
to give a 10μmx10μm image. Guided by this image the nanopipette is manoeuvred to a specific 
point above either a t-tubule or a sarcolemmal element. FRET was imaged as described above and 
the cells were perfused with FRET solution. After the establishment of a baseline FRET ratio, 
pressure was applied to the pipette to dispense isoprenaline onto the portion of the cell selected. 
The isoprenaline can also be applied by reversing the polarity of the electrodes in the SICM system, 
this releases positively charged isoprenaline into the solution above the area of the cell selected.    
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Figure 2.3 Schematic of the SICM system which is superimposed upon the FRET microscopy system 
detailed above, creating a dual-SICM-FRET system. 
2.5 CARDIOMYOCYTE CELL SHORTENING MEASUREMENTS USING THE IONOPTIX SYSTEM 
The IonOptix system is based around an infra-red camera which images the deflections of the high 
contrast membranes of contracting cells. Data concerning the modulation of cardiomyocyte cell 
dimensions during the contraction of electronically stimulated cells can be obtained as the distance 
between highly absorbing membrane regions can be tracked over time. As the cell contracts there is 
a displacement and the cell shortens to a fraction of its length at baseline. This fractional shortening 
is quantified and can be used as an indicator of the relative contractile state of the cell. The 
modulation of this unloaded shortening by pathologies or by pharmacological interventions is 
consequently of great interest to cardiac physiologists. The cardiomyocytes’ contraction is the 
ultimate arbiter of the hearts’ contractile function.  In this work this technique is employed as it 
provides a reporter of the mechanical and as a result the total integrated physiological effect of β2AR 
signaling at the level of the cell. Data from this technique can be utilized to assess whether effects 
measured at the level of cellular cAMP have a bearing on organ function. As this investigations in this 
work are primarily concerned with the direct effects of given levels of β-agonist on cardiomyocytes, 
competing neuro-hormonal factors and nervous stimulation would make data more difficult to 
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interpret. Studying cells isolated from the organ is therefore a useful way of removing these 
confounding factors. 
2.5.1 IONOPTIX SYSTEM SCHEMA 
The system for measuring cell shortening was based around a Nikon TE-200, inverted microscope 
with an IonOptix MyoCam camera scanning at 120Hz by a 60-240Hz (IonOptix Corp. Milton, MA) 
attached. This camera was attached to a PC via an interface module. Cell images were acquired and 
analyzed via the IonWizard 8 software package a schematic of the system is shown in Figure 2.5. The 
high absorption of light by the cardiomyocyte cell ends software can track these areas as they move 
due to the cells contraction. The movements at both ends of the cell were mathematically treated 
and then graphed as the cells’ length over time. Each contraction was therefore represented by a 
peak. Cells were suspended in a 200µl bath on the microscope which also contained two platinum 
electrodes for field stimulation; these electrodes were joined to an electrical stimulator module 
(50V, 0.2Hz human, 0.5Hz Rat, 1Hz Mouse). The cells were perfused with KH -Solution (1mM Ca2+,  
4mM Human) at 37oC using a peristaltic pump at a rate of 2ml/min. All pharmacological agents were 
added in KH.  
Cells were only deemed suitable for testing and analysis if they were: 
1. Rod-shaped, with good striations with a baseline contraction of 2-8% 
2. Quiescent when no electrical stimulation is applied 
3. Stably contracting and relaxing during the 10 minute baseline recording and throughout the 
experimental run 
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Figure 2.4 Image demonstrating the analysis of peaks from Ion Optix recordings 
Figure 2.4 shows a single transient contraction produced in a cardiomyocyte, the different phases 
and how this relates to the derivation of different measurable aspects of the cells contractility and 
lusitropy.  The baseline cell length represented the length of the cell at diastole before the 
application of the pacing current. The cell shortens transiently following pacing, replicating systole, 
the difference between the cell length at systole and diastole is defined as the fractional shortening. 
This value was used as a surrogate measure of contractile amplitude or inotropy; as the cell is 
unloaded it cannot be used as a true measure of contractility. The R50 value was the time taken for 
the cell to relax and restore 50% of the shortening produced by the pacing current. This value was 
used as a measure of the cell’s lusitropy in an unloaded preparation. To assess the effects of 
pharmacological agents on these parameters, protocols are performed as detailed in the individual 
chapters (3, 4 and 5). Upon acquisition of the IonOptix trace a group of ten representative peaks 
were selected from the phase of maximum stable contraction during each treatment phase and 
analysed. The R50 and shortening values were graphed and the magnitude of these values were 
compared between phases, an increase in cell shortening represented an increase in contraction and 
a reduction in R50 represented an increase in lusitropy.         
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Figure 2.5 Schematic of the Ion Optix based microscope system for the measurement of isolated 
cardiomyocyte shortening upon pacing 
2.5.2 IONOPTIX PROTOCOLS 
Standard β2AR response protocol         
The standard test of contractile response to β2AR stimulation was conducted as follows; cells were 
perfused with KH solution for 10 minutes to establish a stable baseline. The selective β1AR Blocker 
CGP20712A (CGP, 300nM) was perfused onto for 10 minutes followed by isoprenaline (1µM) for 10 
minutes. Any change in contractility was confirmed to be a specific β2AR effect by blocking the 
receptor with the specific antagonist ICI118, 551 (ICI, 50nM) for a further 10 minutes. 
Pre-stimulation- Catecholamines and Removal of the effects of Gi or cholesterol 
Either adrenaline or noradrenaline (100nM) was perfused onto a subset of cells for 20 minutes and 
then washed off before beginning the 10minute baseline stage. Treatment with pertussis toxin 
(1.5µg/ml, 3 hours 37oC) was employed to remove the effects of Gi when deemed necessary. A 
subset of cells was pre-treated with MβCD (1-2mM) for 1 hour at 37oC to deplete cellular cholesterol 
and thereby removing the caveolar localization of β2AR, they were analysed within 10 minutes 
(following 1 hour incubation with MβCD). 
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2.6 ANALYSIS OF MYOCYTES BY CONFOCAL MICROSCOPY TO ASSESS RELATIVE T-
TUBULE DENSITY 
The relative density of t-tubules may underlie differences in the physiological responses of 
cardiomyocytes to adrenergic stimulation. As a consequence it was essential that this aspect of the 
apical and basal cardiomyocytes morphology was assessed. Cardiomyocytes were isolated as 
described above (2.2.1) and plated on laminin coated coverslips for culture in M199 at 37oC and 95% 
O2/5%CO2. A solution (~1ml) of 1µM di-8-ANNEPPS was prepared in FRET buffer and sonicated for 20 
minutes. This was diluted to 0.5µM using 0.5ml of warmed FRET buffer. When this solution had 
cooled to room temperature, it was applied to the cells of interest to provide staining of cellular 
plasma membranes and t-tubular membranes. In the experiments in question the cells were 
scanned with a Zeiss LSM-780 inverted confocal microscope. Images were analyzed with MatLab and 
Image J.      
2.7 MEASUREMENT OF REGIONAL CARDIAC CONTRACTILITY IN VIVO BY 
ECHOCARDIOGRAPHY 
2.7.1 INTRODUCTION AND PRINCIPLES OF ECHOCARDIOGRAPHY 
Echocardiography is a non-invasive in vivo imaging modality which utilizes the scattering of sound 
waves. Sound is a pressure wave which has a frequency of between 20-20,000Hz. In air pressure 
waves of this frequency are audible to humans. The frequency of sound waves used in 
echocardiography is in the region beyond 20 kHz which is defined as ultrasound. Like all waves when 
ultrasound meets an obstruction, as it propagates through a field, it can be reflected or scattered. 
The reflected sound may be sensed and the time required for it to return, can be used to quantify 
the depth of the obstruction. Equally, the intensity of reflection of sound waves is a function of the 
relative amount of energy propagating or reflecting through an area of acoustic resistance (or 
impedance). Acoustic impedance occurs as the speed of sound varies between different materials 
being, for example, slower in air than water.  There is enough difference in the acoustic properties of 
different internal organ materials and extra-organ compartments, that reflections can be generated. 
The returning sound can be interpreted as information, allowing a representative image to be built 
up.  The scan area represents a graph of the reflection intensities between the sensor and the 
farthest regions which reflections can return with sufficient amplitude to be sensed. A limitation of 
this method is that resolution decreases as distance from the sensor increases.  This manner of 
image is known as a ‘brightness’ or ‘B-Mode’ image. This mode can be used to measure organ 
morphology and dynamics in real time. It is of special use to cardiovascular researchers as it enables 
rapid assessment of the contractility and size of the heart changes of which, are frequently a marker 
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of pathology. M-mode or ‘motion mode’ is a modification of B-mode which acquires the intensity in 
a line of pixels within the image over a time axis. Any motion of resistive structures within the image 
field will thusly cause areas of differing intensity to appear in different parts of the field over time. 
The resultant increase in resolution allows very rapid organ motion to be quantified making it 
especially useful in cardiac research. The small size of rodent species utilized in pre-clinical research 
means that special ultrasound probes must be employed to allow the sensing of rapidly reflected 
signals. Low frequency ultrasound is deeply penetrating but gives poorer spatial resolution, as the 
rodent is small the frequency must be increased to supply images of acceptable spatial resolution 
produced. The VisualSonicsTM Vevo770 (Ontario, Canada) system was utilized for these studies; this 
system is purposely designed for small animal imaging applications. It provides images with 
resolutions as low as 30µm at frame rates up to 240fps. The true power of this system comes from 
the different Real-Time Micro-Visualization ‘RMV’ scan probes it can employ. The design of these can 
be varied to allow usage on different species and for the acquisition of differing data sets. Large rats 
>250g were employed in these studies, thus the RMV-716 probe was utilized. This has a frequency 
range of 11-24MHz and provides an extended image ‘field of view’ with an enlarged head. The 
musculature and anatomy of rats of this size means that image artefacts are often produced by ribs 
scattering ultrasound of frequencies higher than 20MHz. These distortions result in a loss of image 
resolution.        
2.7.2 ECHOCARDIOGRAPHY PROTOCOL 
Adult rats of either sex were brought to the echocardiography suite and anaesthetised in a chamber 
with an atmosphere of 5% isoflurane (IsoFlo, Abbott, US). Following the loss of the righting reflex, 
the animals were moved to a bench top and fur was rapidly removed from the pectoral region with a 
trimmer.  The animals were then attached to a Visual Sonics ECG plate by their paws in a dorsal 
recumbence using tape. Electrode gel was applied before fixing the paws. Anaesthesia was 
maintained by placing the rat’s nose and muzzle into a cone through which a mixture of 98.5% 
O2/1.5% Isoflurane was passed at 1.5L/min. Pedal and palpebral reflexes were tested at regular 
intervals to ensure that the animals were sufficiently sedated. At this point hair removal gel (Nair 
(active ingredients NaOH/Ca(OH)2), Church and Dwight, US) was applied to the animal’s chest to 
ensure the removal of all hairs, this was removed and the area promptly rinsed after no more than 5 
minutes.  
A lateral incision was made into the area between the right regio axillaris and regio mammaria 
thoracica toward the sternum slightly caudal to the clavicle. After paring away a small amount of 
connective tissue and fat by blunt dissection the jugular vein was revealed. The vein was cannulated 
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using a 26G catheter, after confirmation of blood flow by ‘flashback’ the cannula was flushed with 
heparinized PBS as a lock solution. This provided an intravenous delivery route for any desired 
pharmacological treatments (Figure 2.6).  In the case of catecholamine administration this route 
provides a scenario which mimics the rapid delivery of catecholamines to the myocardium after 
secretion from the adrenals into the plasma. Finally, the ultrasound probe was manoeuvred into 
place above the animal on a specifically designed clamp-stand. Ultrasound gel was applied to the 
animal’s chest to displace any air present between the animal’s skin and the probe head. The probe 
was then lowered into contact and imaging initiated. 
                i)                       ii)    
Figure 2.6 Schematic of the cannulation of the jugular of an anaesthetized rat placed on an electrode 
place in dorsal recumbency 
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2.7.3 EXAMPLE IMAGES OF RAT ECHOCARDIOGRAPHY 
Echocardiography was able to provide images of the rat heart in a variety of views. The brightness 
mode (B-Mode) provided 2D real-time images of the heart which were acquired as an image loop 
see Figure 2.7a. A line was selected through a field of interest; this produced an M-mode image 
where a single line of pixels was mapped over time Figure 2.7 B, C.  Distances between anatomical 
elements can be measured from this mode, in this respect in vivo cardiac contractility can be 
quantified accurately following interventions.  Fractional shortening of the heart was measured by 
measuring the end diastolic and end systolic diameter of the left ventricle.         
Figure 2.7 Representative views of the rat left ventricle a) brightness mode (B-Mode) long axis image 
of the heart b) image planes can be selected in which M-mode images can be acquired, image b) 
shows the areas of interest (Apex, Mid-Left Ventricle (MLV) and Base). c) M-Modes of the apex, MLV 
and base d) analysis of EDD and ESD from M-mode images 
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2.8 NOTES ON THE PHARMACOLOGICAL CHARACTERISTICS OF TOOL COMPOUNDS USED 
FOR Β2AR STIMULATION 
Please refer to appendix 9.4 for tables displaying quantitative data concerning the pharmacological 
properties of drug compounds utilized as tools in this work. Specific β2AR stimulation, as discussed, 
is provided by stimulating cells with a combination of Isoprenaline and the selective β1AR antagonist 
CGP20712A. CGP20712A binds β1AR 550 times more effectively than β2AR and has a pA2 value of 
around 9.0. When employed alongside Isoprenaline at either (ISO 100nM/ CGP 100nM) or (ISO 
1µM/CGP 300nM) 160 and 130 times more β2AR than β1AR is bound. Both these configurations are 
sub-maximal in terms of binding β2AR (25% and 75% respectively) but the efficacy ratio of 
isoprenaline is such that in terms of response both these concentrations should be maximal. A 
concentration of 100nM Isoprenaline is employed in FRET microscopy to allow stimulation at a 
concentration capable of stimulating of maximal physiologic responses without risking saturation of 
the FRET sensor with cAMP. Equally, a concentration of 1µM Isoprenaline was used in the IonOptix 
tests to ensure that absolutely maximal β2AR stimulation was achieved. Adrenaline and 
noradrenaline are employed to cause physiologic desentization at concentrations similar to that 
encountered in vivo. Equally, adrenaline boluses in rat studies are utilized at the concentrations 
established by Paur et al. (2012) which are capable of provoking tako tsubo like symptoms.     
2.9 MATERIALS 
All reagents were purchased from Sigma-Aldrich (Poole, UK) unless otherwise indicated in the text; a 
list of non-Sigma obtained reagents is given below. 
100% Isoflurane, Abbott, US 
Minimal existing media x1 Gibco (via VWR, UK)  
M199 x1 Gibco (via VWR, UK)  
Adrenaline (Epinephrine Hydrochloride) 1mg/ml (Hameln, UK) 
Noradrenaline (Norepinephrine Hydrochloride) 5mg/ml (Hameln, UK) 
100% O2 (BOC, UK) 
95%O2:5% CO2 (BOC, UK) 
Collagenase II 300units/mg (Worthington, UK) 
Electrode Gel (Parker Laboratories Inc, NJ, USA) 
Ultrasound Gel (Henleys Medical, UK) 
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2.10 STATISTICS 
Statistical testing was performed with Graph Pad 4.0 software and all data is displayed as mean± 
standard error of the mean unless otherwise indicated, number of tests is indicated by ‘n’ and 
number of cell preparations (experimental days) is indicated by ‘p’. Multiple treatments were carried 
out on each preparation to remove the effects of any inter-individual variability or effects of 
isolation. Statistical testing is indicated on histograms by a bar between tested columns and asterisks 
are used to denote the p-value obtained from the test in the conventional manner, *=p<0.05, 
**=p<0.01 and ***=p<0.001. A p-value of p<0.05 is deemed significant in this work. Ordinal data 
such as measurements of contraction or distance were tested for normality by the Komogorov-
Smirnov test and if deemed Gaussian tested by parametric tests. Ratio data was deemed non-
parametric even if passing the test of normality and tested with a non-parametric test. 
2.9.1PARAMETRIC TESTS 
2.9.1.1 ONE-WAY ANOVA 
A one-way analysis of variance (ANOVA) test was utilized to test whether data from more than two 
different test groups were drawn from the same sample populations. This was produced by the 
ANOVA tests analysis of the variance of different populations. This allowed one to test whether two 
groups were drawn from different populations and as such whether they were different to a 
statistically significant degree and consequently rejection of the null hypothesis. Following 
assessment of the One-Way ANOVA F-statistic, the Bonferroni post-test was applied to establish the 
p-value of the test between individual pairs of groups. This test was utilized for the analysis of the 
baseline biometric and contractile parameters of rats. 
2.9.1.2 REPEATED MEASURES ONE-WAY ANOVA 
The repeated measures ANOVA allows the assessment of paired data from single populations and 
consequently allows assessment of whether sequential treatments have a significant effect upon the 
population. The test functions similarly to an ANOVA and requires a Bonferroni post test to establish 
the p-value between single pairs of sequential treatment groups. This test was ideal for analysis of 
measures of cell shortening where more than one treatment was applied sequentially.   
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2.9.1. 3 TWO-WAY ANOVA 
The Two-Way ANOVA is yet another extention of the ANOVA test, it permits analysis of data which is 
acquired from more than one pair of groups but the parameter measured alters over more than one 
dimension. For example the contraction of a heart measured following different treatments at 
discrete times. For this reason it is utilized to test data concerning contraction acquired from 
separate rat groups treated with the adrenaline bolus over a 60 minute time period. This test also 
requires a post test to establish whether one can be confident of a difference between groups at 
specific times following treatment.   
2.9.1. 4 STUDENTS T-TEST 
The student t-test is a test which generates a t-statistic from two groups (a single pair) of Gaussian 
data and allows assessment of whether they are significantly different.  The p-value is obtained by 
assessing whether the p-value obtained is larger than that found within a t-table based upon the 
degrees of freedom within the sample populations. In this way one can test the hypothesis that two 
groups are different by generating a t-statistic and assessing whether it is suitability large, if so the 
null hypothesis that the groups are no different can be rejected. In this work a t-test which was 
unpaired (for discrete data sets) was utilized to test for a difference between data sets that 
concerned caveolae number, cell size and protein levels quantified by western blotting.  
2.9.2 NON-PARAMETRIC TESTS 
2.9.2.1 MANN-WHITNEY 
The Mann-Whitney test is the non-parametric counter part of the t-test, in that it assesses pairs of 
sample sets for statistical difference. Much data presented in this work are in the form of a 
corrected ratio, in these cases a non-parametric test is utilized as one cannot be sure how closely the 
data approximates to a normal distribution due to the lack of a clear ordinal value. Measures of FRET 
response, both raw and corrected, and fold change in contractility were assessed by the Mann-
Whitney test. Measurements of arrhythmia between rats treated with an adrenaline bolus were 
analysed using this method.   
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2.9.2.2 WILCOXON MATCHED PAIRS TEST 
The Wilcoxon Matched Pairs test represents a non-parametric test of data drawn from groups which 
are paired in some way. It was used to assess whether the application of a treatment 
(phosphodiesterase inhibitor) caused an increase in FRET response (non-parametric) following the 
application of an initial treatment.     
2.9.2.3 FISHERS EXACT TEST 
This test was utilized to establish whether the mortality of two rat treatment groups was 
significantly different. Fishers Exact test establishes whether the frequency of outcomes entered into 
a contingency table significantly differ from what would be expected if they were no different.  
2.9.2.4 KRUSKAL-WALLIS TEST  
This test is the non-parameteric version of a one-way ANOVA, Dunnett’s post test is used instead of 
a Bonferroni post test to test differences between groups.  
2.9.2.5 POST-HOC POWER CALCULATION 
This test was employed to investigate the statistical power of in vivo data which did not reach 
statistical significance. This analysis was performed by the power calculation wizard in the Graph Pad 
StatMate 2 program.    
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3. Regional Differences in Cardiomyocyte β2AR Response  
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3. REGIONAL DIFFERENCES IN CARDIOMYOCYTE Β2AR RESPONSE 
3.1 INTRODUCTION 
The syndrome of Takotsubo cardiomyopathy appears to be a collection of related disorders 
characterized by the presence of an apparent stunning of specific regions of the myocardium. The 
most common of these is a hypo-contractility of the apical myocardium relative to hyper-
contractility of the basal myocardium. It has been suggested that differing levels of responsiveness 
of the myocardium to adrenergic stimulation are in existence (Mori et al., 1993). The β2AR sub-type 
has been implicated as possibly having a role in this regional disorder. Recently it was demonstrated 
that the ratio of β2AR/ β1AR was higher within the apical myocardium relative to the base. Also 
infusion of adrenaline (β1AR/β2AR agonist) but not noradrenaline (predominantly β1AR agonist) 
initiated Takotsubo like symptoms in rats (Paur et al., 2012). The β2AR, which is usually mildly 
positively inotropic, can have negatively inotropic effects on the apical myocardium. This is 
explained by the higher density of this receptor sub-type in this region coupled with its ability to 
bind Gi. β2AR-Gi has been observed to exert negatively inotropic (Gong, et al 2002) effects by 
inhibiting adenylate cyclase and subsequently reducing the cAMP-dependent PKA phosphorylation 
of effectors controlling cardiomyocyte inotropy. It may also cause the stimulation of negatively 
inotropic kinases via the dissociation of the Gi’s GBY subunit. Equally, however it is suggested that 
adrenergic overstimulation may also be inhibitory via the Gs pathway via cAMP mediated calcium 
toxicity (Nef et al., 2010). An interplay of these factors may be causative, as β2AR may not couple to 
Gi (through the process of stimulus trafficking) without phosphorylation by PKA. This requires Gs, 
activity so the level of Gs and Gi activity are correlated and not mutually exclusive.  
It was not clear whether the increased adrenergic responsiveness of the apical myocardium was a 
product of intrinsic differences between the cells of this part of the rodent heart in comparison to 
the basal region. It was also not known whether a simple difference in receptor density was the 
cause of the differences, or whether other factors such as structural differences between the apical 
and basal cell types were responsible. Paur et al. (2012) reported a difference in receptor sub-type 
ratio is apparent, but no difference in the levels of cAMP measured in apical and basal cells following 
β2AR stimulation. It is therefore unclear as to how β2AR activity levels relate to differences in 
contractility or Gs-activity leading to a pathological outcome in the rat model of Takotsubo 
cardiomyopathy. We sought to test this finding and test our hypothesis, that β2AR-cAMP is restricted 
from influencing cardiomyocyte contractility via PKA in basal but not apical cardiomyocytes. A video 
microscopy technique was used to measure cardiomyocyte shortening as an index of contractility. 
FRET sensors localized to different regions of the cell were used to measure cAMP responses in 
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different sub-cellular compartments following β2AR stimulation. Finally, a combination SICM/FRET 
method was employed to explore the possibility that the β2AR were localized in different sub-cellular 
regions within the different cell types. This may mediate differences in the relative ability of cAMP to 
diffuse into different areas of the cell and differentially control cardiomyocyte contractility.   
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3.2 METHODS 
3.2.1 SOLUTIONS 
CGP20712A, isoprenaline HCl and ICI 118, 551 were supplied by Sigma Aldrich (Poole, UK). All 
solutions were prepared in the media in which cells were subsequently analysed i.e. solutions for 
IonOptix experiments were made in Krebs-Henseleit (composition detailed in section 2.2.1) and 
solutions for FRET were prepared in the HEPES-based FRET buffer (composition detailed in section 
2.3.5).    
3.2.2 MICROSCOPY STUDIES OF PHYSICAL ATTRIBUTES OF APICAL AND BASAL 
CARDIOMYOCYTES 
3.2.2.1 OPTICAL MICROSCOPY STUDIES 
Cardiomyocytes were isolated from the apical or basal thirds of the left ventricle. They were 
subsequently washed with low-calcium HEPES buffer and placed upon laminin coated cover slips 
(25mm) at a density of approximately 150 myocytes per mm2 on a culture plate. They were washed 
with M199 media and incubated in the same medium. After at least an hour of culture, to ensure 
myocyte stability, the plate was transferred to an inverted optical microscope (Nikon TE200). At least 
ten myocytes were selected at random from separate parts of the coverslip and their diameter and 
length was measured. This was repeated for apex and base and data from three separate isolations 
(from different animals) was pooled. 
3.2.2.2 CONFOCAL ANALYSIS OF DI-8ANNEPPS STAINING TO ASSESS T-TUBULE DENSITY 
Apical and basal cardiomyocytes were isolated and plated as per normal protocols and stained with 
di-8-ANNEPS as described in (Ibrahim et al., 2010). Around 1.5ml of FRET buffer was heated to 55oC 
for 10 minutes, 1ml was removed and used to dissolve the di-8-ANNEPS dye. The mixture was 
returned to the water bath and sonicated for 20 minutes. Half of the dissolved di-8-ANNEPS mixture 
(0.5ml) was mixed with a further 0.5ml of warmed FRET buffer. The cardiomyocytes affixed to 
laminin coated coverslips were removed from the incubator and washed with FRET buffer and the 
di-8-ANNEPS was dropped onto the cells. The di-8-ANNEPS was washed off after 1 minute by 
washing with FRET buffer three times. The cells were then imaged using a Zeiss LSM-780 confocal 
microscope using a 63x oil objective employing excitation at 488nm. Z-stack images were generated 
by obtaining a confocal image each 0.49μm through each cell from top to bottom. The z-stacks 
resulting from this were analysed using ImageJ (http://rsbweb.nih.gov/ij/, 2013, NIH), 40x5μm areas 
of the cell interior external to the nucleus were selected. These areas were thresholded and 
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transformed into binarized black and white images. White areas were quantified as a proportion of 
cell area providing an assessment of t-tubule density. These binary images were turned into power-
frequency peaks via a 1D Fourier transform in MatLab (The MathWorks, Inc., Natick, MA, USA). This 
gave, as an output, a peak at the most common frequency (0.5Hz as t-tubules repeat every 2 
microns) with the amplitude displayed as arbitrary units. The amplitude of this peak increases as the 
regularity of di-8-ANNEPS staining increases; the relative regularity of di-8-ANNEPS can be compared 
between cells and cell types.               
3.2.3 ION OPTIX STUDIES OF CARDIOMYOCYTE CONTRACTILITY 
Apical and basal cardiomyocytes were isolated and stored in a low calcium buffer. A flow chamber 
was prepared with a glass cover slip to produce a cell bath for imaging the cardiomyocytes. Krebs-
Henseleit buffer was perfused through the chamber at 37oC (bubbled with O2/CO2 95/5%) at a rate of 
1-2ml/min. When a stable perfusion had been established the flow was switched off and cells were 
placed into the bath. After around 5 minutes the cells had attached to the glass surface and the 
perfusion system was turned on, at the same time as the cell stimulator which produced a voltage of 
50V across the bath at a rate of 0.5Hz. The cells began to contract rhythmically in time with the 
stimulation. After ensuring the cells were contracting stably with no episodes of arrhythmia a single 
cell was selected and targeted by the IonOptix imaging software. The distance between the two 
ends, as selected by the operator, was taken as the cell length and the relative deflection of the ends 
over the course of the contraction cycle was used as an indicator of relative fractional shortening as 
detailed in the materials and methods section in Chapter 2. From this baseline the following 
protocols were employed to provide data concerning different aspects of the cardiomyocyte β2AR’s 
effect on contractility. Experiments designed by Peter Wright with the contribution of some data by 
Laura Pannell. 
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3.2.3.1 INVESTIGATION OF THE RELATIVE CONTRACTILE RESPONSIVENESS OF 
CARDIOMYOCYTES TO Β2AR STIMULATION –SINGLE DOSE 
 
Baseline contractility was observed for 10 minutes to ensure the suitability of the cells contraction. 
Following this the specific β1AR blocker CGP20712A is introduced to the solution to ensure that any 
changes in contractility were related to β2AR activity. The baseline shortening was recorded at this 
point and further increases in shortening were corrected to this value. Isoprenaline was added to 
stimulate β2AR, the peak of contraction was measured during this period. ICI 118,551 was added to 
block β2AR and consequently confirm any changes in contraction were β2AR mediated.       
 
Figure 3.1 Example of fractional shortening time courses measured by the IonOptix method, for 
apical and basal rat cardiomyocytes, demonstrating contraction changes following application of ISO 
in the presence of CGP to provide β2AR stimulation. Following the application of ICI118, 551 
contractile changes induced by β2AR are inhibited. 
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3.2.3.2 INVESTIGATION OF CONTRACTILE RESPONSES OF CARDIOMYOCYTES TO 
ISOPRENALINE (CONCENTRATION-RESPONSE RELATIONSHIP) +/- CGP20712A        
 
In this protocol a baseline was observed for 10 minutes as in the previous protocol and β1AR 
blockade by addition of CGP20712A was imparted if desired. Following this step, isoprenaline was 
added in log and half log steps between 10-10M and 10-6M. This gave a concentration-response curve 
in the manner of Van-Rossum and Van den Brink (1963).  
3.2.4 FRET BASED STUDIES OF CAMP RESPONSES  
Cells isolated from the apex and base of rat or mouse were plated on to laminin coated coverslips. In 
the case of rat these cells were cultured for 48 hours (M199 in presence of adenovirus containing 
the FRET construct of interest) or simply used on the day of isolation in the case of the Epac1 mouse.  
During the imaging run one of the following protocols was performed 
3.2.4.1 TO DETERMINE Β2AR RESPONSE AS A FUNCTION OF FULL CELLULAR ADENYLATE 
CYCLASE RESPONSE   
 
When the cover slip was taken from the plate in the incubator it was washed with FRET buffer and 
fastened into a coverslip holder which formed a 200μl cell bath. This was placed onto the stage of an 
inverted microscope and the perfusion inlet and outlets put in place. The perfusion system inlet was 
attached to a micromanipulator device which meant that the inlet could be manoeuvred close to the 
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cells of interest. As the FRET imaging run began FRET buffer with CGP was applied (1-2ml/min) to 
provide β1AR blockade. After a satisfactory baseline period had elapsed Isoprenaline was applied to 
give β2AR stimulation. After the β2AR response had plateaued the Forskolin analogue NKH477 was 
applied to fully stimulate all cellular adenylate cyclase activity. A modified version of this method, 
without the application of NKH477, is used to provide readouts of the effects of single 
concentrations of isoprenaline between 10-8M and 10-5M. 
 
Figure 3.2 Examples of FRET Response and analysis stages demonstrating the role of different 
pharmacological stimuli in enhancing cellular cAMP responses 
3.2.4.2 TO DETERMINE RELATIVE CONTRIBUTIONS OF ΒAR SUBTYPES TO CARDIOMYOCYTE 
ISOPRENALINE RESPONSE 
 
In this method following a suitable baseline period in the FRET Imaging run isoprenaline was applied 
with no βAR blockade. When the full cAMP response was observed CGP is applied to subtract the 
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β1AR component from the cAMP production. When this removal phase plateaued, ICI was added to 
subtract the β2AR component of the cAMP response. By adding together the sum of β1AR/β2AR 
removal phases together the relative ratio of the βAR subtype contributions was calculated.    
 
Figure 3.3 Example trace of a FRET protocol allowing assessment of the relative contributions of the 
different beta-adrenoceptor subtypes to the cardiomyocyte cAMP response 
3.2.5 COMBINATION SICM/FRET MICROSCOPY WITH MICROPIPETTE AGONIST 
APPLICATION 
In combination SICM/FRET, cells transfected with the cAMP-sensing FRET construct cEPAC2 were 
scanned with the SICM nanopipette to provide a 20μmx20μm image of sub-cellular regions. This 
revealed the gross topography of this sub-cellular area. Areas with prominent areas of z-grooves 
were targeted and scanned at a resolution of 10μmx10μm. This gave a scan of sufficient resolution 
that t-tubular openings could be observed. Equally, a clear distinction could be made between t-
tubule openings and non- t-tubule areas. At this point the area of interest was targeted using a 
command from the SICM software interface, which rasters the pipette to coordinates defined by 
selecting an area on the scan image. An optical image of the cell and pipette was acquired to show 
the overall shape of the cell and to allow separation of the cell into ‘application’ and non-application 
areas. Perfusion was initiated to ensure that any applied substances were removed as rapidly as 
possible from the application site. Fluorescence images were acquired as the FRET run was initiated 
(as per Nikolaev et al. (2010)), after the acquisition of a suitable baseline for the FRET ratio, a 
pressure of around 60psi was applied to the pipette. This pressure was removed after about 50 
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seconds. The FRET ratio responses were subsequently recorded and graphed, by splitting the cell 
into 4 sectors. These were displayed as 1,2; being two regions close to the site of application but in 
front of it in relation to the perfusion. For this reason isoprenaline could not be expected to diffuse 
over this region upon application. Areas 3 and 4 were regions behind the application site relative to 
perfusion, 3 was the region directly around the application site and 4 was the section immediately 
next to the application site. This provides information not just on the relative size of the cAMP 
response but also on the relative localization of this response.         
 
3.2.6 STATISTICAL ANALYSIS BY GRAPH PAD 4.O 
Cell size was analyzed using an unpaired Student’s t-test (Gaussian distribution). Cell contractility 
was analyzed by initially testing pre-treatment, treatment and removal of treatment groups for each 
cell type with a One-way Repeated Measures ANOVA. Subsequently, fold increases between cell 
types were analyzed with an unpaired Mann-Whitney test (Non-Gaussian data). Dose response 
experiments were analyzed by non-linear regression and fitting to a sigmoidal curve. Single dose 
tests to measure cAMP-mediated FRET shifts between cell types were analyzed using an unpaired 
Mann Whitney test (Non-Gaussian Data). Dose response experiments were analyzed by non-linear 
regression and fitting to a sigmoidal curve. Finally, SICM/FRET studies were analyzed using a One-
Way Repeated Measures ANOVA to test diffusion into different sub-cellular regions between cell 
types. Differences between crest and groove cAMP responses and relative apical and basal 
responses were analyzed using unpaired Student’s t-test (Gaussian Data).     
 
95 
 
3.3 RESULTS 
3.3.1 PHYSICAL ASPECTS OF THE EFFECTS OF Β2AR STIMULATION ON APICAL AND BASAL 
CARDIOMYOCYTES 
3.3.1.1. STRUCTURAL PARAMETERS OF APICAL AND BASAL CARDIOMYOCYTES- CELL SIZE 
The two cardiomyocyte cell populations were physically characterized, to assess whether any 
morphological differences may underlie observed differences in function. A microscope with a digital 
camera attached was used to photograph samples of cells, and a software package used to measure 
the length and diameter of apical or basal cells. There were no differences between apical and basal 
cells in either length or width. The graphs in figure 3.4 present these data.     
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Figure 3.4: a) A comparison of the lengths and the b) widths of apical and basally derived rat 
cardiomyocytes.These measurements were achieved bytaking calibrated photographs via optical 
microscopy and cells were measured using the ImageJ program (statistical analysis by Student’s T-
Test).  
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 3.3.1.2 STRUCTURAL PARAMETERS OF APICAL AND BASAL CARDIOMYOCYTE T-TUBULE 
DENSITY AND REGULARITY 
To provide further assurance that intrinsic structural differences between apical and basal cells were 
not present; confocal microscopy was used to determine membrane structure in di-8-ANNEPS 
labelled cells.  It is apparent that there are some underlying differences in the regularity of the t-
tubular invaginations between apex and base.  Basal cells t-tubular network is much more regular as 
the power peak following 1D Fourier transform analysis is significantly greater in this cell type in 
comparison to apical cells, shown in Figure 3.5a. Figure 3.5b shows the difference in the density of 
di-8-ANNEPS staining between the apical and basal cells. This is related to the amount of t-tubules, 
the data suggest that basal cardiomyocytes have a denser t-tubular network than apical cells.  
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Figure 3.5 A) Regularity of di-8-ANNEPS staining of rat cardiomyocyte t-tubular membranes. B) The 
density of t-tubules stained by di-8-ANNEPS as a percentage of cell area in apical and basal rat 
cardiomyocytes. Data was acquired by staining cells and measuring fluoresence intensity, statistical 
analysis by Student’s t-test.  
3.3.1.3 CONTRACTILE RESPONSES OF RAT AND MOUSE CARDIOMYOCYTES TO SELECTIVE 
Β2AR STIMULATION 
 The fractional shortening of apical or basal cardiomyocytes was measured before, during and after 
the removal of selective β2AR stimulation. An IonOptix video microscope technique was utilized for 
the acquisition of these data. Figure 3.6 a) shows the shortening of apical and basal cells isolated 
from rat. Apical cells show an increase in shortening following the addition of isoprenaline, Figure 
3.6a. This is also true of basal myocytes. Both the apical and basal cells shortening reduced back to 
baseline following the addition of ICI 118,551, which confirmed the increase was mediated by β2AR. 
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 Apical and basal cardiomyocytes from mice were assessed in the same way as those from rats. Data 
from this species should allow us to draw conclusions as to whether any regionality is peculiar to rats 
or present in other species. Although historically the favoured experimental animal within this area 
of study is the rat, the array of genetic tools available for the mouse may allow powerful studies of 
factors affecting cardiac regionality in future. Apical and basal cells increased their shortening in 
response to selective β2AR stimulation, Figure 3.6b. Removal of the selective β2AR stimulation using 
ICI 115,881 only confirmed a β2AR effect in the case of the apical cells. There was no significant 
difference between the mean shortening of the basal cells before and after ICI 115, 881. 
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Figure 3.6 a) Rat apex/base cardiomyocyte shortening before (CGP) and after selective β2AR 
stimulation (CGP100nM +ISO 1µM) as well as after the specific removal of stimulation with the 
selective β2AR blocker ICI 115,881 50nM (CGP+ISO+ICI).  b) Mouse apex/base cardiomyocytes cell 
shortening before (CGP) and after selective β2AR stimulation (CGP+ISO), as well as after the specific 
removal of stimulation with the selective β2AR blocker ICI 115,881 (CGP+ISO+ICI). Statistical analysis 
of the data was by One-Way Repeated Measures ANOVA. 
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The increases are quite subtle with respect to previous published examples of the effect of β1AR 
stimulation or the effect of isoprenaline without the presence of CGP (Agarwal et al., 2011). In this 
respect it can be said that the β2AR stimulates increases in cell shortening less potently than β1AR. 
For both the rat and mouse the effect of selective β2AR stimulation is greater on the apical cells as 
function of baseline shortening. The increase in shortening of apical cells was around a doubling 
whereas basal cells increase their shortening about by a third. Data are presented in Figure3.7 a, b 
respectively. Within the intact myocardium this may lead to quite dramatic regional differences in 
β2AR mediated contractility, with consequences for pathology.        
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Figure 3.7 a) Graph presenting the increase in shortening of rat cardiomyocytes from the apical or 
basal myocardium following selective β2AR stimulation by 100nM Isoprenaline, presented relative to 
baseline shortening. Zero represents the basal contractility. b) Graph presenting the increase in 
shortening of mouse cardiomyocytes from the apical or basal myocardium is presented relative to 
baseline. Statistical analysis of the data was by an unpaired Mann-Whitney test. 
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3.3.1.4 THE Β2AR RECEPTOR MEDIATED CONTRACTILITY IS NOT AMENABLE TO STUDY BY 
EXPLORING TRADITIONAL CONCENTRATION-RESPONSE RELATIONSHIPS  
Pharmacologists frequently use assays where tissues of interest are exposed to a cumulatively 
increasing concentration of the pharmacological agent of interest. Classically, if the system is simple 
the concentration/response relationship is sigmoidal. This situation means that quantitative aspects 
of the tissues physiology, for example receptor number, can be inferred. In this respect, it was 
questioned whether the effects observed above were related to an increased receptor number. 
Increasing the number of receptors in a tissue shifts the idealized sigmodal curve to the left meaning 
that maximal biological responses maybe achieved with lower concentrations of agonist. Thus the 
observed effects may be explainable by the presence of many more β2AR in the apical myocardium. 
Initially, the apical and basal cells were exposed to an increasing level of isoprenaline to assess the 
relative amount of βAR (i.e. β1AR+ β2AR).  Data is presented in Figure 3.8.  There appears to be a 
greater responsiveness of the apical cells to isoprenaline stimulation, which has shifted this curve to 
the left of the basal cells on the x-axis.   
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Figure 3.8: Graph displaying cumulative concentration-response curves showing the effect of 
increasing doses of isoprenaline on rat cells isolated from the apex or base of the rat myocardium.  
Curves are determined to be significantly different following non-linear regressionand fitted to a 
sigmoidal curve (p<0.01, n=7 cells from 3 preparations). 
The results concerning βAR could be explainable by an increased amount of β2AR in the apical cells 
alongside a level of β1AR analogous to that of the basal cells. This extra β2AR could relatively 
sensitize the apical myocardium to isoprenaline. The experiment above was repeated but the 
selective β1AR-blocker CGP20712A was added to the Krebs-buffer. A rather inconclusive result was 
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obtained (shown in Figure 3.9) the concentration-response curves for apex and base did not show a 
classical sigmoidal shape. The apical cells appear to be less sensitive to isoprenaline than the basal 
cells.  
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Figure 3.9 a) Graphs displaying cumulative concentration-response studies showing the shortening of 
rat apical and basal cells to an increasing concentrations of isoprenaline in the presence of the 
selective β1AR-blocker CGP20712A. b) The shortening data in figure a) is presented as %maximal 
shortening.These data could not be studied by non-linear regression as they could not satisfactorially 
be fitted to a sigmoidal curve. 
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3.3.2 INVESTIGATIONS OF CARDIOMYOCYTE Β2AR CAMP SIGNALLING IN APICAL AND 
BASAL CARDIOMYOCYTES 
 3.3.2.1 INVESTIGATING THE RELATIVE COMPARTMENTATION OF Β2AR-CAMP UTILIZING 
LOCALIZED FRET SENSORS 
The differences in apical and basal shortening responses are not clearly explained by a simple factor 
such as receptor expression level. Consequently, the suggestion would be that the β2AR-cAMP is 
somehow controlled in a different manner in the different cell types.  The influence of this secondary 
messenger on the PKA compartments, which define the contractile properties of the cell, may be 
different in the different cell types. If this were so then the expectation would be that contractility of 
different cell types would differ following stimulation. Cells were transfected with FRET based cAMP 
sensors using adenoviral vectors. A freely diffusible sensor, cEPAC2, was used to measure β2AR-
cAMP responses within the whole cell. A sensor named RII_Epac was used to measure β2AR-cAMP 
levels in the PKA-RII compartment, this sensor is based on the regulatory subunit of PKA, and 
consequently localizes to the AKAPs giving a striated pattern of fluorescence. A sensor which 
localizes to the plasma membrane with some specificity for caveolin rich regions was also employed. 
This sensor, pmEpac2, is based upon Epac2 but is also fused with a peptide moiety from the SH4 
region of the Lyn kinase.  This becomes myristoylated and as a consequence is trafficked to the 
hydrophobic lipid raft regions of the cell membrane. This sensor would therefore give an indication 
of cAMP levels produced by β2AR in the plasma membrane compartment, with some indication of 
what the levels are like in the caveolar regions. Rat cells were transfected with the sensors described 
and then imaged. A baseline was recorded and then β2AR was selectively stimulated. Full activation 
of cellular adenylate cyclase was produced by stimulating the cells with the forskolin-analogue 
NKH477. 
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The cEpac2 sensor, which is not localized to any particular region of the cell, records equal FRET 
shifts in apical and basal cells following β2AR stimulation Figure 3.10a,i). There was no difference in 
the FRET shift evoked by fully stimulating all adenylate cyclase using the forskolin analogue NKH477 
Figure 3.10 a, i). In consequence there was also no difference between the apical and basal β2AR 
response as corrected to the full activation of adenyl cyclase Figure 3.10 a, ii). The suggestion here 
would therefore be that that the differences in the cell types which contributed to the observed 
differences in shortening were not due to concentrations of cAMP within the cells’ cytosol. If 
receptor expression were much higher in the apical cells we might expect a much higher 
concentration of cAMP to be produced in the cells’ cytosol following β2AR stimulation, this would 
lead to increased PKA activity and increased shortening as a consequence. These data suggest that 
this is not the case. As the amount of cAMP produced by β2AR in the cytosol does not differ it is 
possibly the efficiency of conduction of cAMP to the relevant microdomains which determines 
differences in physiological responses. Recordings with a FRET sensor localized in the plasma 
membrane further suggest the lack of a clear difference between apical and basal β2AR-cAMP 
response, when appraising the raw FRET responses.  
A) cEPAC2                                                                                   
ISO ISO+NKH ISO ISO+NKH
0
5
10
15
Apex Base
NS
NS
%
 F
R
E
T
 R
a
ti
o
S
h
if
t
Apex Base
0
25
50
75
100
NS
%
 T
o
ta
l 
c
A
M
P
O
u
tp
u
t
i) ii)n=22
p=10
n=14
p=10
n=22
p=10
n=14
p=10
 
Figure 3.10 A, i) Graph displaying the FRET response of non-localized FRET sensor cEPAC2 following 
β2AR (ISO 100nM) or full AC stimulation (NKH 5µM) in rat apical and basal cardiomyocytes. A, ii) 
Graph displaying the response of apical and basal cardiomyocytes, as a function of maximal cAMP 
response. Data were analysed by unpaired Mann-Whitney tests. 
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The pmEPAC2 sensor localizes itself into the very regions which harbour most of the cellular β2AR 
and cAMP. This might suggest that it would be more sensitive to differences, as cAMP production 
can be measured without the distortion of diffusion and cAMP removal by phosphodiesterases. 
There is no clear difference between apical and basal β2AR-cAMP FRET responses. There is no 
difference between the uncorrected FRET shift values of apical and basal cells following the 
stimulation of the cells with NKH477 vs. Base. The mean shift in basal cells following NKH477 
treatment is roughly 10% so the lack of a statistically significant difference may be due to variability 
within the cell populations. Due to the differences in construction of the FRET sensors it is important 
that we rely on corrected FRET responses to eliminate error introduced by subtle differences in the 
sensitivity of the different sensors. In Figure 3.10b, ii pmEPAC2 studies one can observe a significant 
difference in the response of apical and basal cardiomyocytes.  Relatively, lower cAMP output in the 
membrane regions of basal cells might suggest a difference in the compartmentation of the β2AR 
which the cytosolic sensor cEPAC2 is not specific enough to detect. This increased β2AR-cAMP 
response in apical cardiomyocytes may result in the physiological differences observed. 
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Figure 3.10 B, i) Graphs displaying the pmEPAC2 (plasma membrane localized) responses in rat apical 
and basal cardiomyocytes following β2AR (100nM ISO) or full AC stimulation (NKH 5µM). B, ii) 
Graphs displaying the β2AR response of apical and basal cardiomyocytes corrected to total cAMP 
response. Data were analysed by unpaired Mann-Whitney tests. 
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The RII_Epac sensor (Figure 3.10ci, ii) localizes itself with the AKAPs which scaffold the PKA-RII 
compartment; therefore any cAMP entering this region may be able to influence cardiomyocyte 
contractility. The raw FRET shift, induced by stimulating the β2AR, is almost four times higher in 
apical cells. The difference between apical and basal measurements with this sensor stands in 
contrast to measurements made with pmEPAC2 or cEPAC2. The β2AR is, as discussed in section 1.4.3, 
a heavily compartmentalized molecule, so it may be the case that β2AR-cAMP is somehow less 
efficiently influencing PKA compartments in basal cells. No difference has been observed in the 
membrane or cytosolic cAMP levels on the basis of raw FRET data. However, after appraising 
corrected values it can be seen that there is no difference between apical and basal cardiomyocytes 
in the cytosolic measurements. There is a difference between the β2AR-cAMP response in apical cells 
membrane and PKA-RII regions and those of the basal cells. Therefore cAMP is differently 
compartmentalized in the apical cardiomyocytes. This does not appear to be as a result of increased 
adenylate cyclase activity. Whilst the FRET shift is on average slightly higher in the apical cells, as 
shown by an apparent increase in the FRET shift induced by NKH477, statistical significance cannot 
be reported. It does not explain why the β2AR mediated FRET shift of the RII_Epac sensor is so much 
smaller in the basal cells. The corrected data set shows more variability within the cell populations.  
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Figure 3.10 C, i. Graphs displaying RII_EPAC (PKA-RII localized) responses in rat apical and basal 
cardiomyocytes following β2AR (100nM ISO) or full AC stimulation (NKH 5µM). Figure C, ii. β2AR 
response of apical and basal cardiomyocytes corrected to total cAMP response. Data were analysed 
by unpaired Mann-Whitney tests. 
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3.3.2.2 ASSESSMENT OF APICAL AND BASAL CAMP RESPONSES IN FRESHLY ISOLATED 
CARDIOMYOCYTES FROM A MOUSE TRANSGENICALLY EXPRESSING THE EPAC1 FRET SENSOR 
Cardiomyocytes isolated from the rat must be cultured for 48 hours with adenoviral vectors, to 
obtain expression of the FRET sensors discussed above. This may not be ideal as t-tubules, a site of 
β2AR localization and control, are demonstrated to gradually breakdown in culture (Pavlovic, 
McLatchie and Shattock, 2010). Fortunately we obtained some mice transgenically expressing a FRET 
sensor known as Epac1 which is similar to the cEpac2 sensor in its freely diffusible properties within 
the cell cytosol. This allowed us to assess some aspects of the receptor function in cells within 8 
hours of isolation allowing comparison with cultured, rat cell data.  
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Figure 3.11 A) Graphs showing measurements of FRET Ratio shift following β2AR (100nM ISO) and full 
adenylate cyclase stimulation (5µM NKH) in mouse cells transgenically expressing the Epac1 FRET 
based cAMP sensor. B) The β2AR responses are corrected and presented as a function of total cAMP 
output.Data were analysed by an unpaired Mann-Whitney test. 
The FRET shifts measured following β2AR stimulation were no different in apical or basal cells 
isolated from mice transgenically expressing Epac1 (Figure 3.11a). There was also no difference 
between apical or basal FRET shifts following full adenylate cyclase stimulation following NKH477 
treatment (Figure 3.11a). β2AR stimulation was no different between apex and base when corrected 
to total cAMP output (Figure, 3.11b).  
3.3.2.3 DEMONSTRATION OF THE RELATIVE COMPARTMENTATION OF THE Β2AR IN 
COMPARISON TO THE Β1AR 
The positively inotropic potential of β1AR is higher than that of β2AR; expression level appears to 
only account for a portion of this effect. Although β2AR is expressed at a lower level compared to 
β1AR, as the rodent myocardium has many ‘spare’ receptors and a full agonist such as isoprenaline 
A) B) 
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should in theory produce a maximum response via β2AR. As discussed, β2AR signals via the same 
positively inotropic pathway as β1AR. It appears that the β2AR receptor is denied a fully positively 
inotropic response via careful cAMP compartmentation. The cAMP produced by β2AR stimulation 
does not have full access to the PKA compartment, thus cAMP’s effect on PKA and consequently 
contractility is reduced. Using a modified version of the technique described above has provided a 
further illustration of this aspect of sub-type specific properties of βAR. Cells from whole heart 
homogenates were transfected with either RII_Epac or cEPAC2 pre-treated with either CGP or ICI. 
After acquiring a sufficient baseline the ISO/NKH protocol was performed. This gives a record of the 
β1AR or β2AR response corrected to the total stimulable cAMP response. It is apparent from Figure 
3.12 that β1AR-cAMP is similar for cEPAC2 and RII_Epac. This suggests that cAMP produced following 
β1AR stimulation is measured both in the cytosol and the PKA compartments. Potentially, cAMP 
from β1AR is fully connected to PKA compartments allowing full influence on contractility. However, 
the FRET shift of RII_Epac following the β2AR stimulation is around half of that of cEPAC2.  cAMP is 
produced following  β2AR stimulation which is measurable in the cytosolic locations where cEpac2 is 
located but much less enters the PKA compartments which determine the cells activity with regard 
to contraction. 
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Figure 3.12 Graph showing data which demonstrate the sub-type specific compartmentation of β2AR 
and β1AR in rat cells. Corrected FRET shifts measured by cEPAC2 or RII_EPAC sensors following β1AR 
or β2AR stimulation are presented.Data were analysed by unpaired Mann-Whitney tests. 
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3.3.2.4 INVESTIGATION OF THE RELATIVE DIFFERENCES BETWEEN APICAL AND BASAL CELL 
POPULATIONS AND THEIR RELATIVE CONCENTRATION-RESPONSE RELATIONSHIPS TO Β2AR 
STIMULATION 
In other studies of β2AR utilizing FRET, similar to the work above, researchers have used a single 
dose of agonist to probe the relative responsiveness of β2AR. When comparing cell types or tissues 
of interests’ pharmacological properties a concentration-response study can be useful. This type of 
study will produce a plot from which multiple aspects of the pharmacology of the receptor agonist 
relationship can be inferred. The studies above do not give us enough data to draw conclusions 
concerning receptor number or the ’fullness’ of the activity of isoprenaline. β2AR may undergo 
stimulus trafficking at very high levels of isoprenaline, this results in peculiar concentration-response 
curves in some scenarios. We do not know whether the stimulus trafficking of the β2AR may affect 
cAMP output in such as way as to produce the relationship observed.  Aspects of signalling such as 
this need to be assessed before we can draw conclusions, as to why the observed differences in 
cAMP compartmentation, are present. In this section, studies where single cells from the two 
separate populations are stimulated with a single dose are discussed. The time-dependent nature of 
stimulus trafficking should mean that, although some β2AR is constitutively bound to Gi, a relatively 
pure β2AR-Gs dose response relationship should be observed.  Studies utilized cEPAC2 and RII_Epac 
cells to give concentration-response relationships from the cAMP levels in the cytosol or the PKA 
compartments. Figure 3.13a presents a concentration-response relationship in which there is a slight 
difference between the apical and basal cells. The basal cells may be demonstrating some effects of 
β2AR ‘stimulus trafficking’ as the two highest doses are not at the maximum level of response. The 
Log EC50 values which describe the concentration at which 50% of total response, of the given 
agonist, is elicited do not seem to be significantly different between apical and basal cells (Apex-
8.12±0.76 Log (M) vs. Base -7.90±1.65 Log (M) mean±sem).  
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Figure 3.13 A. Graphs showing the concentration- response relationships of rat apical and basal cells, 
measuring cAMP output with the cEPAC2 sensor.  B.The concentration-response relationship 
between apical and basal cells cAMP response measured by the RII_Epac sensor. Statistical analysis 
by F-Test. 
An F-test analysis on the comparison of fits suggests that curve parameters are the same for all data 
sets (F-test = NS). Given that there is only a slight left shift of the apical dose response, from these 
data it could be suggested that there was little difference in the relative density of β2AR in the apex. 
Equally, isoprenaline still seems to act as a full agonist on both apical and basal cells. Figure 3.13b 
presents a different scenario where the response of the basal cells is more clearly right shifted with a 
slight depression at the highest concentration. The LogEC50 values are significantly different in these 
data, the apical LogEC50 on average is a unit lower meaning 10 times more agonist is required to 
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elicit a comparable basal response (Apex -8.23±0.87 Log (M) vs. Base -6.98±0.18 Log (M) 
mean±sem).  An F-test comparison of curves shows that curve parameters are significantly different 
between apical and basal cells (F-test p<0.0001).  There is a relative left shifting of the apical 
response compared to the base. Without the a priori knowledge of the data measured with cEPAC2 
we would possible infer that apical cells had a greater density of β2AR.  It is therefore suggested that 
cAMP is also more effectively transmitted to the PKA domains in the apical cells. This concept is 
most effectively expressed when comparing the cAMP measurements with the RII_Epac and cEpac2 
sensors, within the different cell types.  The concentration response curves for apical β2AR-cAMP 
measured by cEPAC2 and RII_Epac are quite similar (F-test = NS).  The full amount of cAMP from 
β2AR which reaches the cytosol therefore also reaches the PKA_RII compartments.  This possibly 
alters the relative change in cell shortening following β2AR stimulation. In contrast the curves for 
RII_Epac and cEPAC2 measurements in basal cells are different (F-test = p<0.01).           
3.3.2.5 RELATIVE CONTRIBUTION OF Β1AR/Β2AR RECEPTOR SUBTYPES TO INOTROPIC 
RESPONSE OF ISOPRENALINE AS MEASURED BY FRET-BASED CAMP IMAGING  
A modified FRET protocol was employed to measure the contribution of the different sub-types to 
the cAMP response elicited by stimulating apical and basal cells with 100nM isoprenaline. The β1AR 
subtype was blocked with CGP20712A; subsequently the β2AR was blocked with ICI 118,551. The 
FRET shift from maximum response back to baseline following introduction of the inhibitors was 
taken as the specific stimulable cAMP response of the cell. The level of FRET reduction from 
maximum or the previous step for either CGP or ICI was recorded as a percentage of the total 
response. Apical and basal cells from the rat have a larger contribution of cAMP from β1AR activity, 
Figure 3.14. Apical cells have a larger contribution from β2AR and a lower contribution from β1AR in 
comparison to basal cells. This suggests a larger ratio of β2AR to β1AR in apical cells and is 
concordant with radioligand binding data previously published (Paur et al., 2012). It could also be a 
product of the decreased compartmentation of cAMP within apical cells. It is noted however that 
the basis of this protocol is that of a cAMP washout. In consequence any differences in the relative 
ease of blocking receptor sub-type between cell types may influence this.  Equally, the efficiency of 
the removal of cAMP will deeply affect this experiment. So unknown differences in 
phosophodiesterase expression and compartmentation of cAMP could be lead to incorrect 
interpretations of these data. 
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Figure 3.14 a) Graphs comparing the relative contribution of β1AR and β2AR to the overall cAMP 
response of apical or basal cardiomyocytes isolated from Rat. B). the relative contribution of β1ARand 
β2AR to the cAMP response in mouse cells. Statistical analysis was performed by an unpaired Mann-
Whitney test.  
Cells from the mouse presented differently to rat as only basal cells had a β1AR response which was 
significantly different to β2AR. Neither the β1AR nor the β2AR responses were different in a 
comparison between apex and base cells. It should be noted that due to the rarity of the Epac1 
mouse cells in our laboratory, this data set lacks statistical power due to the low number of 
replicates. The power of this dataset is only 40% given a desired difference of 0.25 with respect to 
both β1AR and β2AR.  
3.3.2.6 SCANNING ION CONDUCTANCE MICROSCOPY STUDY OF APICAL AND BASAL 
CARDIOMYOCYTES 
Scanning ion conductance microscopy was employed in conjunction with our FRET method. SICM 
was utilized to resolve the scalloped ‘crest and groove’ topography of ventricular myocytes isolated 
from the apical or basal left ventricle of rats. Once an area of interest had been resolved either a 
patch of membrane resembling a t-tubular opening (t-tubule application) or non-tubular, non-z-
groove area was targeted by the nano-pipette (crest application). The cells had previously been 
transfected with the ‘cytosolic’ cEPAC2 cAMP-sensing FRET construct. As the FRET ratio was being 
acquired a pressure was applied to the pipette resulting in a release of isoprenaline resulting in the 
stimulation of β2AR within the immediate vicinity of the application site. FRET Shift was measured in 
4 equal sectors of the cell, 1 and 2 behind the area of application (relative to the application zone), 3 
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the application zone and 4 immediately next to the application zone in the path of the perfusion.  In 
this way it is is possible to estimate the relative diffusivity of β2AR- cAMP emanating from differing 
cellular regions.  This technique allows the investigation of compartmentation differences between 
apical and basal cells β2AR populations. Both in apical and basal cells application to both t-tubule and 
crest regions gave rise to regionally localized cAMP responses. The FRET shift in the application zone 
was significantly larger than the regions in its immediate proximity, behind it relative to the 
perfusion (Figure 3.15 A and B). Potentially, differential localization of β2AR within the two cell types 
may modify signalling outcomes. This was assessed by estimating the corrected amplitude of FRET 
shift over all sectors for either application type (Figure 3.15). A difference could not be established 
between t-tubule or crest amplitude between apical and basal cells (Apex Tubule vs. Apex Crest NS; 
Base Tubule vs. Base Crest NS), although the basal cells seem to have an increased t-tubular 
localization of β2AR. This does not reach statistical significance. This is in opposition to previous data 
from our group demonstrating an increased t-tubular localization of β2AR in adult rat 
cardiomyocytes, in an almost identical experiment.  There is the possibility that isolating cells from 
different regions of the myocardium, culturing them separately and testing the data separately may 
have increased the variability of the data.  Equally, there may be other populations of cells within 
the myocardium (i.e. the mid- part of the left ventricle which have been excluded by the isolation 
procedure. Combining the data obtained from apical and base cells separately and analysing them as 
t-tubule versus crest once again demonstrates the increased localization of β2AR to t-tubular regions 
of cardiomyocytes, although this is not as distinct a difference as observed in previous work (Tubule 
1.36 ± 0.20% n=35 vs. Crest 0.79 ± 0.11% n=23, mean±sem p<0.05) (Nikolaev et al., 2010). In 
previous work the FRET response of the whole cell was assessed rather than different sectors to 
establish the different in t-tubular and crest response. Ultimately, it must be concluded from this 
work that although the β2AR is overall localized to t-tubules and gives rise to localized cAMP 
responses, this method does not demonstrate any differences between apical and basal cells. 
Consequently, it does not readily provide an explanation for the increased contractile 
responsiveness of apical cardiomyocytes to β2AR stimulation. These measurements were conducted 
with the cEPAC2 sensor which did not show any difference between apical and basal cAMP 
responses in whole cell FRET studies.                 
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Figure 3.15 Graphs displaying SICM/FRET analysis of apical and basal rat cardiomyocytes transfected 
with the cEPAC2 FRET sensor. A) Graph showing uncorrected FRET responses in apical cells following 
β2AR stimulation in both the tubule and cell crest region. The cAMP activation is less in regions 
distant to the application site (3) One-way Repeated Measures Anova. B) Graph showing the β2AR-
cAMP response in basal cells after application to the t-tubule or crest.One-way Repeated Measures 
Anova.  C) The amplitude of cellular FRET responses in the tubule or crest regions in apical or basal 
cells. Mann Whitney test. D) Graph showing the combined FRET responses of apical and basal cells 
(to increase sample number) after isoprenaline application to the tubule and crest regions upon β2AR 
stimulation.Mann Whitney test. E) Image showing respresentative application site in relation to 
other FRET measurement zones. 
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3.4 DISCUSSION           
3.4.1 STRUCTURAL AND FUNCT IONAL ASPECTS OF Β2AR SIGNALLING IN ISOLATED 
CARDIOMYOCYTES 
The isolated cardiomyocyte has been utilized in physiological and pharmacological studies of cardiac 
biology since Moscona and Moscona dissociated embryonic cardiomyocytes from chicks (Moscona 
and Moscona, 1952). Although it offers the researcher the ability to evaluate cellular physiology and 
pharmacology in isolation it should be noted that heterogeneity exists in the cardiomyocyte 
population. Thus in this study of regional differences in the physiology of cardiomyocytes from the 
apical or basal regions of the rat myocardium, it is important that we are aware of any variables 
which may distort our data. The mechanics of cell contractility, which is our primary functional 
correlate of β2AR activity, may be modified by cell size. In a study by Chen et al (2007) it was 
observed that cardiomyocytes isolated from the apical and basal regions of the hearts of Sprague-
Dawley rats were no different in size. This study is concordant with the results in Figure 3.1 although 
it is notable that the study by Chen records cells (both apical and basal) being slightly longer. This is 
most likely due to the study utilizing rats between 100-200g heavier (and consequently older) than 
the ones utilized by us. The authors themselves note that cardiomyocyte length is affected by age, as 
well as sex and pathology (Bai et al., 1990). There are also interspecies differences (Campbell et al., 
1987) and within species, rat for example, there are differences in myocyte size transmurally. The 
endocardial cells of the rat heart are greater in cross sectional area and volume than those from the 
epicardium (Gerdes et al., 1986).   
Cell Surface Topography and T-tubular Regularity 
Before the advent of the SICM modality only scanning electron microscopy would have provided 
high resolution 3D images of the surface of cardiomyocytes. These cells would have been fixed prior 
to the imaging study. Previous studies by the Gorelik group have shown that disruption of the z-
groove structures of the surface of cardiomyocytes is found in animal models of heart failure and 
cells isolated from patients (Lyon et al. 2009). This may be to be due to the z-grooves being the 
location of the openings of the t-tubular elements. Loss of t-tubules seems to correlate with loss of 
contractility, in heart failure (Louch et al., 2004). T-tubular structures are known to be highly 
important in balancing excitation-contraction coupling within cardiomyocytes. The data above show 
that the t-tubular regularity is slightly reduced in apical cells. This may mean that at baseline there 
may be a reduction in the contractility of apical cardiomyocytes interfering with their ability to 
respond to β2AR stimulation. This was not demonstrated to be the case, as both apical and basal 
cardiomyocytes have similar degrees of baseline contractility. As alluded to the disruption of t- 
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tubular regularity is correlated with cardiomyocyte damage, occurring either after pathology or 
chemical insult (Lyon et al., 2009). There is no suggestion that the apical cells are more susceptible 
to damage than the basal cardiomyocytes as the equal rates of cell death between apical and basal 
cells in culture demonstrate.  
3.4.2 THE CONTRACTILE RESPONSE OF APICAL AND BASAL CARDIOMYOCYTES TO 
SPECIFIC Β2AR STIMULATION 
The role of the β2AR in the myocardium has been heavily investigated; its cardio-protective 
character in comparison to β1AR has meant it has been explored as a potential target for therapies. 
Many of the studies on the cardiomyocyte activities of the β2AR have yielded seemingly 
contradictory data. For example, there is a broad consensus that the β2AR response appears more 
controlled and compartmentalized than β1AR (Zheng, Han and Xiao, 2004). But β2AR appears more 
compartmentalized in rat than human, as β2AR cannot induce the PKA-mediated phosphorylation of 
PLB in rat (Xiao et al, 1995) but does this efficiently in human (Molenaar et al, 2000). The studies by 
Kaumann and collaborators over the past decades have utilized human tissue from various sources, 
fallot infants/ adult failing (Molenaar et al, 2000), atrial appendages (Kaumann et al, 1996) and even 
single failing myocytes (Del Monte et al, 1993). Isolating single myocytes from human tissue is crude 
compared to the preparation of single cells from rodent tissue, equally it gives a low -yield which 
leads to the suggestion that the cells may not be truly viable. Cell health appears to strongly 
correlate with the fidelity of β2AR compartmentation (Nikolaev et al, 2010). The increased lusitropy 
induced by β2AR observed in human atrial strips is more convincing as the only insult to cell integrity 
would have been the mechanical excision of the tissue. However, it has been noted that atria 
contain relatively more β2AR than ventricle (Motomura et al., 1990). Therefore the true degree of 
β2AR compartmentation in healthy adult human ventricle is comparison to that of rodents is still not 
clear.  Lemoine and Kaumann (1991) reported a large amount of heterogeneity between right 
ventricular papillary muscles isolated from cat hearts. They reported that quite often two muscles 
from the same heart could be found to differ distinctly in their sensitivity to β2AR stimulation, one 
muscle might show no response to β2AR when another might be stimulated maximally.  
Although a positively inotropic character is suggested for β2AR it is not clear whether this has a 
physiological effect in vivo. Studies over the past decades have demonstrated in dog, cat (Kuschel et 
al., 1999), guinea pig and human tissue that contractility is increased by β2AR stimulation (Kuznetsov 
et al, 1995). But β2AR contractile effects on lusitropy in the rat have been somewhat controversial 
showing no effect in some studies (Jiang and Steinberg, 1997) and acceleration of relaxation in 
others (Xiao and Lakatta, 1993). This may however be due to the diverse set of techniques which 
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were employed by the different research groups. It is unlikely that measuring increases in the 
release of calcium from the sarcoplasmic reticulum in unloaded cells is truly as good as ‘loaded’ 
force measurement of muscle strips at predicting in vivo function. Also, there have also been a wide 
range of pharmacological tools employed to investigate the β2AR receptor. Usually, researchers have 
blocked the β1AR with CGP20712A but then used agonists ranging from the truly physiological 
(adrenaline) to highly selective but partial agonists (fenoterol). This has meant that the differential 
pharmacology of the β2AR relative to β1AR has been well resolved but its physiological roles are less 
clear. Many studies have used zinterol as demonstrated above when utilized in the same way as 
isoprenaline it is demonstrated to be far less potent. Observing cumulative concentration-response 
curves created for zinterol (Xiao and Lakatta, 1993) it appears there is also no biased-agonist activity 
compared to results with isoprenaline. It is therefore not clear how accurately zinterol stimulation 
simulates physiological stimulation by adrenaline. The β2AR does not evoke a strong increase in 
inotropy in basal cardiomyocytes when stimulated with a large concentration of isoprenaline applied 
as a bolus. This is strongly concordant with the findings of McDougall et al. (2012) in an almost 
identical test but using zinterol. The results from apical cells described above would be in 
contradiction. McDougall et al. utilized cardiomyocytes isolated in a homogeneous fashion from all 
regions of the healthy rat LV myocardium. Further studies in this area should assess what the 
physiological implications of a two-fold shift in contractility of the unloaded apical myocyte would 
mean for ventricular function as a whole.                                  
Apico-basal differences in adrenergic responsiveness have been reported by various groups and are 
of special interest to those investigating regional myocardial pathologies including that of Takotsubo 
cardiomyopathy. Mori et al. (1993) produced a paper demonstrating the increased responsiveness of 
the left ventricular apical myocardium to noradrenergic stimulation, in dogs, in vivo. A further study 
(Kawano et al, 2003), demonstrated that the degree of autonomic innervation was different 
between apical and basal regions in human hearts. There was a greater degree of innervation in the 
basal regions. These findings lead Lyon et al. (2008) to surmise that this differential regional control 
of the myocardium by the sympathetic system may change the relative ratio of beta-receptor 
subtypes in the two regions of the heart. Given that the neurones will release noradrenaline, which 
has a very low potency at the β2AR sub-type, having many functional β2AR here would be inefficient. 
Indeed, Shcherbakova et al. (2007) demonstrated that innervation of neonatal cardiomyocytes by 
single ganglionic neurones excludes β2AR from the synaptic area and enriches β1AR.  The lack of 
innervation at the apical myocardium leads to the suggestion that the sympathetic control of this 
region is most likely via plasma levels of adrenaline which are regulated by adrenal gland function. 
We have already published data demonstrating the greater ratio of β2AR to β1AR in rat (Paur et al. 
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2012). The greater avidity of adrenaline for β2AR may allow balanced positive inotropy, to be 
brought about by neural and plasma catecholamine release in stressful scenarios.  
3.4.3 Β2AR MEDIATED CAMP RESPONSES IN APICO-BASAL CARDIOMYOCYTES 
It is now a well accepted mechanism that β2AR couples to Gs to mediate a modest effect on rodent 
cardiomyocyte contractility. There were attempts to measure the cAMP responses of β2AR elicited 
by agonists biochemically. It was shown that cAMP responses after β2AR stimulation were not 
dramatic and in some cases very difficult to measure (Steinberg, 2000). These methods have proven 
robust in measuring cAMP responses elicited by β1AR and other receptors in many circumstances.  
However, there is a well characterized biphasic effect of β2AR on inotropy, following stimulation with 
biased agonists such as isoprenaline (Wang et al., 2008; Xiao et al, 1995). The stimulation may be 
being terminated in the negatively inotropic phase when β2AR is coupled to Gi and inhibiting 
adenylate cyclase.  Thus due to the low temporal resolution of these methods the conclusion that 
β2AR does not increase cellular levels of cAMP would be drawn. It is apparent from the experiments 
discussed above that there are difficulties when subjecting the β2AR to traditional concentration 
response experiments in cardiomyocytes. This is possibly due to the ability of the β2AR to undergo 
stimulus trafficking, binding Gi rather than Gs, this will cause an inhibition induced shortening 
blunting the inotropic effect. With respect to the hypothesis that selective regional dysfunction 
occurs in the apical myocardium due to increased β2AR activity the reduction in shortening observed 
in apical cells may, in fact, be an indicator that the apical cells are more affected by β2AR stimulation. 
In either case these experiments do not truly add anything to our understanding of the increased 
responsiveness of the apical myocardium to β2AR observed in the previous section. It demonstrates 
that this type of method will not be of use in studying the difference between apex and base. There 
has historically frequently been a reliance on the non-specific phosphodiesterase inhibitor IBMX to 
ensure that cAMP produced by receptor stimulation is not broken down before quantification. This 
is of concern, as using FRET it is possible to observe IBMX elevating cellular cAMP levels non-
specifically. However, due to modern FRET modalities the cAMP stimulating effects of β2AR 
activation are clear to see, so this capacity of the receptor is now un-controversial. 
3.4.4 FRET MEASUREMENT OF Β2AR-CAMP RESPONSES  
The first real attempt to image the dynamics of β2AR mediated cAMP production in cardiomyocytes, 
in real-time and compare it to β1AR was undertaken by Nikolaev et al. (2006). This study utilized a 
single molecule FRET sensor based upon the cAMP binding domain of the HCN2 channel. This 
provided a sensor with optimal sensitivity to measure cAMP evoked by adrenergic stimulation. Until 
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this time the use of sensors based upon the cAMP binding domain of PKA had predominated and in 
consequence there were concerns over the ability of relatively ‘localized’ sensors to distinguish and 
differentiate between localized and non-localized signals. The cEpac2 FRET sensor is slightly more 
sensitive and consequently provides bigger FRET shifts at a given concentration of cAMP. The study 
of Nikolaev et al. (2006) demonstrates that the β2AR evokes cAMP mediated FRET shifts of about 
half the amplitude of β1AR. This study showed that the relative diffusivity of β2AR-cAMP differed in 
comparison with β1AR-cAMP. This is demonstrated in this work by the relative difference in the FRET 
shifts evoked in plasma membrane and cytosolic regions compared to those in the PKA domain in 
basal cells. β2AR-cAMP appears to be barred from entering the PKA domain save for in the apical 
cells  or is removed less rapidly in this cell type allowing it to have an effect on contractility. These 
differences are speculated to create the differential character of the two receptor sub-types and it 
appears that the differences in cAMP influence on the PKA compartments correlates well with the 
differing responsiveness of the apical and basal cells to β2AR stimulation. Nikolaev pioneered the 
combined modality of SICM/FRET joining the localized application of substances from the 
nanopipette and FRET enabled cells, with the ability to image the structures of the cardiomyocyte 
cell surface. This modality was published (Nikolaev et al, 2010) and utilized the cEpac2 FRET sensor 
as well as transgenic mice. The FRET shifts obtained upon local β2AR stimulation are similar in 
amplitude to those observed in whole cell application experiments using apical and basal cells. The 
SICM/FRET data presented show on average slightly lower FRET shifts compared to previously 
published work and less stringent localization of the β2AR to t-tubular structures versus the cell 
crest. There was still a significant difference between the t-tubule and crest.  
Detailed study of the compartmentation of β2AR-cAMP by FRET was performed by McDougall et al. 
(2012). This study showed interesting parallels with the data presented above (using the cEPAC2 and 
RII_Epac FRET sensor) in that it demonstrated the relative restriction of β2AR-cAMP from the PKA-RII 
compartments whilst the cells remained cholesterol (and consequently caveolae) competent. This 
presents an interesting counterpoint for my work as data from basal cardiomyocytes are exactly 
concordant with the work of MacDougall et al. β2AR evoked cAMP caused FRET shifts in the cEPAC2 
sensor but not RII_Epac, which was correlated with no significant increase  in contractility in 
response to β2AR stimulation. This was what McDougall found in the totality of the cells which were 
isolated as a whole left ventricular homogenate. The apical cells were the direct opposite as 
contractility increased considerably after β2AR stimulation and cAMP was detected the domains 
occupied by both cEPAC2 and RII_Epac. It might be the case that the observed compartmentation 
differences observed between apex and base cells could be due to different compartmentation by 
caveolae within the cell membranes of the two different cell types. The two studies are not exactly 
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comparable due to the McDougall study employing zinterol as the agonist. The RII_EPAC and cEPAC2 
sensors employed by both the McDougall study and my work were identical which is important as 
direct comparisons can be made between their overall responses which appear very similar to those 
observed in my study. For example a 40% FRET shift appears to be maximal for β2AR stimulation in 
cardiomyocytes for both cEPAC2 and RII_EPAC. Different overall responses of the different FRET 
sensors means responses corrected to maximal should be assessed as discussed. When assessing the 
average activation shift without separating apex and base it is possible to observe that the pmEPAC2 
sensor measures higher FRET shifts than cEPAC2 after β2AR stimulation. This suggests that pmEPAC2 
is possibly more effective at measuring the cAMP response. Our results suggest that as the sensor is 
localized more closely to the compartments where the β2AR resides, the cAMP is measured more 
effectively (Appendices Figure 9.1a). When assessing the β2AR mediated FRET shifts as a function of 
total adenylate cyclase response as measured by RII_Epac, against the other sensors, it can be 
observed that RII_Epac measures smaller responses (Appendices Fig 9.1b). This suggests that β2AR-
cAMP may not be well coupled to PKA-RII domains in any cardiomyocyte (apical or basal), this may 
partially explain the differences in its signalling characteristics versus β1AR stimulation. This is also 
concordant with McDougall’s study. It is not clear how the effect of transgenically expressing Epac1 
in the mouse may affect the animal’s β2AR physiology. There may still be a species difference in β2AR 
response but this is unlikely as in the contraction experiments (Figure 3.3) as the mouse cells 
responded very similarly to the rat. It is perhaps more likely that there are some differences 
between the Epac1 and Epac2 sensors’ ability to measure β2AR responses. As in rat cells there is still  
no relationship between the increased β2AR -mediated contractile responsiveness of apical cells and 
cAMP output  as measured by a cytosolic sensor. This is in partial validation of the rat data.        
Extensive study has been made of the β2AR’s cAMP responses by the group of Yang Xiang. This group 
have published a number of papers since 2008 dealing with aspects of the control of β2AR signalling 
which are intrinsic to the receptors structure. For example, the necessity for phosphorylation by 
kinases at defined amino acid sites and complex with arrestins and phosphodiesterases, which are 
responsible for the extinction of the β2AR signal (Wang et al., 2008; DeArcangelis et al., 2009). FRET 
was employed as a means of measuring both cAMP levels and PKA activity. cAMP was measured by 
the ICUE3 construct (Violin et al., 2008) which is analogous to the Epac1 sensor as it is formed by 
sandwiching Epac1 between YFP and CFP. Direct PKA activity, rather than cAMP presence in PKA 
domains, was measured by utilizing a construct called AKAR3 or a variant called AKAR2.2. This 
molecule is composed of an element which is phosphorylated by PKA causing the CFP and YFP 
fluorescent domains to separate, and FRET Ratio to shift. In all cases β2AR produced robust cAMP 
signals and PKA activity; however it is noteworthy that β2AR cAMP signals are usually larger in the 
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cytoplasm than they are within the PKA compartment, which compares favourably with my work. It 
suggests that even in these immature cell types, β2AR-cAMP is somewhat restricted from activating 
PKA. Β1AR and combined β1AR/β2AR signalling do not show this distinction (Agarwal et al., 2011).  
Liu et al. (2012) demonstrate the importance of post-translational modification by palmitoylation for 
the control of β2AR function. cAMP responses appear to be increased in the cytosolic and PKA 
domains and this correlates with an increased contractility when the cells are stimulated with 
isoprenaline. Differences in receptor post-translational modification (palmitoylation, hydroxylation 
and glycosylation (Mialet-Perez et al., 2004; Xie et al., 2009)) in the apical and basal cell populations 
could underpin the differences in contractility. Interestingly this study also utilized a variant of ICUE3 
which was targeted to the plasma membrane. As in my study plasma membrane β2AR -cAMP 
appears to induce less of a shift in the plasma membrane localized FRET sensor than the one 
localized to the cytosol. There appears to be a situation whereby plasma membrane β2AR-cAMP 
levels are more heavily compartmentalized than those in the cytosol and cAMP is relatively 
restricted from PKA compartments (specifically those of the basal cardiomyocytes in my study). It 
may be the case that plasma membrane localization represents a micro-domain defined as crest in 
SICM-FRET studies. β2AR stimulation in this region generates smaller FRET shifts than stimulation in 
t-tubules. In the adult cells utilized in my work it may be the case that whole cell stimulation of  and 
measurement of cytosolic levels of cAMP measures the relatively ‘free’ signalling of t-tubular β2AR, 
whereas whole cell stimulation of cells with measurement of plasma membrane domain cAMP by 
pmEPAC2 measures the restricted signalling of ‘crest’ β2AR. As described, Liu et al. utilize neonatal 
cardiomyocytes which do not have a well defined t-tubular system but do exhibit caveolae (which 
pmEPAC2 utilized in my study has some affinity for). Consequently, the comparison of micro-
domains is inexact; it is not clear from the published work how the pm-ICUE3 peptide is targeted to 
the plasma membrane and if the approach was to use a peptide moiety with some affinity for 
caveolar domains as in the pmEPAC2 molecule. 
3.4.4 THE RELATIVE CONTRIBUTION OF ΒAR SUBTYPES TO THE CAMP RESPONSE 
EVOKED BY ISOPRENALINE STIMULATION 
Various sources report that the ratio of the density of βAR subtypes is around 70/30 in adult rat 
cardiomyocytes (Port and Bristow, 2001), as determined by radioligand binding studies. The relative 
contribution of each sub-type to cellular cAMP levels after stimulation with a given concentration of 
isoprenaline does not seem to have been directly explored by FRET. Given the high 
compartmentalization of β2AR in comparison to of β1AR as well as its ability to bind Gi, it was not 
clear whether density would translate to cAMP responses in a linear fashion. The cAMP responses of 
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apical cells in both the rat and mouse appeared to reflect the relative density of the receptor 
subtypes in a 1:1 fashion with a 70:30 sub-division of the cAMP response, although the study of 
mouse cells is probably statistically underpowered. The basal cardiomyocytes seem to differ from 
the apical in that the contribution is distorted in favour of the of β1AR sub-type. It could be 
suggested that this may be a reflection of a smaller density of β2AR or an increased 
compartmentation of the β2AR, leading to a rapid removal of cAMP and smaller amplitude. Also as 
demonstrated in the methods section these phases reach clearly defined plateaus so removal of 
response is confirmed as being total in each case. The βAR of the rodent myocardium are 
characterised by what seems to be being expressed at a level many fold higher than the level 
required to induce a maximal physiological response upon stimulation. This is often referred to as 
the spare receptor hypothesis.  Various reports (Kenakin et al., 1985) have demonstrated that 
stimulation of only 1% of βAR receptors is sufficient to yield 100% of the physiological response. In 
consequence there does not seem to be a linear relationship between receptor expression and 
adrenergic responsiveness. This suggests that other factors such as compartmentation are pre-
eminent in their control of βAR signalling activities.         
3.4.5 LIMITATIONS AND FURTHER WORK 
The initial aim of this work was to compare cardiomyocytes from the apical and basal myocardium in 
their responsiveness to β2AR stimulation. This aspect of the work was initiated due the apparent 
vulnerability of the apical myocardium to adrenergic mediated ‘stunning’ in the syndrome of 
Takotsubo cardiomyopathy. There are well defined gradients in ion channel expression and elements 
of cardiac electrophysiology (Szentadrassy et al., 2005) between the endocardial and epicardial 
layers of the myocardium. Therefore as modifiers of calcium physiology the β2AR may also have or 
contribute to gradients in activity between these layers. The studies in this thesis have not drawn a 
distinction between endocardial and epicardial layers, so do not have the spatial resolution to assess 
whether differences between endo and epicardium exist. More crucially the relative thickness of 
these layers, which are not clearly separated, will alter as the ventricle thins toward the apex (Seo et 
al, 2010). This may mean that apex and base cells have different epicardial and endocardial 
contribution. It may be this factor which alters apical responsiveness rather than there being a 
difference between all apical and basal cells. Thus future studies need to further sub-divide the heart 
into more longitudinal and transverse sections this will allow any differences to be characterized. 
There may be interesting contributions from more highly differentiated cells such as the mid-
myocardial-M cells which have been missed by simply assessing apex vs. base.  
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Analysis of more cell types will require a more exhaustive study of the relative differences in cellular 
architecture between different regions of the heart. The studies of the t-tubular system above do 
not have the resolution to assess differences in the relative amounts of transverse elements which 
are sometimes apparent in the cardiomyocytes t-tubular system (Lehnart et al., 2005). These may 
intrinsically modify the diffusion of cAMP or the handling of calcium in different cell types.  
Even rodent cardiomyocytes do not survive particularly well in culture once isolated. The gradual 
degradation of the cells is marked by reorganization and loss of the t-tubular system. This makes the 
necessity for culture of rat cardiomyocytes problematic for FRET studies. Although as SICM/FRET 
studies confirm there is still a good t-tubular system present, it is less well defined than immediately 
after isolation. This structural disruption and possible damage by adenoviral entry into the cells may 
serve to reduce the distinction between different cell populations. Thus, although I still observe a 
distinction between apical and basal cells using the RII_Epac sensor the differences may have been 
more distinct on day one, before culturing. In future it would improve matters if more studies could 
be performed on mouse cardiomyocytes transgenically expressing FRET sensors. Good use was 
made of the EPAC1 mouse in this study but mice expressing a plasma membrane and PKA 
compartment would be needed in future. pmEPAC2 studies were performed relatively late in the 
production of this work as the construct became available to us only towards the end of my studies. 
Thus a dose-respose study of the kind conducted for RII_Epac and cEPAC2 should be performed.       
3.4.6 CONCLUSION 
Apical and basal cardiomyocytes isolated from rat left ventricle do not appear to be different in size, 
although there seem to be slight morphologically and structural difference. Apical cardiomyocytes 
isolated from rat or mouse left ventricle are more responsive to β2AR stimulation and increase their 
contractility more in comparison to basal cardiomyocytes. The β2AR displays rapid desensitization 
which is possibly due to the effects of GI, GRK or β-arrestins. This makes it unsuitable for study by 
means of a cumulative dose-response method. It is possible to see that cAMP produced by β2AR 
stimulation is relatively restricted from PKA domains compared to β1AR. This gives rise to the most 
interesting data included in this sub-set of the work. cAMP levels evoked by β2AR stimulation are 
higher in the plasma membrane compartments of apical cells and cAMP is restricted from RII-PKA 
compartments in basal cells which correlates with a reduced contractile response to β2AR 
stimulation in this cell type. The suggestion would be that some difference in the compartmentation 
of β2AR-cAMP is present in the basal cardiomyocytes which underpins the relative differences in 
β2AR mediated contractility. This may have a bearing on the pathology of disease as less restriction 
of cAMP may have a less well defined control of PKA and the mediation of cardiomyocyte 
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contractility. Equally, it may cause the aberrant phosphorylation of downstream effectors 
contribution to apical vulnerability which may play a role in the sequelae of events leading to 
regional myocardial pathologies.                                                           
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4. PHYSICAL CONTROL OF THE Β2AR RESPONSE UNDERLIES THE REGIONAL 
DIFFERENCES IN CARDIOMYOCYTE CONTRACTILITY  
4.1 INTRODUCTION 
In chapter three the apico-basal gradient in contractile responsiveness following β2AR stimulation 
was assessed. Basal cells are demonstrated to be relatively unresponsive. Intriguingly little 
difference is found in the levels of cAMP produced in the apical and basal cells cytosol. This 
suggested there was little difference between the receptor expression densities in the two cell 
types. Although, we have reported the presence of a difference in β2AR/ β1AR receptor ratio but not 
number between apical and basal cells (Paur et al., 2012). Apical cells are demonstrated to increase 
inotropy more in response to isoprenaline stimulation which echoed the study of Mori et al. (1993). 
There were no major differences in the cell’s gross or sub-cellular surface morphology, which could 
explain the difference in contractility. Greater β2AR-cAMP activity was found in apical cells when 
measured with selectively localized FRET sensors, measuring in either the PKA-RII or the plasma 
membrane compartments. This suggested that there may be some mechanism or the lack of some 
control system in the apical cells leading to enhanced β2AR responses leading to greater influence of 
cAMP in the compartments responsible for determining contractile response in this cell type. This 
chapter will describe the methods utilized to investigate the mechanisms which produce greater 
control of cAMP in the basal cells. 
Cholesterol dependent micro-domains such as caveolae have been demonstrated to be intrinsically 
important to the actions of cardiomyocyte β2AR actions (Balijepalli et al., 2006; Pontier et al., 2008; 
McDougall et al., 2012). β2AR is found to selectively localize in these regions with members of its 
signalling cascade. There is controversy as to whether these domains enhance or control the 
responsiveness of β2AR signalling. It seems that cholesterol depletion (and caveolar disruption) 
reduces the ability of β2AR to control LTCC which is an essential component of the cardiomyocytes 
excitation-contraction coupling machinery, although it must be noted that these experiments were 
conducted following pertussis toxin mediated ablation of Gi (Balijepalli et al., 2006). Other reports 
observe the same treatment to enhance β2AR-cAMP which one would expect to increase PKA 
activity and subsequently alter contractility. The relative inability of β2AR to influence contractility in 
most studies is attributed to its localized, transient cAMP response (Nikolaev et al., 2006). In this 
respect a more tonic cAMP response may stimulate the phosphorylation of these targets (for 
example RyR, PLB and TNI) by PKA.  
The cellular mechanism of cAMP control is via the family of cyclic-nucleotide hydrolyzing 
phosphodiesterases as cAMP is otherwise kinetically stable. These enzymes act as the gatekeepers 
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of GPCR activity via structurally compartmentalizing the cAMP responses of receptors as discussed in 
the introduction. β2AR is regarded as a heavily compartmentalized receptor (Xiang et al., 2011). The 
question was therefore raised what, if any, were the compartmentation differences between apical 
and basal cells resulting in a greater ability of β2AR-cAMP to access PKA compartments in the apical 
cells. In this respect both the number of caveolae and the relative levels of caveolae scaffolding 
proteins were assessed. Equally, the phosphodiesterase activity and levels of phosphodiesterases 
were compared from apical and basal cells.  
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4.2 MATERIALS AND METHODS 
4.2.1 SOLUTIONS 
Cyclodextrin, rolipram, EHNA, milrinone and IBMX were obtained from Sigma-Aldrich (Poole, UK). 
Caveolin-3 antibody was obtained from (Santa Cruz Biotech, USA). Paraformaldehyde and 
glutaraldehyde were obtained from Sigma, Nitrocellulose was obtained from Millipore (Millipore 
Corp., Bedford, MA, USA) and HRP-Tagged anti-mouse was obtained from Sigma (St Louis, MO, USA) 
4.2.2. IONOPTIX STUDIES OF CARDIOMYOCYTE CONTRACTILITY 
The relative contractile responsiveness of apical and basal cardiomyocytes was assessed by the 
IonOptix method discussed in Chapter 2, following manipulation of cellular and molecular elements, 
known to control the compartmentation of β2AR. The method outlined in section 3.2.3 was utilized 
as this provides an assessment of the β2AR responsiveness with reduced contributions from β2AR-Gi 
signalling and desensitization; in comparison to dose-response studies.  
Protocol 1:   
 
4.2.3 EFFECT OF CHOLESTEROL CHELATION AND CONSEQUENT CAVEOLAR DISRUPTION 
ON APICAL AND BASAL CARDIOMYOCYTES Β2AR RESPONSIVENESS 
Apical and basal cardiomyocytes were incubated for an hour in the presence of methyl-β-
cyclodextrin (1mM cyclodextrin- diluted in M199 and incubated 37oC, 95/5% O2/CO2). They were 
then assed as per Protocol 1.  
 
 
 
    
Baseline 
CGP20712A  
300nM 
CGP+ 
Isoprenaline 
1μM 
CGP+ISO 
ICI 118, 551 
50nM 
10 min 10 min 10 min 10 min 
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4.2.4 EFFECT OF PHOSPHODIESTERASE 4 INHIBITION ON APICAL AND BASAL 
CARDIOMYOCYTES CONTRACTILE RESPONSE TO Β2AR STIMULATION 
Apical and basal cells are maintained in the presence of rolipram, a selective inhibitor of 
phosphodiesterase 4 subtypes. Then selective stimulation of β2AR is produced with CGP and ISO, 
with rolipram still present in the solution. This will provide an assessment of β2AR activity in the 
absence of PDE4 subtypes control of β2AR-cAMP. Rolipram has a different IC50 value for each PDE4 
subtype; a concentration of 10µM is over 20 times higher than the IC50 for PDE4C, the 
phosphodiesterase subtype for which rolipram has least affinity. This will mean that at this 
concentration it is certain that all PDE4 is inhibited. No data seems to be in existence suggesting off 
target effects of rolipram, so this is not considered to be an issue, but the wide range of subtype 
affinities renders rolipram a slightly coarse tool. Further data concerning the pharmacological 
properties of rolipram can be found in the appendicies 9.4. 
Protocol 2: 
  
 
 
 
 
 
 
The system settings were as discussed in 3.2.3 with regard to the pacing, temperature and flow rate. 
The data were analyzed by the Ion Wizard program. 
 
 
 
 
 
    
Baseline 
CGP20712A  
300nM 
10 min 10 min 10 min 10 min 
 
Rolipram 10μM 
CGP+ 
Isoprenaline 
1μM 
CGP+ISO 
ICI 118, 551 
50nM 
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4.2.5 CONFOCAL MICROSCOPY OF APICAL AND BASAL CARDIOMYOCYTES FOLLOWING 
IMMUNO-LABELLING OF CAVEOLIN-3 
 Immuno-labelling of cellular proteins can provide a useful method of quantitatively or qualitatively 
assessing the amount and localization of a protein of interest. In this case a monoclonal antibody 
raised against caveolin-3 is introduced to the cells and following binding, a fluorescent secondary 
(anti-IgH Alex Fluor 488) antibody is bound to this. These fluorescent cells can be imaged by a 
confocal microscope to provide a high resolution image of the pattern of the fluorescence and 
consequently the locations of Cav3. 
4.2.6 CELLULAR FIXATION AND IMMUNO-LABELLING PROTOCOL 
Cells isolated from apical or basal myocardium were washed in Enzyme buffer and plated onto 
laminin coated Matek dishes. The buffer was removed and a 4% solution of paraformaldehyde in 
PBS introduced. After 15 minutes the fixative solution was removed and fresh PBS is used to wash 
and maintain the cells. Before use the cells were washed a further three times with PBS. A solution 
of 0.1% Triton detergent in PBS was used to permeabilize the cells, in a humid chamber for 20 
minutes. The Triton containing solution was washed off with fresh PBS 3 times. A solution of 20% 
goat serum in PBS was used to block any proteases which might have been present. The cells were 
kept in the presence of this solution for 60 min at 370C in a humid chamber. The primary antibody 
(anti-Caveolin3) was prepared at a concentration of 1:100 in a solution of PBS plus 0.1% goat serum. 
The cells were exposed to this solution overnight in the humid chamber at 370C. Before microscopy 
the samples were washed four times in PBS at RT and exposed to the secondary antibody (anti-IgH 
Alex Fluor 488) in a solution of PBS with 0.1% Goat Serum for 30 minutes at 370C. 
4.2.7 CONFOCAL MICROSCOPY PROTOCOL 
Cells labelled as detailed above on Matek dishes were placed upon the sample hold of the confocal 
microscope. The confocal system was a Zeiss LSM 780 inverted microscope equipped with a 
63x/1.40 planar apochromatic oil objective. An argon laser was used to excite the Alexa-Fluor at 
488nm, filters at 493-630nm were used for the excited fluorescence. The images were acquired by a 
computer system running Windows 7 and the Zen Black software package. Image slices of 0.5μm 
were acquired through the full thickness of the cell (which was usually around 30μm). The image 
stacks which were acquired were analyzed in the Fiji software package (freeware).      
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4.2.8 QUANTIFICATION OF CAVEOLIN-3 LEVELS IN APICAL AND BASAL 
CARDIOMYOCYTES BY WESTERN BLOTTING 
Cells isolated from the apical or basal myocardium of rats were washed with physiological buffer 
once and homogenized in a lysis buffer which contained: 300mM sucrose, 150mM NaCl, 1mM EGTA, 
2mM CaCl2, 1% Triton-X-100, 10 mM HEPES, pH=7.4. Samples of 5µg of protein were separated on a 
15% SDS-polyacrylamide gel and blotted onto a nitrocellulose membrane. The nitrocellulose 
membranes were blocked for an hour at room temperature with a solution PBS including 0.05 % 
Tween-20 and 5% non-fat milk powder. The membranes were then incubated overnight at 4°C with 
a primary monoclonal Cav3 antibody (1:5000). The membranes were washed in PBS and probed with 
horseradish peroxidase (HRP)-conjugated anti-mouse IgG (1:5000) and visualized using the ECL kit 
(Amersham Biosciences). Blots were quantified using ImageJ software and corrected to expression of 
GAPDH. Experiments and Analysis performed by Karine Zimmerman.  
4.2.9 QUANTIFICATION OF CAVEOLAE NUMBER IN APICAL AND BASAL 
CARDIOMYOCYTES USING TRANSMISSION ELECTRON MICROSCOPY 
Apical and basal cardiomyocytes were fixed in a solution of 2.5% glutaraldehyde in PBS for 2 to 4 
hours. Subsequently they were centrifuged at 500g for 5 min and the pellet was left in the fixative 
solution overnight. This pellet was washed three times in a cacodylate buffer and fixed in a solution 
of 1% osmium-tetroxide. This step was then followed by a 5-10 min washing step with distilled 
water. Around 25 to 50μl of liquid agar (2% solution) at 45°C were added to the pellet. Small 
portions of the liquid were left to solidify on polythene, this gave small amounts of solidified agar 
with evenly distributed cells. These were dehydrated in the presence of graded alcohols and 
propylene oxide. The blocks were subsequently embedded in araldite. This allowed low power 
examination by light microscopy before EM examination. Sections of around 1μm thick were cut 
using a microtome and stained with 1% toluidine blue in 1% borax. To allow examination by 
transmission electron microscopy, ultra-thin sections from the existing blocks and were stained with 
uranyl acetate and lead citrate. Images of the cardiomyocytes cellular membranes were taken. 
Following isolation a group of 10 cells were selected from either the apical or basal groups at 
random and 10 separate fields of view were taken for each cell. This process was repeated more 
than three times. The number of caveolae-like elements (both opened and closed) was counted. 
Caveolae number per 1μm of membrane was calculated as an index of the relative level of caveolae 
in the cell type of interest.  Experiments and analysis performed by Ivan Diakonov. 
 
130 
 
4.2.10 STUDIES OF THE CAMP COMPARTMENTATION OF THE Β2AR IN APICAL AND 
BASAL CARDIOMYOCYTES USING FRET MICROSCOPY 
As in the IonOptix studies, the methods in this section are largely adaptations of those utilized in 
Chapter Three and described in section 3.2.4. Equally, following the IonOptix studies discussed in 
4.2.1, the aim of the studies described in this section is to assess the cAMP responses in different 
regions of the cell after manipulation of caveolar or phosphodiesterase compartmentation of the 
β2AR response. In all cases apical and basal cells are plated on laminin coated coverslips and 
maintained in culture for 48 hours in the presence of the necessary adenoviral construct (as 
described in section 3.2.4. This provides fluorescent cells which will indicate cellular cAMP levels 
when imaged using the FRET microscopy method detailed in section 3.2.4. 
4.2.11.1DETERMINING THE Β2AR-CAMP RESPONSE AS A FUNCTION OF FULL ADENYLATE 
CYCLASE ACTIVITY FOLLOWING THE REMOVAL OF CAVEOLAE OR WITH THE REMOVAL OF 
PHOSPHODIESTERASE ACTIVITY 
Protocol 1 
 
In this protocol the cells are pre-incubated for 1 hour in the presence of 1-2mM cyclodextrin if the 
removal of caveolar compartmentation of β2AR-cAMP is desired. If the removal of the effects of 
phosphodiesterase compartmentation is required then the cells are pre-incubated with the desired 
selective or non-selective phosphodiesterase inhibitor. 
PDE 2 - EHNA at 10μM, PDE3 – Milrinone at 1μM, PDE 4 – Rolipram at 10μM, Non-selective – IBMX 
at 100μM 
 This inhibitor is then present in the other solutions utilized in the protocol, as β2AR and then 
adenylate cyclase are selectively stimulated.  
 
 
   
CGP20712A  
100nM 
CGP+ 
Isoprenaline 
100nM 
CGP+ISO 
NKH 477 
5μM 
250 secs 250 secs 250 secs 
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Protocol 2 
This is an adaptation of protocol 1 and serves to assess the relative tone under which a specific 
phosphodiesterase of interest holds β2AR. In this scenario the phosphodiesterase is added following 
β2AR stimulation. This may prevent the distortion of FRET responses by cellular cAMP levels which 
are high at baseline due to pre-stimulation with specific phosphodiesterase inhibitors. 
 
Protocol 3  
Protocol 3 is an adapted FRET method which seeks to measure the persistence of β2AR-cAMP 
responses in apical or basal cardiomyocytes. cAMP does not spontaneously degrade in cells due to 
its chemical stability, this reaction must be catalyzed by phosphodiesterases. Consequently, 
measuring the persistence of the FRET responses after rapid withdrawal of the stimuli becomes an 
adjunct to studying the activity of phosphodiesterases. The approach is to apply a rapid whole cell 
β2AR stimulation utilizing a micro-manipulator based solution inlet which is manoeuvred close to the 
cell of interest. This is then switched to non-ISO containing CGP FRET solution. In consequence FRET 
responses gradually dissipate as cAMP is broken down. Complete removal of ISO stimulation is 
ensured by washing >20 bath volumes through the coverslip dish within the first five minutes. Due to 
the position of the inlet, next to the cell, the amount of ISO present in the solution surrounding the 
cell of interest should drop even more rapidly.  
 
 
 
 
 
 
CGP20712A  
100nM 
CGP20712A  
100nM 
CGP+ 
Isoprenaline 
100nM 
CGP+ 
Isoprenaline 
100nM 
250 secs 
PDE 
Inhibitor 
50 secs 
250 secs 
+300 secs 
250 secs 
CGP20712A  
100nM 
250 secs 
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4.2.12 ASSESSMENT OF THE LOCALIZED Β2AR-CAMP RESPONSES IN HEALTHY 
CARDIOMYOCYTES AFTER DISPLACEMENT OF CAV3 FROM CAVEOLAR DOMAINS 
The combination SICM/FRET method is performed as described in section 3.2.5. Control cells were 
isolated as a ‘whole heart’ homogenate, i.e. with no distinction between apical and basal regions. An 
adenoviral vectors were utilized at an MOI of 300 to transfect cells with native a dominant-negative 
version of Cav3 (Cav3DN) which displaces Cav3 and reduces cellular caveolae number (Koga et al., 
2003). Following 48 hours in culture the cells were assessed by SICM/FRET as described above. 
4.2.13 STATISTICAL ANALYSIS  
Cell contractility was analyzed by initially testing pre-treatment, treatment and removal of treatment 
groups for each cell type with a One-way Repeated Measures ANOVA. Subsequently, fold increases 
between cell types were analyzed with an unpaired Mann-Whitney test (Non-Gaussian data). 
Concentration-response experiments were analyzed by non-linear regression and fitting to a 
sigmoidal curve.  
Single dose tests to measure cAMP-mediated FRET shifts between cell types were analyzed using an 
unpaired Mann Whitney test (Non-Gaussian Data).  
Caveolae number and protein expression in apical and basal cardiomyocytes were quantified and 
tested using unpaired t-test. 
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4.3 PHYSICAL ASPECTS OF THE STRUCTURAL AND MOLECULAR CONTROL OF 
DIFFERENTIAL MYOCYTE RESPONSIVENESS TO Β2AR-CAMP IN APICAL AND BASAL 
CARDIOMYOCYTES 
4.3.1 THE EFFECT OF CHOLESTEROL REMOVAL ON THE DIFFERENTIAL CONTRACTILE 
RESPONSIVENESS OF APICAL AND BASAL CARDIOMYOCYTES  
Caveolae are cholesterol containing micro-domains which have been shown to play a role in the 
localization, compartmentation and control of β2AR in cardiomyocytes (Calaghan et al., 2012). 
Caveolae are possibly implicated in the differential contractile response of apical and basal 
cardiomyocytes to selective stimulation. This is because they could be organizing the cAMP 
responses without causing detectable differences in cAMP amplitude between apical and basal 
cardiomyocytes. The protocol described in 4.2.3 was employed to assess the β2AR responses of 
apical and basal cardiomyocytes with cholesterol depleted by the agent cyclodextrin. Significant 
increases in cell shortening were observed for both apical and basal cardiomyocytes upon 
isoprenaline stimulation (Figure 4.1). These increases in shortening were followed by a significant 
reduction toward baseline after inhibition of β2AR by ICI 118,551 in both apical and basal cells- 
confirming a selective β2AR response. The apical cells in particular displayed significant levels of 
arrhythmia following cyclodextrin treatment and isoprenaline stimulation meaning many cells were 
excluded from analysis. This suggests that in apical cells in particular cholesterol reserves and 
possibly caveolae prevent β2AR stimulation from causing arrhythmic effects. Intriguingly, in the 
apical cells in particular repeated measures ANOVA showed that after ICI 118,551, shortening 
responses remained elevated above baseline. Apical and basal shortening responses to β2AR 
stimulation were not significantly different.  When correcting the β2AR stimulated shortening 
response to the baseline there is still no difference between apex and base responses. This presents 
a direct contrast to the control situation for cells with cholesterol reserves intact as can be seen from 
figure 4.1 c). It appears that the apical response is slightly downshifted from control by cholesterol 
depletion. Conversely, the response of basal cardiomyocytes is shifted upward by cyclodextrin 
treatment which suggests that cholesterol treatment equilibrates the apical and basal β2AR 
shortening responses. This implicates the role of cholesterol containing domains in the differences in 
contractile responses observed in apical and basal cells following β2AR stimulation.       
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Figure 4.1 a) Graph demonstrating the equilibration of rat apical and basal β2AR (CGP 300nM+ ISO 
1µM) induced shortening responses following cyclodextrin treatment. Data analysis by One-Way 
Repeated Measures ANOVA. b) The data from part a) graphed as fold increases in shortening 
responses following correction to baseline, apical and basal responses are equalized by cyclodextrin 
treatment. Data analysis by Mann-Whitney test. c) Graph displaying this equilibration in relation to 
control data. 
β2AR stimulation significantly reduces the time apical cells take to relax to 50% of their shortening 
length (R50) (Figure 4.2). The opposite is true for basal cardiomyocytes where there is no change in 
R50 following β2AR stimulation Figure 4.2. Calculating the relative change reveals a significant 
difference between apical and basal cells, with reductions in R50 only for the apical cell type (Figure 
4.2c). It can be suggested that β2AR stimulation is able to modulate factors involved in EC-coupling 
such as phospholamban or TnI, which control cardiomyocyte lusitropy, in apical cardiomyocytes but 
not basal. Phospholamban function is governed by phosphorylation state which in turn is governed 
by the activation of PKA by cAMP. Equally, phosphorylation of TnI reduces its calcium sensitivity 
meaning contraction is reversed more rapidly, enhancing lusitropy. Thus these data are concordant 
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with data in Chapter 3 demonstrating greater influence of β2AR-cAMP on RII_Epac in apical versus 
basal cardiomyocytes. 
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Figure 4.2 a) Graph displaying the change in cellular relaxation R50 values following β2AR stimulation 
(CGP 300nM + ISO 1µM) of rat apical cells. b) The R50 value of rat basal cells following β2AR 
stimulation. c) Comparison of the changes in R50 values of rat apical and basal cells, changes 
corrected to baseline. The R50 value of apical cells decreases whereas the R50 of basal cells increases 
upon β2AR stimulation.Statistical testin by Mann Whitney test. 
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Treatment with cyclodextrin seems to shift this balance somewhat. Apical cells still exhibit a 
reduction in R50 following β2AR stimulation (Figure 4.3). No significant decrease is observed in the 
R50 of basal cells following β2AR stimulation (Figure 4.3). Interestingly, after correction cyclodextrin 
treatment appears to have equalized apical and basal responses to β2AR stimulation in terms of 
alterations of R50 value Figure 4.2. This has apparently been achieved by significantly reducing the 
effect of β2AR stimulation on apical cells, whilst the slight trend towards an increase in R50 in the 
basal cells has been removed.  
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Figure 4.3 a) Graph showing the effects of cyclodextrin treatment on the R50 value of rat apical cells 
following β2AR stimulation (CGP 300nM + ISO 1µM). b) Graph showing the effects of cyclodextrin pre-
treatment on the R50 of rat basal cells. c) Graph displaying the corrected R50 values of apical and 
basal cells following cyclodextrin treatment. d) Graph showing a comparison of the corrected 
changes in R50 of apical and basal cells following β2AR stimulation with or without cyclodextrin 
treatment.Statistical analysis was by Mann Whitney test.   
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4.3.2 THE EFFECT OF PHOSPHODIESTERASE INHIBITION ON THE DIFFERENTIAL 
CONTRACTILE RESPONSIVENESS OF APICAL AND BASAL CARDIOMYOCYTES 
Cardiomyocytes isolated from the apical and basal thirds of the rat myocardium were placed into the 
tissue bath of the IonOptix system as described in Chapter 2 (2.2.2). The protocol detailed in 2.2.2 
was employed to remove the effect of phosphodiesterase 4 on the differential contractile response 
of apical and basal cardiomyocytes to specific β2AR stimulation. Significant increases in the 
shortening of cardiomyocytes from both apical and basal regions were observed after application of 
isoprenaline. Although there is a possibility that the addition of a phosphodiesterase inhibitor 
interferes with the protocol, which relies upon the ability of the selective β2AR inhibitor ICI 118,551 
to reduce evoked contractile changes to a basal level, thus confirming selective β2AR activity, neither 
apical nor basal cardiomyocyte responses return to basal levels and the reductions in shortening 
after ICI 118,551 are not statistically significant. ICI was effective in confirming the selectivity of 
CGP+ISO in stimulating just β2AR in similar protocols. When correcting the increases in shortening 
evoked by β2AR to baseline contractility it is clear that β2AR stimulation has induced a contractile 
response in both apical and basal cardiomyocytes. This is in direct contrast to control cells where 
apical cells respond significantly more to β2AR stimulation in comparison to basal cells. This 
equilibrating effect of rolipram on the region differences is clear to see from Figure 4.4 where 
differences are present between the control apical-basal responses but not after phosphodiesterase 
inhibition. There appears to be a relative down shifting of the apical response as well as an increase 
in the basal response which underlies this equilibration. However, there do not seem to be any 
statistically significant increases in the contractile responses of basal cells following rolipram 
treatment. This is equally true of the apex where there is not a statistically significant down shifting 
caused by the rolipram treatment. The lack of statistical significance is likely to be due to the slightly 
smaller sample size of the rolipram treated cells and variability introduced by this agent. In fact a 
large amount of arrhythmic contraction was observed after ISO stimulation of these cells, which is 
not observed in control cells. This suggests PDE4 activity is important for preventing β2AR from 
causing arrhythmic effects in cardiomyocytes. Thus it seems PDE4 control of the β2AR response may 
have some control over the apical and basal contractile dichotomy but it is not clear how this occurs 
from these data.      
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Figure 4.4 a) Graph showing the effect of rolipram treatment on apical and basal rat cardiomyocytes 
shortening responses following β2AR stimulation (CGP 300nM + ISO 1µM). Statistical analysis by One-
Way Repeated Measures ANOVA. b) Graph showing corrected shortening responses of apical and 
basal rat cells. Graph showing a comparison of the fold change in shortening after rolipram 
treatment or in control cells c).Statistical testing by Mann-Whitney test. 
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The lusitropy of apical and basal cells is demonstrated to be affected differently by β2AR stimulation 
Figure 4.1. This difference can be equalized by removing cellular cholesterol. The same measures are 
assessed to establish whether PDE4 inhibition is able to produce the same effect. Figure 4.5 shows 
that after Rolipram treatment apical cells R50 is not significantly altered by β2AR stimulation. This is 
also true in basal cells; an apparent small decrease in R50 does not reach statistical significance. 
Correction of these alterations to baseline shows that after rolipram treatment apical and basal cells 
differ in their R50 responses to β2AR stimulation. This finding is intriguing as it is an apparent 
reversal of the situation seen in control cells. Indeed, rolipram treatment seems to reduce the basal 
cell R50 after β2AR stimulation whereas it apparently induces a lengthening of the R50 in apical cells 
following β2AR stimulation. A caveat in this analysis is that the rolipram treatment has apparently 
induced a reduction in the baseline R50 of both apical and basal cardiomyocytes suggesting this 
agent has non-specific effects. This is probably due to it raising cellular levels of cAMP and 
consequently increasing PLB phosphorylation. The sample number is also low due to arrhythmic 
activity induced by rolipram and discussed above.  
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Figure 4.5 part 1 a, b) The effect of rolipram treatment on rat apical and basal cells lusitropic 
responses (R50) following β2AR stimulation (CGP 300nM + ISO 1µM). Cells are almost maximally 
lusitropic at baseline following rolipram treatment. c,d Graphs displaying corrected measures of 
these changes in R50. Statistical analysis was achieved by Mann Whitney Test. 
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Figure 4.5 part 2 a,c Graph demonstrating the comparison of raw R50  values for apical rat cells R50 
responses following β2AR stimulation (CGP 300nM + ISO 1µM)  with/without Rolipram b,d Graphs 
demonstrating the data for basal cells 
 4.3.3. TRANSMISSION ELECTRON MICROSCOPY STUDY OF APICAL AND BASAL 
CARDIOMYOCYTES CELL MEMBRANES TO ESTABLISH RELATIVE NUMBERS OF CAVEOLAE 
Given the ability of cholesterol depletion and phosphodiesterase inhibition to enhance the inotropic 
and lusitropic responses of basal cardiomyocytes following β2AR stimulation, apical and basal cells 
were fixed and stained for study by electron microscopy. It was hypothesised that a greater number 
of caveolae and consequently enhanced caveolar localization of β2AR; could impinge upon β2AR’s 
ability to influence contractility in basal cells. Figure 4.6 presents a striking difference between the 
number of caveolae in apical and basal cells. Basal cells present around eight times more caveolae 
like domains per micron of membrane than apical cells. The levels of caveolae we report in the basal 
cells are around four times that previously reported in the literature for an adult rat cardiomyocyte, 
equally the level of caveolae in apical cells is about half that reported (Kozera, White and Calaghan, 
2009). Cyclodextrin treatment can disrupt caveolae domains to a degree that apex and base cells 
present an equal number of caveolae. The level of caveolae in apical cells is not significantly altered 
by cyclodextrin treatment suggesting that these cells do not possess many disruptable caveolae at 
baseline. Consequently the exaggerated effect of cyclodextrin treatment on the basal cells may 
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explain the increase in β2AR mediated contractility on this sub-population. Equally, it implicates an 
increase in caveolae density and enhanced caveolar localization of β2AR in the differential response 
of apical and basal cardiomyocytes to β2AR stimulation. It may equally be responsible for restricting 
cAMP from RII domains as demonstrated by the FRET experiments detailed in 3.11.     
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Figure 4.6 Graph showing the quantity of caveolar domains present in the cell membranes of rat 
apical and basal cardiomyocytes. Basal cells present around 8 fold more caveolae than apical cells. 
This difference can be equalized by removal of cellular cholesterol with cyclodextrin. Analysis 
performed by Ivan Diakonov.Statistical analysis by unpaired Student’s t-test.  
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Figure 4.7 Representative images demonstrating the increased density of caveolae in rat basal 
cardiomyocytes in comparison to apex. The images demonstrate the effect of cyclodextrin; this 
treatment significantly reduces the number of caveolae in basal cardiomyocytes. Analysis performed 
by Ivan Diakonov. 
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4.3.4 QUANTIFICATION OF CAV3 EXPRESSION LEVELS 
Given the striking difference between apical and basal cardiomyocytes with respect to caveolar 
number it was questioned whether there were differences in cellular levels of caveolin-3. As the 
main scaffolding component of caveolae, larger quantities of these molecules should lead to greater 
caveolae stability and consequently increased caveolar number. For this reason apical and basal cells 
were isolated and Cav3 levels were quantified by western blotting.  
 
Figure 4.8 a) A representative blot showing the quantification of Cav3 expression in apical and basal 
rat cardiomyocytes the top band is GAPDH for correction as a ‘housekeeping’ gene b) A histogram 
demonstrating the parity of cav3 expression in apical and basal cells. Produced by Karine 
Zimmerman, Nikolaev Laboratory. Statistical analysis by Mann-Whitney test. 
Interestingly the expression levels of Cav3 were equal between apical and basal cardiomyocytes. The 
suggestion is that the differences in the levels of caveolae presented by apical and basal 
cardiomyocytes is not a product of increased or decreased Cav3 expression. The difference between 
the cell types is not due to innate differences in gene expression but possibly due to dynamic 
physical effects.    
4.3.5 CONFOCAL MICROSCOPY ANALYSIS OF APICAL AND BASAL CARDIOMYOCYTES 
AFTER IMMUNE-LABELLING CELLULAR CAV3 
A study was made of cardiomyocytes after immuno-labelling of Cav-3 and subsequently labelling 
anti-Cav3 with a fluorescent secondary antibody. There do not appear to be distinct differences in 
the amounts of Cav3 present in apical and basal cells as quantified by western blotting. Equally the 
localization and 3D images provided by confocal microscopy do not indicate differences in the 
cellular localization of Cav3 between Apex and Base. Cav3 seems to localize predominantly in the 
membrane regions, as expected, with a punctate staining indicative of caveolar micro-domains. 
ii) n = 3 
p= 3 
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There are smaller amounts of fluorescence located at non-uniform intervals throughout the cell 
interiors of both cell types. There seem to be some elements of cav3 within the cell interior, possibly 
projections into the cell cytosol which may be evidence of quantities of Cav3 being present in t-
tubules.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 A) A 1μm z-plane (1024px) confocal microscopy image of an apical rat cardiomyocyte with 
Cav3 immuno-staining B) An image of a basal rat cardiomyocyte which has undergone the same 
treatment. C) An enlarged image showing the punctate staining observed in the apical 
cardiomyocyte, indicative of Cav3 staining of caveolae, micro-domains D) Enlarged image of 
membrane projections penetrating the cardiomyocyte cytosol staining for Cav3 – suggestive of t-
tubular elements. The regions enlarged in iii) and iv) are indicated in image i). 
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4.3.7 ASSESSING THE ROLE OF CAMP COMPARTMENTATION IN THE APICAL/BASAL 
DICHOTOMY WITH RESPECT TO CONTRACTILE RESPONSIVENESS FOLLOWING SELECTIVE 
Β2AR STIMULATION 
The lack of a difference between the cAMP responses of apical and basal cardiomyocytes within the 
cytosol which was observed in the studies discussed in chapter one is intriguing; given the distinctly 
higher contractile responsiveness of apical cells to β2AR. This leads to the hypothesis that β2AR-
cAMP handling was somehow different in the apical cells. This may lead to differential control of the 
PKA activity, which controls contractile responses in cardiomyocytes. Subsequently, it was shown 
that higher β2AR-cAMP responses were elicited in apical cells when measured in the PKA-RII 
compartments as opposed to the cytosol. This was a clear indication of differential cAMP handling 
giving rise to a variable influence of β2AR on the PKA compartments. In the first part of this chapter it 
has been shown that these different cAMP responses may have a structural basis. Basal cells have a 
greater amount of their membrane sequestered in caveolae like regions in comparison to apical 
cells. Past studies have demonstrated β2AR-cAMP to be spatially restricted (Nikolaev et al., 2006 and 
2010) and to co-immunoprecipitate with caveolae like membranes (Head et al., 2005). This is in 
contrast to β1AR. Caveolar disruption with the agent cyclodextrin caused the equilibration of 
contractile responses in apical and basal cardiomyocytes. Therefore FRET studies were performed to 
analyze the effect of cyclodextrin upon the β2AR-cAMP responses in different cellular compartments. 
It seemed likely that relative de-compartmentation of β2AR in the caveolae presenting basal cells 
was causing β2AR-cAMP to have a greater influence on PKA-RII and thus an equilibration in 
contractile responses was observed.  
Initially, cells transfected with the cytosolic cAMP sensor Epac2 were assayed. An increase was 
observed after cyclodextrin pre-treatment, in uncorrected FRET Ratio shift, in the basal 
cardiomyocyte’s β2AR-cAMP and β2AR response corrected to total cAMP response in comparison to 
apical cells (Figure 4.10 a). No differences are observed between the β2AR-cAMP responses of apical 
and basal cells treated by cyclodextrin in comparison to control (Figure 4.10 b). Equally, the 
differences between apical and basal cardiomyocytes after cyclodextrin treatment are no longer 
present after correcting the β2AR response to maximum cellular cAMP output (Figure 4.10 c). There 
are no apparent differences between these corrected β2AR responses after cyclodextrin treatment 
and control values. Cyclodextrin does not seem to affect β2AR-cAMP responses measured in the 
cytosol by the cEPAC2 sensor.                          
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Figure 4.10 a) Graphs showing the β2AR-cAMP responses (CGP 100nM +ISO 100nM) of rat apical and 
basal cardiomyocytes measured with the cEpac2 FRET sensor (cytosolic localization) following 
cyclodextrin treatment. b) Graphs showing β2AR-cAMP responses in cells with or without cyclodextrin 
treatment, represented as raw FRET responses. c) Graphs showing β2AR-cAMP responses presented 
as %Total cAMP response. Statistical analysis by Mann-Whitney test. 
The RII_Epac was demonstrated to be far more effective at predicting the regional responsiveness of 
apical and basal cardiomyocytes in response to β2AR stimulation. After cyclodextrin treatment of 
apical and basal cardiomyocytes the β2AR-mediated cAMP responses detected with the RII_Epac 
sensor are equal, as are the total cAMP responses (Figure 4.11 a). Comparison of the β2AR responses 
of cyclodextrin treated apical/basal cells with control reveals a reduction in the apical response after 
treatment with cyclodextrin (Figure 4.11 b). This is similar to the effect observed with the cEpac2 
sensor, but a large amount of variability in the cyclodextrin group prevents this effect reaching 
statistical significance. Like the basal cells transfected with cEpac2, cyclodextrin appears to increase 
the β2AR response but the effect is not statistically significant. The overall effect of cyclodextrin is to 
remove the relatively spatially restricted PKA domain cAMP response in basal cardiomyocytes versus 
apical. This also clearly the effect of cyclodextrin when correcting the β2AR to maximal cellular cAMP 
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output (Figure 4.11 c). Even though the decrease in the apical cells response and the increase in the 
basal response following cyclodextrin treatment is not significant in the case of the RII_Epac sensor 
and disappears upon correction in the cEpac2 sensor; both scenarios very similar to the subtle 
changes that can be observed in the contractility studies discussed in Figure 4.1. It suggests that the 
changes in control of cAMP may be small and that the localization of the FRET sensors is not 
completely able to resolve the physiological changes in β2AR signalling evoked by the cyclodextrin. 
However, the effect of cyclodextrin on the contractility of apical and basal cells, which is an 
equilibration, is accurately predicted by the RII_Epac results.             
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Figure 4.11 a) Graphs showing the effect of cyclodextrin on apical and basal rat cardiomyocte cAMP 
responses to β2AR stimulation (CGP 100nM +ISO 100nM) measured by the RII_Epac FRET sensor in 
the PKA_RII domains without adjusting total cAMP responses b) Graphs showing the raw FRET data 
presented in part a). c) Graphs showing β2AR responses corrected to %Total cAMP output. Statistical 
analysis by Mann-Whitney test. 
The effect of cyclodextrin on cAMP responses may be hypothesised to be more distinct when 
measured by the pmEpac2 sensor, but this sensor is less specific than the RII_Epac for prediction of 
β2AR-mediated effects on cellular physiology. The pmEpac2 sensor has some localization to the 
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caveolae rich fraction of the cell membrane. Even so no differences were observed between the 
uncorrected FRET responses in control apex and base cells. This was surprising in the context of the 
electron microscopy data discussed in Part 1 of this chapter. Caveolae are demonstrated to 
compartmentalize the β2AR response and reduce its effects on cardiomyocyte contractility 
(McDougall et al., 2012), the effects of caveolae on β2AR may be more subtle than simply reducing 
the cAMP signal. In this respect it is possible to surmise that β2AR-cAMP responses are produced in 
caveolar domains and that cAMP enters the cytosol, but that some aspect of caveolar or cholesterol-
dependent localization prevents movement of cAMP from these compartments to the PKA-RII 
domain which controls contractility. There are no differences between the uncorrected β2AR and 
maximal cAMP responses of apical and basal cells after cyclodextrin treatment (Figure 4.12 a). It 
appears that the role of the caveolae in compartmentalizing the β2AR is not to reduce the amplitude 
of cAMP production upon stimulation. The caveolae presenting basal cells are as unaffected by 
cyclodextrin treatment as the caveolae-less apical cells. This is also demonstrated by the fact that 
there are no differences between the amplitudes of the β2AR-cAMP response in the cyclodextrin 
treated cells and control (Figure 4.12 b). Upon correction of the β2AR response to the total cellular 
cAMP response it is clear to see that the relatively enhanced apical cAMP response seen in control 
cells is removed by cyclodextrin treatment. Apical and basal β2AR-cAMP responses are equalized by 
cyclodextrin treatment (Figure 4.12 c). The removal of the difference between the cell types may be 
due, in part, to the introduction of an increased amount of variability. As previously discussed, there 
is also an apparent increase in the responsiveness of the basal cells although this does not reach 
statistical significance against control (Figure 4.12 c).  
In conclusion it appears that, from FRET based measurements of β2AR-cAMP responses corrected to 
total cellular cAMP responses, cyclodextrin treatment increases the basal cells β2AR-cAMP responses 
to equilibrate them with the response of the apical cells. This is apparent from the data produced by 
the more localized FRET sensors, and seems to predict the contractile responses of apical and basal 
cells, following cyclodextrin treatment. However, there is not a clear linear relationship between 
caveolar number cyclodextrin treatment and consequent cAMP response amplitude.                                
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Figure 4.12 a) Graphs showing the apical and basal rat cardiomyocyte β2AR-cAMP (CGP 100nM and 
ISO 100nM) responses measured by the membrane localized pmEpac2 FRET sensor following ISO and 
NKH stimulation following cyclodextrin treatment. b) Graphs showing the raw FRET response of 
control and cyclodextrin treated apical and basal cardiomyocytes either with or without cyclodextrin 
treatment. c) Graphs displaying corrected FRET responses of control and cyclodextrin treated 
cardiomyocytes as a function of the Total cAMP response. Statistical analysis by Mann-Whitney test. 
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4.3.8 CONTROL OF THE AMPLITUDE OF THE Β2AR-CAMP RESPONSE IN APICAL AND 
BASAL CARDIOMYOCYTES IS ALMOST COMPLETELY VIA THE PDE4 SUBTYPE AS 
MEASURED BY THE CEPAC2 CYTOSOLIC FRET SENSOR   
The molecular basis of cAMP compartmentation partially based upon the association of GPCRs and 
their associated adenylate cyclases with phosphodiesterases. This arrangement results in the GPCR 
stimulation event activating a distinct panel of downstream effectors. This situation amounts to a 
controlled diffusion/conduction of cAMP within cell compartments. The expression and role of 
phosphodiesterase subtypes varies with species. Phosphodiesterase 4 seems to play a vital role in 
rodent cardiomyocytes whereas this role is shared between PDE4 and 3 in human cells.  A small but 
statistically significant increase in the %FRET ratio shift following the application of EHNA was 
observed in apical but not basal cardiomyocytes. Milrinone application does not cause any increase 
in %FRET Ratio shift in either apex or base cells. Rolipram application following CGP+ISO caused a 
significant increase in %FRET ratio shift in both apical and basal cardiomyocytes. As expected the 
non-selective PDE inhibitor IBMX caused increases in %FRET Ratio shifts in both apical and basal 
cardiomyocytes. These results are displayed in Figure 4.13.      
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Figure 4.13 a) Graphs showing apical rat cells responses to CGP 100nM+ISO 100nM and the 
subsequent effect of PDE 2, 3, 4 selective and full PDE inhibitions by the use of (EHNA, milrinone, 
rolipram and IBMX respectively) as raw FRET response (cEPAC2 sensor). b) Graphs showing the same 
data observed in basal cardiomyocytes. Statistical testing by Wilcoxon matched pairs test.  
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These data are corrected to show the increase in FRET Ratio shift percentage following inhibitor 
application to allow comparison between apical and basal cardiomyocytes. As the graph in Figure 
4.14 shows there is not a large difference between the apical and basal cAMP increases after β2AR 
stimulation and subsequent PDE inhibition for the PDE2 and PDE3 subtypes. Significantly more PDE4 
activity is uncovered in basal cells in comparison to apical cells, suggesting there is a greater control 
of the β2AR by PDE4 in basal cells. The removal of all PDE subtypes by IBMX gives rise to a significant 
increase in FRET Ratio Shift but these data do not show a statistically significant difference between 
apex and base cells.      
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Figure 4.14 Graph showing the rat apical and basal cells responses to PDE2, 3, 4 or total PDE removal 
with the initial cAMP responses subtracted (cEPAC2 sensor), raw data displayed in figure 4.14. The 
increase in FRET shift therefore represents an index of the level to which the activity of a specific 
phosphodiesterase is inhibiting the β2AR-cAMP mediated response within the cell type. Statistical 
analysis was performed by Mann-Whitney test. 
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4.3.9 ROLIPRAM INCREASES THE FRET RESPONSE OF THE RII_EPAC SENSOR IN BASAL 
CELLS 
Similarly, to the experiments using the cEpac2 sensor the infusion of rolipram increases the FRET 
response significantly more in basal cardiomyocytes than in apical cells when measuring cAMP in RII-
PKA compartments (Figure 4.15). The FRET response revealed by rolipram is almost three times 
higher in basal cells than apical. This confirms that a greater amount of PDE4 activity/tone is acting 
upon the cAMP produced following β2AR stimulation in basal cardiomyocytes compared to apical. An 
interesting aspect of this experiment is that the sensor localized in the RII domain allows us to see 
quite clearly that this increased PDE4 activity would be restricting cAMP produced by β2AR 
stimulation from exerting an effect on cellular contractility. The difference in the effect sizes 
measured by the different FRET sensors is interesting as it echoes previous data from MacDougall et 
al (2012). The β2AR stimulation evokes cAMP responses which are lower in the RII domains 
compared to the cytosol in both apical and basal cells. β2AR does not appear to be able to fully 
influence the RII_Epac compartment even following cyclodextrin treatment the FRET shifts remain 
25% of total as compared to around 50% in the cytosol. This is not due to differences in sensor 
function as the FRET shifts evoked by NKH477 in both cEpac2 and RII_Epac are similar. As figure 4.15 
shows rolipram causes about half the response in the RII_Epac compared to the cEpac2 in both cell 
types. The suggestion here is that cyclodextrin and PDE4 are most likely not the only 
compartmentalizing factors exerting influence on β2AR.           
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Figure 4.15 Graph showing a comparison of the relative increases in β2AR-cAMP (CGP 100nM+ISO 
100nM) upon addition of rolipram (5µM) in apical and basal rat cells as measured by cEpac2 for the 
localized RII_Epac sensor. Statistical analysis by Mann-Whitney test. 
155 
 
4.3.10 THE REMOVAL OF CAMP BY PHOSPHODIESTERASES DIFFERS BETWEEN APICAL 
AND BASAL CARDIOMYOCYTES  
The rate of removal of cAMP following β2AR stimulation of apical or basal cardiomyocytes was 
measured with both the cEpac2 and RII_Epac sensors using Protocol 3 as described in section 4.2.9 
Figure 4.16. Studies utilizing the cEpac2 sensor show that the β2AR-cAMP response is far more 
persistent in apical cells than basal. This can be observed from the average trace of FRET responses 
following washout. Basal cells are fairly consistent in reducing their cAMP levels to near baseline 
within 200s of the maximal response. The population of apical cells responses is more 
heterogeneous; some cells resemble basal cells and reduce their responses back to baseline whereas 
others cAMP levels remain almost unchanged after washout. Care was taken to ensure that only 
viable cells were utilized and, as covered in chapter two, apical cells show no differences in their 
relative viability in comparison to basal.    
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Figure 4.16 Time trace showing the cAMP induced FRET responses of apical or basal rat 
cardiomyocytes measured by the cEPAC2 sensor following β2AR stimulation (CGP 100nM and ISO 
100nM), with a rapid washout. 
The consequences of this are unclear but given the enhanced contractile responsiveness of apical 
cardiomyocytes following β2AR stimulation this may possibly result in a greater influence of β2AR-
cAMP on PKA compartments. Equally, it is possible to observe within these data the enhanced 
phosphodiesterase activity present in basal cardiomyocytes discussed in Figure 4.15. Significantly 
more cAMP responsiveness was uncovered after PDE4 inhibition than in basal cardiomyocytes. This 
suggested there was a greater tone of phosphodiesterase inhibition on β2AR responses in basal 
cardiomyocytes than in the apex. However, as previous studies showed studies with cEpac2 are less 
156 
 
predictive of contractile outcome of β2AR stimulation than studies with RII_Epac. Washout studies 
were repeated for apex and base cells transfected with RII_Epac.  
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Figure 4.17 Time traces showing the FRET responses of apical or basal cardiomyocytes measured by 
RII_Epac sensor following β2AR stimulation (CGP100nM ISO 100nM), with rapid washout a) with b) 
rolipram added to prevent PDE4 effects. c) cAMP levels remain more elevated on average in apical 
cells. d) This difference appears to be equalized by the effects of Rolipram. Statistical analysis by 
Mann-Whitney test. 
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As shown in figure 4.17 the cAMP appears to be removed from the RII-PKA domains more rapidly in 
apical cardiomyocytes than basal. This situation is reversed when the rapid washout solution (-ISO) 
has the specific PDE4 inhibitor rolipram added. This confirms that restricted β2AR-cAMP signalling in 
basal cardiomyocytes prevents persistent cAMP levels from influencing the cardiomyocytes PKA 
compartment and altering contractility after β2AR stimulation. This restriction appears to be 
supported by the increased activity of PDE4 in basal cardiomyocytes. The removal of PDE4 tone 
returns the rate of cAMP removal of the basal cardiomyocytes to that of the apical cells. 
Interestingly, the rate of cAMP production in apical cardiomyocytes does not reach its maximum 
inside the interval where ISO is being applied. This is exaggerated in tests where rolipram is added 
during the washout phase. This may potentially mean that there is some aspect of the apical cells 
physiology or biochemistry which means that isoprenaline is not washed off effectively. Equally, the 
amplitude overall appears slightly lower in the apical cells where washouts are performed with 
rolipram. It might be possible that in both experimental set-ups, the β2AR stimulates a self-limiting 
cAMP toxicity.      
4.3.11 Β2AR-CAMP SIGNALS BECOME LESS LOCALIZED IN CARDIOMYOCYTES 
FOLLOWING DISPLACEMENT OF CAV3 FROM CAVEOLAE IN CARDIOMYOCYTES WITHOUT 
INTERFERING WITH T-TUBULAR LOCALIZATION OF THE RECEPTOR 
Caveolar stabilization by the peptide Cav3 is demonstrated to physically compartmentalize β2AR 
signalling in cardiomyocyte cell membranes. As Nikolaev et al (2010) demonstrated and the data in 
Chapter 3 show, β2AR-cAMP signals are somewhat physically localized within the cell, the FRET 
response is not as large in regions of the cell exterior to the application site. Equally, stimulation of 
the t-tubular regions of cardiomyocytes yields a β2AR response but stimulating the crest region does 
not. This seems to suggest that the receptors are restricted to specific regions and this is also the 
case for the resultant signalling. This spatial localization can be specifically disrupted by 
overexpressing the dominant negative version of Cav3 (Cav3DN) which cannot stabilize caveolae. 
This causes the β2AR-cAMP signals to become diffusible (see representative traces) but does not 
appear to cause a relocalization of β2AR from the t-tubules to the cellular crest see Figure 4.18. The 
caveolar localization of β2AR (with the caveolae scaffolded by Cav3) appears to control the 
diffusibility of β2AR-cAMP but not where β2AR-cAMP can be formed. This is a counterintuitive 
scenario as an appendix figure of Nikolaev et al. (2010) demonstrated that cyclodextrin treatment 
caused both a relocalization of the β2AR and the signals to become diffusible. One possible reason 
for this could be the relative strength of Cav3DN and cyclodextrin in removing cellular caveolae.   
158 
 
Tubule Crest
-1
0
1
2
3
4
n=8
p=5
n=5
p=5
**
a)
%
  
C
h
a
n
g
e
 i
n
F
R
E
T
 
0 30 60 90 120 150
0.93
0.94
0.95
0.96
0.97
0.98
0.99
1.00
Zone 1
Zone 2
Zone 3
Zone 4
Time (seconds)
R
at
io
 Y
F
P
/C
FP
(N
or
m
al
iz
ed
)
b)
 
Figure 4.18 a) Graph showing the localization of β2AR in rat cells overexpressing Cav3DN to disrupt 
caveolae. β2AR still  appears exclusively within the cellular t-tubules as opposed to on the cellular 
crest. b) Representative time course showing that the cAMP signals evoked by β2AR stimulation 
applied to t-tubules are apparent in regions external to that of application. 
 
 
 
 
 
 
159 
 
4.4 DISCUSSION 
The first two experiments described in this chapter demonstrate that the apical and basal 
differences in inotropic and lusitropic responsiveness to β2AR stimulation can be equalized. The 
suggestion is therefore that there are dynamic differences in the two cell type’s physiology which 
are not innate, controlling these differential reactions to stimulation. Experiments with cyclodextrin 
demonstrate that cholesterol plays an active role in preventing basal cells from increasing their 
contractility in response to β2AR stimulation. Treatment with cyclodextrin results in increased 
amounts of cAMP reaching the RII_Epac FRET sensor in basal cells equilibrating apical and basal FRET 
responses. Equally, amounts of cAMP measured by cytosolic cEpac2 appear increased in basal cells 
after cyclodextrin treatment, although a true increase is not observed due to the relative down-
shifting of the apical response. Increases in cardiomyocyte contractility following β2AR stimulation 
are dependent on PKA activity which in turn is dependent on cAMP levels.  
The phosphodiesterases are the primary agents within the cytosol responsible for the extinction of 
β2AR-cAMP signals. Pharmacological inhibition of the phosphodiesterase 4 sub-type using rolipram 
equilibrates apical and basal inotropic responsiveness in a similar way to cholesterol depletion, 
although the effect on lusitropy was not clear. The velocity of relaxation appeared to be maximal at 
baseline and consequently  no change in cellular lusitropy occured. The arrhythmic effect observed 
in many cells (not presented) was responsible for the low sample number and may have resulted in 
non-specific βAR mediated toxicity in some cases, making the data difficult to interpret. This effect 
of rolipram on isolated cardiomyocytes has been reported in the literature by another group 
(MacDougall et al., 2012). Rolipram also reveals more β2AR-cAMP responsiveness in both the 
cytosolic and RII-PKA compartments of basal cells in comparison to apical. This suggests that the 
PDE4 subtype tone is higher in the basal cardiomyocytes and that this may play a role in selectively 
restricting β2AR-cAMP from influencing the RII-PKA compartments.  The suggestion here is that in 
basal cells the relative restriction, of cAMP from β2AR, means that PKA may not have an effect on 
the phosphorylation state of down stream effectors such as phospholamban (this is inferred by 
observation of the effects of treatments on cellular lusitropy). In this respect phosphorylation of the 
contractile myofilaments, desensitizing them to calcium may also play a role. The control of the β2AR 
appears to be heavily dependent on cholesterol. In the basal cells cyclodextrin treatment has 
possibly caused the cAMP signalling to be less restricted causing the reduction of the change in R50 
observed in control cells. This implicates caveolae and cholesterol-dependent signalling micro-
domains in establishing the regional differences in the contractile responsiveness following β2AR 
stimulation. Basal cells were discovered to have a greater number of caveolae and to be under 
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increased tone of phosphodiesterase 4 (which was found to be the sole phosphodiesterase inhibiting 
β2AR-cAMP levels in the cell cytosol). β2AR stimulation of the basal cells appears not to affect the 
lusitropy of cardiomyocyte contraction (a factor which is usually attributed to the phosphorylation 
state of PLB and consequently is a marker of the diffusiveness of cAMP) (Calaghan et al, 2006; 
Calaghan, Kozera and White, 2008). Removal of cellular cholesterol (and caveolae) equalized the 
apical and basal contractile responses as did inhibition of PDE4. Live-cell measurements of cytosolic 
or PKA-RII domain levels of cAMP revealed that these treatments caused cAMP to become available 
to the RII domains in basal cells where it had once been restricted. This was demonstrated by the 
fact that the usually abbreviated basal cAMP response became persistent following treatment with 
the PDE4 inhibitor rolipram.  
Phosphodiesterases are demonstrated to be more effective at removing cAMP in basal cells in both 
cytosolic and RII-PKA compartments; this difference is demonstrated by inhibiting PDE4. Finally, the 
Cav3 peptide which scaffolds cellular caveolae is demonstrated to be essential for localizing β2AR-
cAMP responses, but not localizing the β2AR to t-tubules. On the basis of the data presented here 
the following hypothesis is given for the difference in contractility, following β2AR stimulation in 
apical and basal cardiomyocytes. Basal cells may dynamically build more caveolae than apical cells, 
resulting in an increased localization of β2AR meaning PDE4 can remove cAMP more rapidly; as a 
consequence the β2AR is prevented from influencing PKA and this reduces contractile 
responsiveness. The PDE4 subtype is responsible for restricting cAMP from the PKA compartments 
scaffolded by AKAP and β2AR upon activation in a signalsome. It seems that this sub-type is the main 
sub-type restricting β2AR-cAMP within the cytosol and rolipram treatment demonstrates that cAMP 
signalling is relatively unrestricted in the apex and that the basal cell’s activity can be equalized by 
removing PDE4’s effects. Restricting cAMP from the PKA-RII domains could theoretically play a major 
role in reducing the β2AR’s effects on cardiomyocyte contractility and lusitropy. It is not clear from 
these data whether the increased number of caveolae and thus the possibility of increased β2AR 
localization in basal cells are somehow linked to the increased tone of PDE4; or that these are two 
concomitant mechanisms which provide increased control of β2AR in the basal cell type. 
An initial set of FRET experiments used a protocol based upon the one utilized in the IonOptix 
studies, involving pre-stimulation of the apex/base cells with rolipram and subsequent β2AR 
stimulation. This is shown in the Appendices Figure 9.3. It was quickly established that this was an 
imperfect method to try to establish compartmentation differences between the cell types and the 
role of the phosphodiesterase sub-types. On this basis, it seemed that that the method of Nikolaev 
et al. (2006) would be more appropriate. This method reveals the extent to which a particular PDE 
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sub-type was restricting the cAMP production of the particular receptor i.e. its level of ‘tone’ upon 
the receptor system. In the case of FRET methods this has the advantage of being measured against 
a normal baseline level of cAMP within the cell. Using this method it is possible to see that of the 
particular phosphodiesterase sub-types PDE4 inhibition by rolipram reveals the greatest inhibitory 
effect on β2AR-cAMP. 
As previously suggested the use of IBMX to stimulate full cell cAMP responses is problematic and 
appears so from these data. There are nine phosphodiesterase subtypes PDE2, 3 and 4 are specific 
for cAMP and are reported as the principle elements of cAMP control in cardiomyocytes (Nikolaev et 
al., 2006). Even so, the IBMX response in apical cells is far in excess of that following PDE4 inhibition 
and all there subtype responses in total, although we cannot discount possible synergistic effects of 
inhibiting one or more PDE sub-types. This suggests that either sub-types other than 2, 3 or 4 control 
compartmentation of β2AR in apical cardiomyocytes or IBMX may be able to evoke a cAMP response 
without adrenergic stimulation. In the basal cells the response of PDE4 obviously accounts for a 
sizeable proportion of the IBMX response. This however points to fundamental differences in the 
control of β2AR-cAMP by cells in different regions of the myocardium. The cEpac2 sensor is possibly 
not specific enough to resolve the fine alterations in cAMP physiology which may have a 
disproportionate effect on contractile response. Indeed this sensor was not able to indicate the 
differences between the apical and basal cells which lead to the observed regional differences in 
shortening.  The PDE8 and PDE9 are both IBMX insensitive and are expressed in the heart (Francis, 
Blount and Corbin 2011). Neither of these subtypes were explored in the studies detailed above and 
may therefore also play a role in the apical and basal differences.  
The element or elements of the excitation-contraction coupling machinery that are affected by the 
de-restricted cAMP signalling of β2AR in the apical cells are as yet undetermined. The study of 
McDougall et al. (2012), shows that the ICa is largely unaffected by β2AR and that this is still the case 
after the removal of cellular cholesterol by cyclodextrin treatment. This suggests that the influence 
of β2AR on cardiomyocyte contractility is not via increasing LTCC activity through increased PKA 
phosphorylation. Intriguingly, the studies of Jacobo et al. (2009) and Balijepalli et al. (2006) 
demonstrate that caveolae are essential for β2AR to influence ICa, although as previously mentioned 
this study was performed with Gi inhbition. Electrophysiological studies of the influence of β2AR on 
apical and basal ICa were not undertaken in my work. The McDougall study may have assessed a 
population with an increased presence of basal cells (as this type may represent a larger proportion 
of the myocardium) where restricted β2AR-cAMP does not influence ICa and this scenario is not 
altered by cholesterol depletion. The other studies may have assessed an increased amount of apical 
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cells and where the unrestricted cAMP influences ICa, cholesterol depletion seemed to disrupt this as 
it caused non-specific disruption of the interaction of β2AR and LTCC. Equally, the studies utilized 
different methods of selectively stimulating β2AR. The earlier studies utilized a combination of 
salbutamol and atenolol (Calaghan and White, 2006; Calaghan, Kozera and White, 2008) whereas 
the study of McDougall utilized a combination of zinterol and CGP20712A. This may mean that the 
stimulation of β2AR was different in terms of agonist bias and potency, zinterol is a more selective 
β2AR agonist and CGP20712A is a more selective β1AR antagonist, for this reason the observed 
effects on ICa maybe due to off target β1AR stimulation (MacDougall et al., 2012). However, a study 
by Agarwal et al. (2012) demonstrates that at low levels of β1AR stimulation the influence on ICa is 
enhanced by cholesterol depletion. There is also a disconnect in that variously adult and neonatal 
cardiomyocytes are utilized in these studies and there is a suggestion that cAMP signalling is less 
restricted in neonatal cardiomyocytes due to their less complicated internal structure (Soto et al., 
2009). Therefore the results of these studies are concordant with beliefs about the restriction of 
cAMP upon maturation of myocytes.   
McDougall et al. (2012) suggest that the increased influence of β2AR on PKA after cholesterol 
depletion increases the phosphorylation of PLB which results in the increased uptake of Ca2+ 
following  influx due to reduced SERCA2A inhibition. This is equally plausible as a mechanism for the 
difference between apex and base with the β2AR in the caveolae deficient apex apparently able to 
cause increases in the lusitropy of the myocyte, whereas β2AR-stimulation partially decreases the 
lusitropy of basal cells. This finding is partially corroborated by the data presented in this chapter. 
The authors of that study utilized adult rat cardiomyocytes isolated as a single homogenate from the 
left ventricle. In this respect one might suggest that basal cells (the base being a thicker part of the 
myocardium), is more representative of the ventricle as a whole. In this respect the findings 
described are concordant with those of McDougall et al. It is not clear whether the increase in R50 
observed for the basal cardiomyocytes is a true increase due to the actions of β2AR or is just due to 
non-specific degradation of the cellular physiology. It is possible that in caveolae competent, basal 
cardiomyocytes the effect of stimulus trafficking of β2AR binding to Gi and subsequently reducing 
cellular cAMP levels could have this affect. In this respect it not possible to say whether the 
reduction in R50 induced by cholesterol depletion is due to an increased PLB phosphorylation or 
simply the removal of the ability of β2AR to traffic to Gi. It is difficult to infer where the increase in 
basal contractility originates from, as after cholesterol depletion R50 is not reduced below baseline.  
It is possible that the compartmentation and subsequently the influence of β2AR on downstream 
effectors varies very widely throughout the myocardium. As such the exact role of β2AR in the 
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excitation-contraction coupling pathway is heavily dependent on the provenance of the 
cardiomyocytes being studied. This suggestion is borne out by the observation that there is a wide 
variation in the baseline R50 values of both apical and basal cardiomyocytes. The variability of 
baseline R50s is equalized by the depletion of cholesterol and the inhibition of PDE4 by rolipram. 
This factor is most visible in experiments where the cells have been exposed to rolipram before the 
contractility experiments and suggests that the variability may in fact be introduced by the 
differential activity of PDE4 in the different cells. There may also be a variation in the amount of 
phosphorylation of PLB at baseline creating different sub-populations of cells with different levels of 
responsiveness to adrenergic stimuli within the myocardium. As suggested by the FRET studies, pre-
stimulation of the cells with Rolipram may not be an ideal method for removing the PDE4 tone on 
β2AR. This is because the baseline level of cAMP is raised and in the case of FRET it seems to obscure 
any modifications to β2AR activity made by removing the effects of PDE4. The alteration of baseline 
levels of PDE4 activity and cholesterol seem to be especially problematic for apical cells. As was also 
described in McDougall et al. (2012) cyclodextrin and rolipram seem to induce a rather large amount 
of arrhythmia and dysynchronous contractility. In the apical cells where the cAMP signalling is 
relatively de-restricted there could be toxic non-specific effects after these treatments. This may be 
the explanation for the apparent down shifting of the apical response after rolipram treatment. The 
decreased variability of cells after rolipram pre-stimulation may also be the explanation for the lack 
of a statistically significant difference between control and rolipram treated basal cells. The 
difference in apical and basal caveolae number does not appear to be influenced by expression of 
Cav3 or the localization of the molecule within the cell. There is therefore a possibility that the cells 
are equally able to produce caveolae but the caveolae are dynamically disrupted in the apical cells.   
In consequence this chapter suggests there is an increased β2AR responsiveness of the apical cells 
and consequently the myocardial apex, which is vulnerable to catecholamine mediated damage. This 
is due, in part, to the fact that the β2AR-cAMP responses are relatively unrestricted due to 
differences in the membrane morphology of these cells relative to the cardiomyocytes isolated from 
the basal myocardium. It is not clear whether increased caveolar localization of β2AR in the base and 
increased PDE4 tones are connected. However, these two mechanisms are demonstrated to be 
major players in supporting the regional dichotomy in β2AR response. These phenomena may result 
in the syndrome of Takotsubo as the stimulus trafficking of β2AR to bind Gi initially requires high PKA 
activity. The increased access of cAMP to PKA in the apical myocytes may be the reason for the 
apparent ‘apical stunning’ at high levels of catecholamine, in times of stress. 
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5. THE EFFECTS OF ACUTE CATECHOLAMINE STIMULATION ON THE CARDIOMYOCYTE 
Β2AR RESPONSE 
5.1 INTRODUCTION 
The syndrome of Takotsubo cardiomyopathy results from situations where levels of both adrenaline 
and noradrenaline are high (Lyon et al., 2008). In the previous chapters apical cardiomyocytes have 
been demonstrated to be sensitized to catecholamine stimulation relative to basal cardiomyocytes. 
This may be the basis of the vulnerability of the apical myocardium to acute and chronic 
catecholamine mediated damage (Nef et al., 2010; Rona et al., 1986). Increased vulnerability of the 
apex has been demonstrated in animal models acute and chronic models of catecholamine 
stimulation and is suggested to underlie the syndrome of Takotsubo cardiomyopathy (Paur et al., 
2012). Consequently, an investigation of the effects of pre-stimulating cardiomyocytes with 
catecholamines was made. Cells were prestimulated with concentrations of adrenaline or 
noradrenaline which are above those encountered in normal physiology, but lower than those 
encountered in the pathology of Takotsubo (Wittstein et al., 2005). In this way it would be likely that 
effects upon β2AR function evoked in vitro would be similar to those experienced in the course of 
Takotsubo. In particular it was questioned how pre-stimulation would alter β2AR’s effect on 
contractile function and whether this receptor could be rapidly switched to binding Gi and 
consequently cause negatively inotropic effects when stimulated with isoprenaline. This protocol 
simulates the phasic stimulation and re-stimulation of the β2AR which would occur in Takotsubo by 
high levels of catecholamines.  
The evaluation of apical and basal cells contractility separately should allow speculation as to the 
relative role of the differences in β2AR-cAMP control in underlying the regional differences observed 
in Takotsubo. Greater β2AR activation in the apex and a greater influence on PKA compartments may 
subsequently result in a greater stimulus trafficking in this myocardial region and therefore a greater 
negatively inotropic effect of β2AR stimulation in this cell population. As well as this the loss of a 
positive lusitropic effect of β2AR within the apical cardiomyocytes would result in the reduced 
contractility of this segment. Catecholamines were perfused onto cells from the apical or basal 
myocardium and the β2AR was subsequently re-stimulated.  
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5.2 METHODS 
5.2.1 SOLUTIONS 
Pertussis toxin was obtained from Sigma (Poole, UK). CGP20712A, ICI118, 551, isoprenaline and 
cyclodextrin were obtained from Sigma-Aldrich, as previous chapters.    
5.2.2 MEASURING THE EFFECT OF ADRENERGIC PRE-STIMULATION UPON Β2AR-
MEDIATED MODULATION OF CARDIOMYOCYTE CONTRACTILITY 
The Ion Optix video microscopy technique was employed to assess the shortening of single isolated 
cardiomyocytes as a surrogate measure of contractility, as in previous chapters. A number of 
protocols were employed in this work. The effect of both adrenaline and noradrenaline pre-
stimulation were investigated, as well as β2AR’s capacity to traffic to Gi. Cardiomyocytes must be 
kept in culture to enable transfection for FRET analysis; this possibly has an effect upon the β2AR and 
cellular physiology in general. Thus the shortening responses were tested in cardiomyocytes 
maintained in culture for 48 hours. A subset of cells was subjected to adrenaline pre-stimulation 
after depletion of cellular cholesterol to investigate the role of cholesterol dependent micro-
domains on the effects of adrenaline pre-stimulation. The protocols for these various treatments are 
detailed below. Experiments designed by Peter Wright with the contribution of some data by Laura 
Pannell. 
5.2.2.1 ADRENALINE/NORADRENALINE PRE-STIMULATION PROTOCOL 
Catecholamines are perfused onto the cells for 20 minutes and the 10 minute phase where 
CGP20712A is washed on serves to return cardiomyocyte contractility to a normal baseline level. 
Fresh cells were tested between 1-8hours following isolation, cultured cells were tested between 48-
56 hours post-isolation having been maintained in M199 culture as detailed in Chapter 2. 
Unfortunately a modification had to be made to the culturing process, as the cells could not be 
attached to laminin coated glass as IonOptix requires cardiomyocytes to be transferred from the 
culture dish to a tissue bath for imaging. Hence cells were cultured unattached. One limitation of this 
is that culturing on laminin coated coverslips allows the removal of damaged and dead cells; in this 
case this could not be performed. There is therefore a possibility that factors (such as necrosis 
factors or proteolytic enzymes) from the dead or collapsed cardiomyocytes may have some 
influence upon the health of the rod shaped ones.    
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The concentration of 100nM adrenaline was selected as it is one order of magnitude less than the 
initial plasma concentration of adrenaline in rats used in an in vivo model of Takotsubo 
cardiomyopathy (Paur et al, 2012). As the plasma half life of adrenaline is less than 3 minutes, this 
will provide a validation of whether dysfunction like that seen in the in vivo model can be induced in 
vitro.   
 
The concentration of noradrenaline was selected on the same basis as the adrenaline; however this 
concentration did not evoke Takotsubo like symptoms in a rat model of Takotsubo.  These 
experiments were controlled alongside cells which received no pre-stimulation which were simply 
maintained in the perfusate solution for 20 minutes. These are the cells referred to as controls in 
chapter 3 and 4.  
5.2.2.2 MOUSE CARDIOMYOCYTE ANALYSIS  
Cardiomyocytes isolated from mice were assessed on the day of isolation. They were subjected to 
the adrenaline pre-treatment protocol as detailed above. As detailed in Pavlovic et al. (2010) mouse 
cells are not stable in culture and as transgenic mice expressing FRET constructs are available the 
effect of culture did not need to be assessed.  As for the rat control cells, mouse controls were 
simply exposed to perfusion media and no pre-stimulation for 20 minutes, this data set appears in 
chapter 3 as control.    
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5.2.2.3 REMOVAL OF THE EFFECTS OF GI FROM ADULT RAT CARDIOMYOCYTES 
Cardiomyocytes were incubated in the presence of 1.5μg/ml pertussis toxin (PTX), for 3 hours at 
35oC, immediately after isolation or after 48 hours in culture. The concentration of PTX and 
treatment protocol has been the standard methodology in Professor Harding’s lab for many years 
and is demonstrated to remove the negatively inotropic effects of 5μM carbachol (a muscarinic 
acetylcholine receptor agonist (M2)), which stimulates the activation of Gi (Gong et al., 2002). The 
efficacy of this PTX treatment has been confirmed utilizing both contraction and FRET 
measurements. Demonstrating that following pertussis toxin treatment carbachol treatment cannot 
inhibit isoprenaline induced increases in contractility (measured by IonOptix) or cAMP (measured by 
FRET).  
 
These cells were controlled by cells subjected to the same treatment but without adrenaline added 
to the perfusate at the relevant step. Following treatment with pertussis toxin there were notable 
increases in arrhythmic activity and a reduced number of viable, rod-shaped cardiomyocytes. This 
required a more stringent selection of cardiomyocytes on the basis of the parameters defined in 
chapter two.   
5.2.2.4 CONFIRMATION OF THE EFFICACY OF PTX IN REMOVING EFFECTS OF G I UPON 
CARDIOMYOCYTE CONTRACTILITY 
Following stimulation of β2AR by CGP+ISO carbachol (CCH) is applied, without PTX pre-treatment this 
reduces contractility to baseline by stimulating M2 receptors evoking a Gi mediated inotropic 
response. In cells pre-treated with PTX this effect is ablated. 
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Figure 5.1 Diagramatic examples of the effects of PTX pre-treatment on the anti-adrenergic Gi 
activity induced by carbachol upon ISO stimulated shortening responses in cardiomyocytes. As can be 
observedpre-treament of cells with PTX ablates the Gi activity of the cell.  
5.2.2.5 GROSS EFFECTS OF CULTURE UPON CARDIOMYOCYTES 
After 48 hours of culture rat cardiomyocytes were still contractile, contracting stably in synchrony 
with field stimulation. Subjectively, these cells appeared more stable in contractility experiments 
than freshly isolated cells and interestingly, these cells appeared easier to track via the IonOptix 
method. This was because the ends of cardiomyocytes round and thicken as their cytoskeleton 
responds to unloading, meaning a greater amount of light is absorbed. As a result the peaks and 
troughs of absorption were enhanced and were easier for the software to track. It is known that 
cardiomyocytes internalize their connexins upon isolation and culture. This means that these 
cultured cardiomyocytes are no longer as permeable to the extracellular fluid. This possibly makes 
them less susceptible to modulation by very small fluxes of ions within the perfusion media. 
5.2.2.6 REMOVAL OF THE EFFECTS OF CHOLESTEROL-DEPENDANT MICRO-DOMAINS 
(CAVEOLAE)                
A subset of experiments was performed to assess the role of these micro-domains in the 
phenomena observed following pre-stimulation with adrenaline.   
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These cells were controlled by cells subjected to the same treatment but without adrenaline added 
to the perfusate in the relevant step.  As described in chapter 4 cyclodextrin treatments resulted in 
an increased prevalence of arrhythmias following isoprenaline treatment.  
5.2.3 MEASUREMENT OF THE EFFECTS OF ADRENALINE OR NORADRENALINE PRE-
STIMULATION UPON THE Β2AR MEDIATED CAMP RESPONSE 
FRET microscopy was conducted as described in chapter 2. These experiments were carried out on 
cells transfected with either the cEPAC2 (in rat) or the transgenically expressed Epac1 (in mouse). 
This means that all levels of cAMP relate to cytosolic responses induced by either β2AR or Adenylate 
cyclase. Cells were pre-stimulated with adrenaline (100nM) or noradrenaline (100nM/1μM) in 
culture media, without inhibitors at 37oC, inducing both β1AR/β2AR effects before undergoing 
measurement of their β2AR and AC-cAMP responses. Alongside the same experiments were 
repeated but with a 20 minute wash off period, including complete removal of the adrenergic pre-
stimulation period before FRET analysis. In a further subset of cells the effects of Gi were removed 
by treating the cells with 1.5μg/ml of PTX for 3 hours at 37oC, before pre-stimulations and 
subsequent FRET responses. The protocols for these experiments are outlined immediately below.  
5.2.3.1 INVESTIGATING THE EFFECTS OF ADRENERGIC PRE-STIMULATION UPON Β2AR-CAMP 
AND ADENYLATE CYCLASE RESPONSES 
Cells were exposed to media (control) or exposed to adrenaline (100nM) or noradrenaline (100nM 
or 1μM) for 20 minutes they were then rapidly moved to the FRET microscope and exposed to CGP 
to block β1AR. The cells were then imaged and exposed to isoprenaline to stimulate β2AR activity; 
following this treatment the cells were treated with NKH477 to stimulate adenylate cyclase activity.      
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5.2.3.2 INVESTIGATING THE RELATIVE PERSISTENCE OF THE EFFECTS OF ADRENALINE OR 
NORADRENALINE PRE-STIMULATION ON Β2AR-CAMP AND ADENYLATE CYCLASE RESPONSES 
The stimulus trafficking of the β2AR is demonstrated to be a time-dependent effect requiring 
internalization in experiments utilizing HEK293 cells. To investigate the time dependence and 
persistence of any desensitizing effects the catecholamine pre-stimulations were applied and then 
washed off after twenty minutes. The cells were then cultured in catecholamine free solution for 
twenty minutes and assayed by blocking β1AR and stimulating β2AR followed by AC as described in 
the section above.    
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5.2.4 INVESTIGATING THE ROLE OF G I  IN THE EFFECTS OF ADRENALINE OR 
NORADRENALINE PRE-STIMULATION ON Β 2AR-CAMP AND ADENYLATE CYCLASE 
RESPONSES 
To investigate whether desensitizing effects of catecholamine pre-stimulation are Gi sensitive, cells 
were treated with pertussis toxin for three hours and were then assayed as above. The time-
dependence of these effects was also assessed in a subset of cells where catecholamine pre-
stimulation was applied and then washed out for 20 minutes before assessment of β2AR and AC 
function.     
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5.2.4.1ENSURING THE REMOVAL OF GI ACTIVITY IN FRET EXPERIMENTS 
As in contractility experiments the efficacy of PTX pre-treatment is confirmed by the following 
protocol. Both βAR are stimulated with isoprenaline and a profound cAMP response is elicited, this 
can subsequently be inhibited by CCH. After PTX pre-treatment this capacity of CCH is removed.  
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Figure 5.2 Graphs displaying FRET data which demonstrate the efficacy of PTX pre-treatment in 
removing the inhibitory effects of Gi signalling from cardiomyocytes in rat cardiomyocytes. 
5.2.4.2 MEASURING THE EFFECT OF ADRENERGIC PRE-STIMULATION UPON Β1AR-CAMP 
AND ADENYLATE CYCLASE RESPONSES 
Utilizing a further set of cells the protocols above were modified to explore whether the effects of 
pre-stimulation were specific to the β2AR-cAMP response or if they affected the β1AR-cAMP 
responses equally. The essential modification here was that the specific inhibitor of β1AR 
CGP20712A was replaced with a specific inhibitor of β2AR, namely 50nM ICI 118,551. Experiments 
assessing the effect of Gi blockade on β1AR were not performed. 
5.2.5 STATISTICAL ANALYSIS 
Cell contractility was analyzed by initially testing pre-treatment, treatment and removal of treatment 
groups for each cell type with a Repeated Measures ANOVA. Subsequently, fold increases between 
cell types were analyzed with an unpaired Mann-Whitney test (Non-Gaussian data). Concentration-
response experiments were analyzed by non-linear regression and fitting to a sigmoidal curve. Single 
dose tests to measure cAMP-mediated FRET shifts between cell types were analyzed using a Mann 
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Whitney test (Non-Gaussian Data). A Kruskal-Wallis test with Dunn’s post-test was employed in 
analysis of the effects of adrenaline and noradrenaline on fold-change in shortening (Non-Gaussian) 
(assessment of more than one group including control).   
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5.3 RESULTS 
5.3.1 ASSESSING THE EFFECT OF ADRENALINE PRE-STIMULATION UPON THE Β2AR 
MEDIATED CONTRACTILE RESPONSE UTILIZING RAT CARDIOMYOCYTES WHICH WERE 
EITHER FRESHLY ISOLATED OR HAD BEEN MANTAINED FOR 48 HOURS IN CULTURE 
The effects of a 20 minute pre-stimulation of adrenaline were assessed for both apical and basal 
cardiomyocytes. Equally, data are shown for cardiomyocytes which had been maintained for 48 
hours in culture, so as to be comparable to those utilized for FRET experiments. As demonstrated in 
Figure 5.3 a) cardiomyocytes isolated from the apical myocardium increase their contractility upon 
β2AR-stimulation, this stimulation can be confirmed as being β2AR dependent by the removal of 
effects following ICI 118,551 treatment. Following pre-treatment of apical cardiomyocytes with 
adrenaline there is not a significant increase in contractility mediated by β2AR and equally ICI 118, 
551 has no effect.  The baseline level of contractility appears elevated in cells pre-treated with 
adrenaline although this does not reach statistical significance, most likely due to intrinsic variability 
induced by adrenaline pre-stimulation. There appears to be a greater degree of variability in the 
cellular population with respect to contractile baseline. This may be due to the relative differences 
between intrinsic cAMP compartmentation between β1AR and β2AR, suggested by the literature and 
demonstrated by the different responsiveness of Epac2 and RII_Epac FRET sensors (Nikolaev et al., 
2006; MacDougall et al., 2012). These issues suggest that this method may need to be somewhat 
reassessed if used to investigate β2AR after pre-stimulation in future. Figure 5.3 b) shows that when 
the stimulated contractile increases are corrected to baseline the adrenaline pre-stimulation 
appears to have blunted the apical cells response to β2AR-stimulation. In cells which have been 
cultured for 48 hours Figure 5.3c, d) similar phenomena are present, suggesting that FRET responses 
within apical cells will be predictive of those for a theoretical rat cell which is analyzed by FRET on 
the day of isolation. β2AR stimulation still increases contractile response significantly. However, ICI 
118, 551 does not seem to have the same level of effect it remains significantly elevated compared 
to the CGP stage. It significantly reduces the ISO stimulated increase but not to baseline. As 
previously suggested, ICI 118, 551 has been shown in some cases to require the effects of Gi to take 
effect (although this is in the case of cells following myocardial infarction (Gong et al., 2004).  
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Figure 5.3 a) Graphs displaying values for %shortening of apical rat cardiomyocytes following β2AR 
stimulation (CGP 300nM and ISO 1µM) with or without adrenaline pre-stimulation on the day of 
isolation, b) values corrected to baseline from freshly isolated cells. c)  Graphs displaying values for 
%shortening of apical cardiomyocytes after culture for 48 hours, d) Increases in contractility 
corrected to baseline from cultured cells.Raw shortening data analysed by One-way repeated 
measures ANOVA and corrected data analysed using Mann-Whitney test. 
Potentially, the culture of the cells may be interfering with the compartmentation of β2AR by Gi. The 
baseline of the adrenaline treated cells is apparently elevated in the same way as in the freshly 
isolated cells, following adrenaline pre-stimulation. Although this does not reach statistical 
significance and the contraction level of the adrenaline pre-stimulated cells would not prevent them 
from inclusion based on our criteria, adrenaline pre-stimulation appears to prevent an increase in 
contractility following β2AR-stimulation which is similar to the situation in freshly isolated cells. In 
this case cultured cells following adrenaline, ICI 118,551 appears to reduce the contractility back 
toward baseline but as the contractile increase stimulated by β2AR is not-significant, ICI 118, 551 
does not truly affect the cells activity. When corrected to baseline the effect of adrenaline pre-
stimulation appears once again to be a blunting of the β2AR mediated increase in the contractility of 
apical cardiomyocytes. It appears that that adrenaline pre-stimulation blunts the relative increases 
in contractility mediated by β2AR, although this cannot be completely separated from the apparent 
increase in baseline contractility observed in adrenaline treated cells. This raises possibility that the 
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amount of shortening inducible by β2AR in apical cells where this receptors signalling is apparently 
high, is limited to around 6%. Although ICI 118, 551 does not reduce cell shortening beyond intial 
baseline contractility, suggesting adrenaline pre-stimulation is causing a persistent increase in 
shortening which would render isoprenaline stimulation ineffective.   
Figure 5.4a shows the % shortening of freshly isolated basal cardiomyocytes, the stimulation of β2AR 
responses by isoprenaline and its reversal by ICI 118,511. Basal cardiomyocytes show a small but 
significant increase in contractility, mediated by β2AR stimulation. This is confirmed by the effects of 
ICI 118,551 which reduces %shortening back to near baseline levels. This was not the case for cells 
after adrenaline pre-stimulation. β2AR stimulation did not significantly raise %shortening above 
baseline, ICI 118,551 had no effect. However, if increases in shortening are corrected to the baseline 
contraction 5.4 b) it is clear to see that there is a negligible effect of β2AR stimulation upon basal 
cardiomyocytes both with and without adrenaline pre-stimulation, and that the effect of adrenaline 
pre-stimulation is not significant upon basal cardiomyocytes. This means that a negatively inotropic 
effect of adrenergic pre-stimulation would not be found for basal cardiomyocytes. This situation 
alters slightly for basal cardiomyocytes after 48 hours in culture 5.4 c) as cells without adrenaline 
pre-treatment begin to show a more distinct increase in shortening after β2AR stimulation. This 
increase is selectively reduced by the effect of ICI 118, 551 meaning it is attributable to the direct 
effects of β2AR.  The effects of β2AR stimulation are blunted by adrenaline pre-stimulation. 
Interestingly, even though there is not a significant increase in shortening and a negligible effect of 
β2AR it appears that ICI 118,551 is still able to reduce %shortening. This could be attributed to the 
inverse agonist effects of ICI 118,551 or its ability to cause stimulus trafficking of β2AR to Gi by direct 
biased agonism. Adrenaline pre-stimulation may have initiated this as more β2AR had trafficked to 
Gi.  The same effect of adrenaline is observed in cultured cells as compared to control, and apex 
control/cultured cells, in that adrenaline pre-stimulation blunts the effects of β2AR stimulation 
Figure 5.4 d). Unlike apical cells the baseline contractility of cells does not appear to be affected by 
adrenaline pre-stimulation, however this apparent difference was not statistically significant.This is 
in line with the data showing an increased responsiveness of the apical myocardium to adrenergic 
stimuli. It could also be the case that increases in contractility do not persist as a result of the 
increased cAMP hydrolysis activity observed in basal cardiomyocytes in both cytosolic and PKA-RII 
domains. 
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Figure 5.4 a) Graph displaying values for %shortening for basal rat cardiomyocytes following β2AR 
stimulation (CGP 300nM and ISO 1µM) with or without adrenaline pre-stimulation on the day of 
isolation, b) increases in contractility corrected to baseline from freshly isolated cells. c)  Graph 
displaying the values for %shortening for basal cardiomyocytes after culture for 48 hours. d) Graph 
showing increases corrected to baseline from cultured cells. Raw shortening data analysed by One-
way repeated measures ANOVA and corrected data analysed using Mann-Whitney test. 
It appears that the apico-basal gradient in β2AR responsiveness is partially lost as a result of culturing 
cardiomyocytes. It is likely that the lack of statistical significance is due to variability within each 
population, caused by the culturing process. Figure 5.5 shows that apical β2AR responses are still on 
average roughly twice as high as basal but much variability is present in both cell populations. 
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Figure 5.5 Graph showing a comparison of apical and basal rat cells corrected increases in shortening 
induced by β2AR (CGP 300nM+ ISO 1µM), after 48 hours in culture. Data analysed using Mann-
Whitney test. 
5.3.1.1THE EFFECT OF ADRENALINE PRE-STIMULATION APICAL AND BASAL LUSITROPIC 
RESPONSES TO Β2AR STIMULATION   
The effect of adrenaline and noradrenaline on apical and basal lusitropic responses is quite distinct, 
Figure 5.6. Adrenaline pre-stimulation causes a reduction in lusitropy as the relaxation time is 
increased 44% by β2AR stimulation in comparison to the positive lusitropic effect induced in control. 
The basal cells by comparison are unaffected. The noradrenaline pre-stimulation has no effect on 
the lusitropic effect of β2AR in apical cells.   
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Figure 5.6 a) Graph showing the lusitropic response of freshly isolated rat apical and basal 
cardiomyocytes induced by β2AR stimulation (CGP 300nM+ ISO 1µM) either with or without 
adrenaline pre-stimulation. b) Graph showing the effect of noradrenaline pre-stimulation on apical 
cardiomyocytes lusitropy. Data were analysed with a Mann-Whitney test. 
This may possibly be a pathological process in TTC as the slowed relaxation in the apical segment 
following hyper-adrenergic states may be involved in the reduced contracture. The lack of effect 
caused by noradrenaline suggests that this may be due to the ability of adrenaline to induce 
trafficking of the β2AR to produce binding to Gi. Interestingly, as discussed before, there is a great 
deal of variability within these data sets, possibly indicative of a wide variation in the 
compartmentation of β2AR within different cells, possibly as a result of them initially being present 
in different parts of the myocardium.      
5.3.2 ASSESSING THE EFFECT OF ADRENALINE PRE-STIMULATION UPON THE Β2AR 
MEDIATED CONTRACTILE RESPONSE UTILIZING MOUSE CARDIOMYOCYTES 
Utilizing mouse cardiomyocytes has the potential to circumvent some of the issues raised by the 
culturing of the rat cardiomyocytes for the purpose of FRET studies, as mouse cells transgenically 
expressing a FRET sensor are available. This means FRET studies can be performed on the day of cell 
isolation removing any effects caused by culture. For this reason apical and basal cells isolated from 
the left ventricle of adult mice underwent β2AR stimulation with or without adrenaline pre-
stimulation. Apical cells respond similarly to their freshly isolated and cultured rat counterparts. 
Without adrenaline pre-stimulation they significantly increase their contractility, which is confirmed 
to be dependent on selective β2AR stimulation. As for rat cells, adrenaline pre-stimulation resulted in 
a slightly (although not statistically significant) increase in baseline contractility, Figure 5.7. There 
was not a significant increase in contractility following β2AR stimulation. When corrected to baseline 
it is apparent that adrenaline caused a relative blunting of the positively inotropic effects of β2AR 
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stimulation. This is in agreement with data from freshly isolated and cultured rat cardiomyocytes. In 
basal cells not-treated with adrenaline, as detailed in chapter 3, there was a small but significant 
increase in cellular contractility following β2AR stimulation. However, this increase in shortening 
cannot be completely attributed to the effects of β2AR stimulation as ICI 118,551 treatment does not 
return shortening to baseline. Adrenaline treatment apparently made these cells more responsive to 
β2AR stimulation than control; this is reversed by treatment with ICI118, 551. Adrenaline appears to 
reduce the basal contractility level to around 1.03%. If this were not a treated group one might have 
excluded these cells from analysis due to the low level of contraction. Consequently, the increase in 
shortening post CGP+ISO when corrected to baseline appears very significant although the maximal 
shortening is not higher than the mean shortening of basal myocytes not pre-treated with 
adrenaline. Overall it appears that adrenaline induces a hypercontractile set of cells in the apex and 
a hypocontractile population in the base, the apical cells become unresponsive to repeat β2AR 
stimulation whereas the basal cells are sensitized. Apical cells but not basal cells bear a distinct 
resemblance to the rat fresh and cultured myocytes. Like rat cells adrenaline pre-stimulation 
apparently raises the baseline level of shortening in apical but not basal cells isolated from mouse.       
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Figure 5.7 a) Graphs showing the effect of adrenaline pre- stimulation on the shortening induced by  
β2AR (CGP 300nM+ ISO 1µM) stimulation of mouse cardiomyocytes isolated from the apical 
myocardium presented as %shortening b) data presented as Fold increase in shortening. c) The effect 
of adrenaline pre-stimulation on the shortening induced by β2AR mouse cardiomyocytes isolated 
from the basal myocardium presented as % shortening, d) data presented as Fold increase in 
contractility. Raw shortening data analysed by One-way repeated measures ANOVA and corrected 
data analysed using Mann-Whitney test 
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5.3.2.1 ASSESSING THE EFFECT OF THE REMOVAL OF G I ON THE EFFECTS OF ADRENALINE 
PRE-STIMULATION  
Apical and basal rat cardiomyocytes, freshly isolated or maintained in culture were treated with 
pertussis toxin to remove the activity of Gi; enabling investigation of its role in the effects of 
adrenaline pre-stimulation Figure 5.8. It was hypothesized that it would remove the relative blunting 
of the β2AR response following adrenaline pre-treatment. In freshly isolated and cultured apical 
cardiomyocytes treated with PTX, β2AR stimulation increases cell shortening to a greater degree 
than in untreated cells, demonstrating that tonic β2AR-Gi restricts β2AR signalling at baseline. There 
does not appear to be an elevation of the baseline shortening in comparison to control and β2AR 
stimulation increased cell shortening to the same degree. 
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Figure 5.8 a, b) Graphs showing the effect of adrenaline on the increase in shortening induced by 
β2AR stimulation (CGP 300nM and ISO 1µM) apical rat cardiomyocytes in freshly isolated and c, d) 
cultured cells pre-treated with PTX. Data presented as %shortening. Statistical testing was performed 
by One way repeated measures ANOVA. 
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When these increases in shortening are corrected to baseline, Figure 5.9, it is apparent that PTX 
treatment results in adrenaline pre-treatment having no dampening effect on subsequent cell 
contractility, suggesting that adrenaline-mediated desensitization is a Gi-dependent process. In the 
case of the freshly isolated cells it seems that adrenaline pre-treatment may even potentiate the 
stimulating effects of β2AR stimulation. 
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Figure 5.9 Graphs showing the effect of adrenaline pre-stimulation on the β2AR activity of pre-
stimulated rat apical cardiomyocytes after pre-treatment with PTX in a) freshly isolated and b) 
cultured cells. Data presented as Fold change in contractility. Statistical testing was performed by 
Mann-Whitney test. 
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Basal Cardiomyocytes post-PTX treatment with or without adrenaline pre-treatment 
Control freshly isolated basal cells treated with PTX do not increase their contractility significantly 
upon β2AR stimulation Figure 5.10. Equally, the small decrease in β2AR–stimulated contractility 
observed in these cells following adrenaline pre-treatment is abolished by PTX pre-treatment. 
Cultured cardiomyocytes presented a slightly larger β2AR mediated increase in contractility which 
was reduced by adrenaline pre-treatment. Treatment with PTX appears to prevent the adrenaline 
mediated decrease in β2AR induced inotropy with little effect on the basal response to β2AR 
stimulation in this cell type. It is important to note that it does not appear that increased tone of Gi 
itself is responsible for the apico-basal difference in contractility as even after PTX treatment basal 
cells still do not increase their shortening significantly relative to apical cells. After correction to 
baseline, it is apparent that following PTX treatment of basal cells adrenaline pre-stimulation 
potentiates β2AR mediated increases in contractility in freshly isolated cells and has no effect on 
β2AR in cultured cells. These findings suggest that although the increases in contractility caused by 
β2AR in basal cells are small relative to apical cells, the blunting of these effects caused by adrenaline 
involves the actions of Gi.       
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Figure 5.10 a) Graphs showing the effect of adrenaline pretreatment on the β2AR activity (CGP 
300nM and 1µM) of basal rat cardiomyocytes , after pre-treatment with PTX a, b) freshly isolated 
and c, d) cultured cells. Data presented as %shortening. Statistical testing was performed by one way 
repeated measures ANOVA. 
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Figure 5.11 Graphs showing the effect of adrenaline pre-stimulation on rat basal cardiomyocytes 
β2AR activity (CGP 300nM and 1µM) after pre-treatment with PTX data presented for a) freshly 
isolated and b) cultured cells. Data presented as Fold change in contractility. Statistical testing was 
performed by Mann-Whitney test. 
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The effect of PTX upon lusitropy is shown in Figure 5.12; PTX removes the lusitropic effect of β2AR 
from apical cardiomyocytes. The effect of adrenaline then seems to be a return of the positively 
lusitropic effect of β2AR. PTX has removed the apical dysfunction induced by adrenaline pre-
stimulation confirming a Gi-dependent process. The PTX may be increasing the lusitropy at baseline 
and subsequently no more can be induced by β2AR, the effect of adrenaline pre-stimulation is then a 
further de-compartmentation and increased functionality of the type observed in the experiments 
measuring contractility.    
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Figure 5.12 a) Graph showing the effect of adrenaline prestimulation on β2AR (CGP 300nM and 1µM) 
induced lusitropy following PTX treatment of apical rat cardiomyocytes, b) PTX adrenaline in 
comparison to adrenaline control. Statistical testing was performed by Mann-Whitney test. 
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5.3.3. THE EFFECT OF CHOLESTEROL DEPLETION ON THE BLUNTING OF Β2AR  INDUCED 
CONTRACTILITY CAUSED BY ADRENALINE PRE-TREATMENT 
In chapter 4 the presence of cholesterol-dependent micro-domains was demonstrated to be 
essential in maintaining the apico-basal difference in β2AR-mediated contractility. Thus it was 
questioned whether these domains have a role in the adrenaline-mediated reduction in the induced 
contractility of apical and basal cells. Figure 5.13 shows that following cyclodextrin treatment the 
effect of β2AR stimulation is enhanced. In apical cells the difference between baseline and CGP+ISO 
is marked in cyclodextrin treated cells. Somewhat counter-intuitively it appears that cyclodextrin and 
adrenaline pre-treatment slightly reduces the baseline contractility of apical cells in comparison to 
adrenaline stimulation alone. This is in fact comparable to apical cells following PTX pre-treatment 
where adrenaline pre-stimulation does not result in a relative elevation of the baseline contractility, 
potentially some shared mechanism may be present. The cholesterol reserves present in apical cells 
may have a role in mediating the persistence of β2AR signalling in this cell type. Also similar to results 
in PTX treated cells, apical cells treated with cyclodextrin do not decrease their contraction to 
baseline after ICI treatment. As previously mentioned some of the effects of ICI are not completely 
attributable to pure antagonist processes. The effect of cyclodextrin may therefore be taken as 
further evidence of role for caveolae in controlling β2AR-Gi signalling.  In basal cells the ability of 
cyclodextrin to reveal otherwise silent β2AR capacity is observed and the blunting effects of 
adrenaline pre-treatment are removed.  However, after ICI treatment cells contractility returns to 
baseline. There is no clear reason why this should be the case as both the effects of Gi and caveolae 
compartmentation are suggested to be removed by cholesterol depletion. It is possible therefore 
that the increased speed of cAMP hydrolysis is not reliant upon caveolar localization of β2AR and 
that cholesterol dependent micro-domains and increased PDE activity are separate mechanisms 
contributing to the increased control of β2AR-cAMP and β2AR function  within basal cardiomyocytes. 
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Figure 5.13 a) Graph showing the effect of adrenaline on β2AR (CGP 300nM and 1µM) induced 
shortening in freshly isolated rat a) apical and b) basal cardiomyocytes pre-treated with cyclodextrin. 
Data presented as %shortening. Statistical testing was performed by one way repeated measures 
ANOVA. 
After correcting increases in shortening to baseline, the effect of cyclodextrin in removing the 
adrenaline mediated blunting is even clearer, Figure 5.14. This is equally true for both apical and 
basal cells. 
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Figure 5.14 Graphs showing the effect of adrenaline pre-stimulation on β2AR (CGP 300nM and 1µM) 
induced shortening in a) apical and b) basal rat cardiomyocytes after pre-treatment with 
cyclodextrin. Data presented as Fold change in shortening. Statistical testing was performed by 
Mann-Whitney test. 
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5.3.4 THE EFFECT OF NORADRENALINE PRE-TREATMENT UPON THE INCREASES IN 
CARDIOMYOCYTE CONTRACTILITY FOLLOWING Β2AR STIMULATION  
5.3.4.1 APICAL CARDIOMYOCYTES 
The effect of noradrenaline, on cardiomyocytes isolated from the apical myocardium and tested 
fresh or after 48 hours culture, is similar to that of adrenaline. It appears to slightly elevate the 
average baseline shortening of the cardiomyocytes and then seems to blunt further increases in 
contractility mediated by β2AR stimulation. This is shown in figure 5.15a or b. 
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Figure 5.15 a) Graphs showing the effect of noradrenaline on β2AR (CGP 300nM and 1µM) induced 
shortening in freshly isolated and b) cultured rat apical cardiomyocytes. Data presented as 
%shortening. Statistical testing was performed by one way repeated measures ANOVA. 
The effect of noradrenaline becomes more apparent upon correcting, the shortening stimulated by 
β2AR, to baseline. In this respect it is possible to see that noradrenaline removes the contractility 
induced by β2AR stimulation in both freshly isolated and cultured cells. This is identical to the effect 
of adrenaline. It is notable that an effect of noradrenaline pre-stimulation is, like adrenaline, to 
elevate the contractile baseline of the apical cardiomyocytes. The effects of β1AR stimulation can be 
removed effectively within 10 minutes of washout and noradrenaline would predominantly have 
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stimulated this subtype, equally our washout method included CGP20712A a potent β1AR 
antagonist. The low potency of noradrenaline at the β2AR would suggest that effects on positive 
inotropic activity via β2AR should not be persistent. Once again the fact that ICI 118,551 treatment 
does not return the cells to a lower level than the baseline measured prior to β2AR stimulation. In 
this respect more weight is given to the argument that catecholamine pre-stimulation may be 
changing the test population. Noradrenaline seems to have a similar effect to adrenaline upon fresh 
and cultured apical cells, Figure 5.16.  
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Figure 5.16 Graphs showing the effect of noradrenaline pre-stimulation on β2AR (CGP 300nM and 
1µM) induced shortening in a) freshly isolated and b) cultured apical cardiomyocytes. Data presented 
at Fold change in shortening.c) Graph showing the comparison of adrenaline and noradrenaline 
effects on freshly isolated and cultured apical cells. Statistical testing was performed by Mann-
Whitney Test. 
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Basal Cardiomyocytes  
The same experiment was attempted for basal cardiomyocytes. Noradrenaline pre-stimulation 
seemed to abolish the modest increases in contractility caused by β2AR stimulation. This reduction 
did not reach significance when the relative increases in shortening following β2AR stimulation were 
corrected to baseline, most likely due to the small size of the basal response in control. The lack of 
effect of ICI 118,551, i.e. it not returning noradrenaline pre-stimulated basal cells to a lower 
baseline, presents once again the suggestion that pre-stimulation changes the test population. 
Adrenaline does this to apical but not basal cells, whereas noradrenaline can do this to both. The 
reason that adrenaline spares the base could be as a result of the protective effects of very 
compartmentalized β2AR. Adrenaline appears to cause specific effects at the apex whilst sparing the 
base as in animal models of TTC (Paur et al., 2012; Izumi et al., 2009). It is noted that delivery of 
noradrenaline by perfusion is a less physiological method of delivery in comparison to adrenaline as 
in vivo it is delivered via neural release alongside other co-factors, as such it may be more toxic than 
adrenaline delivered this way, providing a more a global activation of β1AR, than would be found in 
vivo.   
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Figure 5.17 Graphs showing the effect of noradrenaline pre-stimulation on β2AR (CGP 300nM and 
1µM) induced shortening on freshly isolated basal cardiomyocytes. Data presented as %shortening. 
Statistical testing was performed by one way repeated measures ANOVA. 
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Figure 5.18 a) Graphs showing the effect of noradrenaline pre-stimulation on β2AR (CGP 300nM and 
1µM) induced shortening in freshly isolated basal cardiomyocytes. Data presented as Fold change in 
shortening b) Graph showing the comparison of adrenaline and noradrenaline effects on freshly 
isolated and cultured basal cells. Statistical testing by Mann-Whitney test. 
5.3.5 THE ROLE OF G I  IN THE NORADRENALINE-INDUCED REDUCTIONS IN Β2AR 
MEDIATED CONTRACTILITY, AS ASSESSED IN CELLS WITH G I  EFFECTS ABLATED VIA 
TREATMENT WITH PERTUSSIS TOXIN.   
Noradrenaline is reported to be ineffective at inducing β2AR to stimulus traffick to Gi, due to this it 
was hypothesized that although reductions in β2AR activity were induced in apical and basal cells 
these would not be sensitive to pertussis toxin. Noradrenaline can mediate significant internalization 
of β2AR and the observed effects were attributed to this and phosphorylation of the receptor by a 
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PKA-mediated intra-system feedback loop (Liu et al., 2009). Apical (freshly isolated and cultured) and 
basal (fresh) cardiomyocytes were treated with PTX and subjected to noradrenaline pre-stimulation. 
The controls are cells treated with PTX but not noradrenaline (these were the same controls utilized 
in section 5.3.1). PTX pre-treatment appears to partially restore the β2AR activity in freshly isolated 
cardiomyocytes, although this does not reach control levels and displays the same degree of 
potentiation that combined PTX and Adrenaline pre-treatment has on apical cells. So it would seem 
that this effect is sensitive to PTX treatment but not in the same way as the adrenaline mediated 
effect.  
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Figure 5.19 a,b) Graphs showing the effect of noradrenaline pre-stimulation on β2AR (CGP 300nM 
and 1µM) induced shortening in apical rat cardiomyocytes after pre-treatment with PTX,  freshly 
isolated or c,d) cultured cells. Data presented as %shortening. Statistical testing was performed by 
one way repeated measures ANOVA. 
This is especially true if one looks at Figure 5.20A displaying responses as a function of baseline 
contractility; the noradrenaline+PTX response is around 1fold as compared to 4 for adrenaline+PTX. 
In the case of cultured cardiomyocytes PTX pre-treatment has no effect on the reduction of β2AR 
response caused by noradrenaline pre-stimulation. Unlike in fresh cells PTX treated cultured cells 
pre-stimulated with noradrenaline also display increased shortening at baseline. Figure 5.20B 
demonstrates the complete lack of a β2AR response after PTX and noradrenaline pre-treatment. 
Correcting contractile responses to baseline shows that the reduction of the β2AR response in fresh 
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cells by pre-stimulation with noradrenaline is returned to control level by ablation of Gi activity. 
However it is noted, as above, that this return to baseline does not present the apparent 
potentiation of the β2AR response that pre-treatment of PTX treated cells with adrenaline shows. 
Cultured cells show that the noradrenaline induced reductions in β2AR are not mediated by Gi.    
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Figure 5.20 A) Graphs showing the effect of noradrenaline on apical cardiomyocytes in freshly 
isolated and B) cultured cells after PTX pre-treatment. Data presented as fold change in contractility, 
after pre-treatment with PTX. C) Comparison of the effects of adrenaline and noradrenaline pre-
stimulation following the removal of the effects of Gi. Statistical testing was performed by Mann-
Whitney test. 
 
It is possible to speculate that these potentiating effects have the hallmarks of a de-
compartmentalizing treatment and thus Gi’s real role in these phenomena is being masked. 
Subsequently, it seems that Gi is involved but it is not clear to what extent as noradrenaline’s specific 
effects should not be sensitive to pertussis toxin treatment. The toxic effects of catecholamine 
stimulation after the loss of Gi activity may be enough that structural disruptions occur in the cells 
due to the effect catechomine toxicity by factors such as reactive oxygen species. This may have the 
de-compartmentalizing effect on β2AR suggested above. 
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5.3.6 THE EFFECTS OF ADRENERGIC PRE-STIMULATION ON Β 2AR-CAMP RESPONSES IN 
ADULT RAT AND MOUSE CARDIOMYOCYTES 
5.3.6.1 THE EFFECT OF ADRENALINE PRE-STIMULATION ON APICAL AND BASAL RAT 
CARDIOMYOCYTES 
Adrenaline pre-stimulation does not affect the raw FRET responses measured by the cytosolic 
cEPAC2-cAMP probe, Figure 5.21, upon stimulating β2AR (CGP+ISO) or maximal cellular cAMP 
responses following NKH477 application, in either apical or basal cardiomyocytes. Given the 
elevated basal contractility of apical cardiomyocytes following adrenaline pre-stimulation it was 
questioned whether cAMP levels remained high, resulting in a relative loss of cAMP response (due to 
the cAMP levels were elevated). It would appear that this is not the case, or that elevated cAMP 
levels are not solely responsible for increased inotropy, as neither of the total cAMP responses 
(stimulated by NKH477) are affected in apical or basal cardiomyocytes. There is a slight elevation in 
the cAMP responsiveness of the cells overall, thus β2AR responses relative to the total FRET response 
of the cells should be assessed. Adrenaline pre-stimulation may cause a slight selection effect with 
healthier cells which are also more optimally transfected being more likely to be selected. From this 
analysis it is possible to see that the slight increase in overall FRET and a decrease, in β2AR-induced  
cAMP response, by adrenaline pre-stimulation is apparent, reduced to around a half of the relative 
β2AR response. This is the same for both apical and basal cells which, as in contraction experiments, 
both show a relative reduction in β2AR mediated inotropy. This effect is more subtle in FRET 
experiments, as when correcting the response to baseline, only half the response is lost compared to 
most or all of it in the contraction experiments. The raw FRET responses are not sufficient to 
interrogate the subtle effects of catecholamine pre-stimulation. From this point forward, therefore, 
FRET data is expressed as a function of the total cellular cAMP response induced by NKH477 alone.  
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Figure 5.21 a) Graphs showing measurements of β2AR (CGP 100nM and 100nM) FRET response by 
the cEPAC2 sensor in apical rat cardiomyocytes in control cells or cells following adrenaline pre-
stimulation presented as %FRET Response or c) %Total cAMP response. The same data is shown for 
basal rat cardiomyocytes b) and d). Statistical analysis was by a Mann-Whitney test. 
Equally, there do not seem to be differences between apex and basal cells in this respect. So 
experiments from this point utilize cells isolated as a single population to establish what the effects 
of the treatments would be on cells of both types. This is deemed acceptable as the effects of 
adrenaline on cAMP are noted to be very similar for apical and basal cardiomyocytes. The cEpac2 
sensor is employed and apical and basal responses in cells with no pre-treatment are identical with 
this sensor.     
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5.3.6.2 THE EFFECT OF ADRENALINE AND NORADRENALINE PRE-STIMULATION ON Β2AR-
CAMP RESPONSES – THE ROLE OF TIME 
Cells were treated with adrenaline or noradrenaline, they were tested after 10 minutes or washed 
and re-incubated for 20 minutes and tested after a further 10 minutes. This allowed assessment of 
the relative persistence of the adrenaline/noradrenaline induced reductions in β2AR responses. 
Adrenaline induces a rapid reduction in β2AR-cAMP which persists and deepens following washout. 
This suggests that the β2AR -desensitization is induced rapidly but following this stage does not 
require further stimulation to deepen and is not reversible. Noradrenaline was demonstrated to 
reduce β2AR- mediated increases in contractility. In the FRET experiments Noradrenaline does not 
appear to induce reductions in the β2AR-cAMP response as rapidly as adrenaline but reductions in 
β2AR-cAMP are clearly present following Noradrenaline pre-stimulation and washout. This suggests 
an intriguing scenario where noradrenaline like adrenaline is able to initiate the desensitization 
rapidly, but this effect does not reach the level of the persistent adrenaline-mediated reduction until 
the end of a washout period. This suggests that adrenaline and noradrenaline may have similar 
effects on β2AR-cAMP responses via slightly differing mechanisms at different rates.                
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Figure 5.22 a) Graphs showing the effects of adrenaline on β2AR (CGP 100nM and 100nM) FRET 
response by the cEPAC2 sensor in rat cardimyocytes a) immediately or after washout. b) Graph 
showing the effects of noradrenaline on β2AR-stimulated cAMP immediately or after washout. 
Statistical analysis was by a Mann-Whitney test. 
5.3.6.3 THE ROLE OF G I PROTEIN IN THE EFFECT OF ADRENALINE AND NORADRENALINE 
PRE-STIMULATION ON Β2AR-CAMP RESPONSES  
As detailed in the last section the similar effects of adrenaline and noradrenaline on β2AR-cAMP 
seem to result from slightly differing mechanisms due to the amount of time they take to elicit. The 
same experiment was repeated in cells with Gi effects removed following PTX treatment, Figure 
5.23. Adrenaline pre-stimulation initially induces a similar level of desensitization as in cells with Gi 
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signalling intact. This suggests that this first phase of desensitization does not involve stimulus 
trafficking of β2AR to Gi. However, adrenaline pre-stimulations depressive effects do not persist in 
PTX treated cells, suggesting that this particular effect of adrenaline mediated pre-stimulation is 
related to β2AR binding Gi. In PTX treated cells the effects of noradrenaline are distinct from 
adrenaline, as in control cells the β2AR is not initially affected by pre-stimulation. But unlike 
adrenaline pre-stimulated cells the persistent desensitization induced by noradrenaline is not 
reversed in PTX treated cells. This suggests a Gi-independent mechanism is responsible for the 
persistent reduction in β2AR-cAMP in cardiomyocytes pre-stimulated with noradrenaline. This is 
concordant with findings in cultured cardiomyocytes in contractility experiments where PTX 
treatment did not reverse noradrenaline-induced β2AR desensitization. This, equally, is reminiscent 
of the smaller effect of noradrenaline pre-stimulation on freshly isolated cells where it did not 
induce dramatic, synergistic sensitization compared with adrenaline pre-stimulation. 
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Figure 5.23 A) Graphs showing the effects of adrenaline on β2AR (CGP 100nM and 100nM) FRET 
response by the cEPAC2 sensor in rat cardimyocytes a) immediately or after washout pre-treated 
with pertussis toxin. B)  Graph showing the effects of noradrenaline on β2AR-stimulated cAMP 
immediately or after washout in the PTX treated cells.C, D) Control cell data displayed for 
comparison. Statistical analysis was by Mann-Whitney test.  
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One possibility is that although the role of cAMP is critical in β2AR modulation of inotropy, FRET 
methods (particularly those using cytosolic measurements) are possibly not sensitive or specific 
enough to fully explain the contractility measurements. Equally, although FRET measurements 
predict the return of β2AR modulation of contractility in shortening experiments they do not predict 
the sensitization. This may be due to the relative simplicity of the β2AR’s control of positive inotropy 
(by stimulating Gαs and hence AC) in comparison to the effects of Gi. The Gi may cause negatively 
inotropic effects via either Gαi or Gβγ subunits. These FRET experiments can only evaluate the AC-
dependent negatively inotropic effects (mostly attributed to Gαi). Due to this the negatively 
inotropic effects of Gi upon pre-stimulation are not being fully explored here and in contractility 
experiments it is not clear what role the basal activity of Gi is having on cellular physiology and 
subsequently the relevance of data from PTX pre-treated cells is not clear.          
5.3.6.4 THE EFFECT OF ADRENALINE ON Β2AR SIGNALLING ON MOUSE CARDIOMYOCYTES 
AND THE ROLE OF G I 
In freshly isolated mouse cardiomyocytes adrenaline was demonstrated to induce a reduction in 
β2AR-induced shortening in apical cardiomyocytes but seemed to induce an increase in β2AR induced 
shortening in basal cardiomyocytes which was counter to all other data in this area. Cardiomyocytes 
were isolated from mice transgenically expressing Epac1 in a signle population. The effect of 
adrenaline pre-stimulation appears more distinct in mouse cells although as in rat cells in 
measurements of %FRET these differences are not statistically significant. However, when correcting 
the β2AR responses to those induced in the presence of NKH477 a statistically significant reduction in 
the β2AR-cAMP response is observed. This is concordant with findings in shortening experiments 
with mouse apical cells, at least, and is similar to rat cells from apical and basal regions. The 
difference is more distinct than in cultured rat cells. It may be the case that the effect of culture, 
which is essential to FRET experiments with rat cells, may be obscuring the complete connection 
between contraction and FRET experiments. This is even though comparable contraction data is 
produced with cultured cells. As previously discussed the effect of β2AR appears enhanced in 
cultured cells which may induce more variability within the dataset. This presents a case for  utilizing 
mouse cardiomyocytes for these experiments as opposed to rat which is the predominant model 
animal in this area.          
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Figure 5.24 A) Graphs showing the effects of adrenaline upon β2AR-stimulated cAMP responses in 
mouse cardiomyocytes transgenically expressing the Epac1 FRET sensor. Data presented as a) %FRET 
response or b) %Total cAMP response. Data produced by Viacheslav Nikolaev, Nikolaev Laboratory. 
Statistical analysis was by Mann-Whitney test. 
Mouse cells were pre-treated with PTX for 3 hours before testing and this perfectly re-capitulated 
the β2AR-induced cAMP response, implicating once again the role of Gi in adrenaline mediated 
desensitization. It is also, once again, a neater scenario than that presented for rat cardiomyocytes 
which must be cultured to allow transfection with FRET constructs.  
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Figure 5.25 Graphs showing the effects of adrenaline upon β2AR-stimulated (CGP 100nM and ISO 
100nM) cAMP responses in mouse cardiomyocytes trangenically expressing the Epac1 FRET construct 
pre-treated with pertussis toxin. Data presented as a) %FRET response or b) %Total cAMP response 
after PTX pre-treatment.c and d) present control data for comparison. Data produced by Viacheslav 
Nikolaev, Nikolaev Laboratory. Statistical analysis was by Mann-Whitney test. 
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5.3.2.5 THE EFFECT OF ADRENALINE OR NORADRENALINE PRE-STIMULATION ON Β1AR 
SIGNALLING 
During acute Takotsubo syndrome both the β1AR and β2AR receptors are stimulated, and therefore it 
was questioned whether adrenaline and noradrenaline would have any negatively inotropic effects 
upon β1AR-cAMP. This was investigated in the same way as β2AR, i.e. after adrenaline or 
noradrenaline stimulation with or without a refractory period. Neither adrenaline and or 
noradrenaline induced a significant reduction in the cardiomyocyte β1AR-cAMP response.  
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Figure 5.26 Graphs showing the effects of adrenaline upon β1AR-stimulated (ICI 50nM and ISO 
100nM) cAMP responses, measured by the cEPAC2 sensor in adult rat cardiomyocytes a) immediately 
or after washout upon β1AR-stimulated cAMP responses and the effects of noradrenaline on β1AR-
stimulated cAMP b) immediately or after washout. Statistical analysis was by Mann-Whitney test  
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5.4 DISCUSSION 
β2AR signalling is noted to be rapidly quenched in comparison to that of the β1AR. This has been 
demonstrated in the literature to be as a result of stringent compartmentation via structural and 
molecular mechanisms (Liu et al., 2009; DeArcangelis et al., 2010). In the previous chapters this 
stringent control has been demonstrated to be variable depending on the anatomical position of the 
cardiomyocyte itself. The effect of anatomical position appears to be correlated with alterations of 
the sub-cellular structure of cardiomyocytes and as a result may alter the localization and 
compartmentation of the receptor. Removal of these structures and removal of the effects of the 
main source of molecular compartmentation, phosphodiesterases, are able to remove the apico-
basal difference. A further method of compartmentation of the β2AR or innate control of this 
receptor system is observed in this chapter, the ability of the β2AR to become rapidly desensitized. In 
the case of the β2AR this desensitization is not simply in the form of phosphorylation and 
internalization which removes or modifies its activity. These familiar desensitization pathways are 
subverted allowing the β2AR to switch its agonism away from the Gαs mediated control of cAMP 
production to a Gi pathway.  
It was questioned how rapidly these effects could be produced in vitro. The work of Liu et al. (2009) 
has demonstrated that in a transgenic expression system using HEK293 cells, fluorescently tagged, 
β2AR can be observed to rapidly cycle away (<10 minutes) from the membrane as a result of 
adrenaline stimulation. The receptors would then return to the membrane surface (after a further 
10 minutes). The effect of noradrenaline was somewhat distinct in that receptors were internalized 
but less rapidly. This internalization did not reverse within the course of the experiment. The authors 
implicated the differential phosphorylation of the receptor, as a result of the relative difference in 
agonist potency between adrenaline and noradrenaline stimulation, in this phenomena. Adrenaline 
was able to stimulate phosphorylation of the β2AR a specific site for phosphorylation by PKA. 
Equally, it could cause the phosphorylation of the receptor at a different site by GRK2. A 
physiological reason for this effect was not defined but the authors reasoned that this effect may 
underlie the observation that adrenaline but not noradrenaline causes stimulus trafficking of the 
β2AR. It was decided that an experiment should be performed to assess whether these interesting 
effects exist in adult cardiomyocytes a cell type where more profound physiological outcomes may 
result from these effects, than in the HEK used by Liu et al. (2009). Subsequently, 20 minute pre-
stimulations with adrenaline or noradrenaline were applied to the apical or basal cardiomyocytes 
and β2AR responses were then assessed after a 10 minute equilibration. Both apical and basal cells 
did not present increases in inotropy upon subsequent β2AR stimulation.  
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Future work should assess the time course of the withdrawal of β2AR-mediated positive inotropy. 
The FRET experiments clearly demonstrated that there are two phases to this process one which is 
not Gi-mediated (PTX insensitive) and a later phase which is Gi-mediated (PTX sensitive). The 
lusitropy of apical cardiomyocytes was reduced by adrenaline pre-stimulation whereas the basal 
myocardium was unaffected. Similar to the in vivo model of TTC, noradrenaline pre-treatment had 
no effect upon the apical cardiomyocytes which still presented a positively lusitropic response upon 
β2AR stimulation. Gi was implicated in the adrenaline-mediated apical dysfunction as removal of its 
effects saw an increased lusitropic response of β2AR in comparison to control. The effects of 
adrenaline on lusitropy are more striking than those upon the amplitude of contraction leading to 
the speculation that the decreased contractile function induced by adrenaline, in the in vivo model 
and in TTC, is due to decreased relaxation velocity as a result of β2AR switching from providing  
lusitropic support to inhibiting it via a Gi pathway.  
Control of cAMP may not fully explain the situation and other downstream mediators of the Gi 
acting via non-cAMP pathways may be behind this response. One suggestion is that the cEpac2 FRET 
sensor employed in this process is shown to be relatively poor at predicting the contractile outcome 
of treatments. RII_Epac has been shown to be more proficient in this respect by data presented in 
chapters three and four; as a result, future work should be conducted using this sensor to assess 
these affects. We must also investigate the role of protein phosphatases which function to remove 
the effects of PKA phosphorylation. These molecules rapidly extinguish the effects of β2AR 
stimulation and are demonstrated to effectively compartmentalize the receptor and control its 
physiological effects (MacDougall et al., 2012). Measuring cAMP alone with FRET sensors cannot 
provide us with any information concerning the role of protein phosphatases in the effects 
discussed. 
The utilization of cells which have been maintained in culture for 48 hours is not optimal. This is 
probably demonstrated by the cytosolic Epac1 sensor in cells freshly isolated from mouse correctly 
predicting the effect of adrenaline pre-stimulation on contractile function. This suggests that 
cytosolic levels of cAMP can predict these effects and that possibly some effect of culture is 
responsible for reducing the sensitivity of cEpac2 in the rat cardiomyocytes. A study by Chakir et al. 
(2011), cautions against culturing rat cardiomyocytes, before assessing β2AR function due to the 
observed up-regulation of the peptide RGS2. This peptide is responsible for returning β2AR back to 
Gs signalling following its binding to Gi. As a result β2AR induced contractile responses appear 
enhanced following culture. This can be observed by the increase in apical contractile response and 
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the appearance of a contractile response in basal cardiomyocytes when there was none in freshly 
isolated cardiomyocytes.  
Adrenaline pre-stimualtion is able to induce negatively lusitropic effects in the basal cells but 
produced little effect on contractility. Even upon removal of Gi effects by culture or PTX β2AR’s 
control of the contractile function of basal cardiomyocytes appears to be slight.  The removal of 
caveolae prevented the desensitizing effects of adrenaline on β2AR in a similar way to removing Gi. 
Given that apical cardiomyocytes are relatively caveolae poor this may be a further mechanism 
allowing the increased influence of β2AR-cAMP on PKA compartments within the apical 
cardiomyocytes. Mouse cardiomyocytes and rat cells cultured for 48 hours were assessed to ensure 
that FRET experiments using rat cardiomyocytes transfected in culture for 48 hours were not 
misinterpreted. The lusitropic response of β2AR was removed by adrenaline but not noradrenaline in 
apical cardiomyocytes. The rate of relaxation of basal cardiomyocytes was not altered by either 
adrenaline or noradrenaline pre-stimulation.    
Limitations and Further Work 
A technique which is able to measure the calcium levels within the cardiomyocytes might possibly be 
able to better discriminate between effects where a treatment (such as PTX or adrenaline pre-
stimulation) has induced increases in baseline levels of calcium as opposed to simply an effect on 
cAMP. This may explain the observation that, after pre-stimulation, apical cells appear more 
contractile at baseline. It is not clear why the noradrenaline and adrenaline pre-stimulation of the 
apical cells induced increased contractility at baseline. This situation was altered by PTX or 
cyclodextrin treatment suggesting that toxicity and alteration of the population of cells tested are 
not the causes. It would be useful to establish whether the toxic effects of isoprenaline reported by 
Shao et al. (2013 A, B) are present. The mouse has shown to be very useful in these experiments; it 
would be useful to look more carefully at the dynamics of internalization of the β2AR in these 
cardiomyocytes. This would have more relevance than the former studies in HEK293 cells. It is not 
clear what the role of caveolae is in allowing the β2AR to exert negatively inotropic effects on the 
cardiomyocytes. It appears to mimic the effects of Gi as cyclodextrin removes the inhibitory effects 
of adrenaline like PTX. In some cases cholesterol may be necessary for Gi function, Pontier et al. 
(2008) demonstrate that cyclodextrin pre-treatment enhances β2AR activity overall but initially it 
prevents the binding of agonists to the high affinity binding site of β2AR.                 
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6. Gender-Differences in Response to Acute Adrenaline Shock, the Role of Oestrogen  
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6. GENDER-DIFFERENCES IN RESPONSE TO ACUTE ADRENALINE SHOCK, THE ROLE OF 
OESTROGEN  
6.1 INTRODUCTION 
The syndrome of Takotsubo appears to primarily afflict post-menopausal women, which is 
speculated to be as a result of the withdrawal of oestrogen (a cardio-depressant) and the hyper-
responsiveness of the sympathetic nervous system of these women (Lindheim et al., 1992). 
However, it is not clear to what extent each factor is involved or whether in fact, as a result of its 
transient reversible nature. Takotsubo is a protective effect. In this respect rather than being made 
vulnerable by the menopause the women possess some of the protective effects of oestrogen and 
are thus escaping the lethal effects of adrenergic overstimulation which would afflict the male of the 
same age. As a result it was questioned whether the Takotsubo model which utilizes male animals 
(which are still relatively juvenile) could be improved by using ovariectomized females (OVX) which 
are a more accurate model of the post-menopausal female. These animals were obtained and 
assessed alongside oestrogen competent females and males. This allowed assessment of whether 
the same Takotsubo like symptoms, observed in the males, were present in the females and 
presented any differently in the OVX females. As relatively few specific treatment options exist for 
Takotsubo it was questioned whether acutely dosing the OVX females with oestrogen would in some 
way ameliorate the effects of the adrenaline bolus in this study group.  Oestrogen has also been 
demonstrated to have anti-arrhythmic properties so the ovariectomized animals’ 
electrocardiographic parameters were assessed. Equally, oestrogen appears to be a potent 
vasodilator (Sung et al., 1999, Morimoto et al., 2004) and recent studies have shown vasodilatation 
by adenosine to ameliorate the effects of large doses of isoprenaline (Shao et al., 2013C).   
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6.2 MATERIALS AND METHODS 
6.2.1 SOLUTIONS AND REAGENTS 
Adrenaline (epinephrine) Hydrochloride was obtained as a Ph. Eur. grade injection solution from 
Hameln (1mgl/ml). Estradiol (estrogen) was obtained from Sigma. Absolute ethanol was purchased 
from VWR as was Gibco PBS (+CaCl2+MgCl2). Isoflurane (IsoFlo 100%w/w) was obtained from Abbot 
and medical grade 100% O2 was obtained from BOC. 
6.2.2. ANIMALS 
As previously detailed in Chapter 2,  all animals were prepared, treated and maintained under 
conditions fulfilling the criteria of Animals in Scientific Procedures Act 1986 (UK Home Office, ASPA 
1986). Both male female and ovariectomized female rats were kept on 12-hour light/dark cycle at 
21oC. Overall 54 rats were utilized for this study. Of that number 32 were surgically prepared by 
ovariectomy before use by Harlan.  
6.2.3 ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT VENTRICULAR FUNCTION –  
PROCEDURE 
The rat is moved to a chamber with an atmosphere of 5% isoflurane to quickly bring about 
anaesthesia. At this point the rat is rapidly weighed, shorn and affixed to an electrode plate with 
micro-pore tape. The muzzle was placed in a nose cone and oxygen provided with isoflurane given at 
a level of 2%. Anaesthesia was ensured and a homoeothermic heat blanket with a rectal 
thermometer probe was used to ensure an optimal body temperature of 37.0-38.0oC. At this point 
platinum ECG electrodes were attached in the lead II conformation. The stability of the rat’s vital 
signs and ECG features were recorded. The jugular vein was exposed by an incision through the first 
layer of skin and blunt dissection. The vein was then cannulated with a 22G Abbocath catheter 
(Venisystems, Hospira). Access to the circulation was confirmed by flushing the catheter with PBS 
and ensuring venous blood would pool in the syringe (flash-back) under slight negative pressure. PBS 
was applied as a lock solution. For a sub-set of the rats a solution containing estrogen (600ng/ml) 
was given as a bolus (0.5ml, 300ng) and then infused (30ng/min for 10 minutes) via an Aladdin – 220 
syringe driver (World Precision Instruments, UK). Finally, ultrasound gel was layered onto the rat’s 
thorax and the echo probe lowered. After obtaining a good quality image in the B-Mode, baseline 
measurements were taken of the animal’s vital signs, and the contractility of the apical, basal and 
mid-left ventricle is recorded in 1D mode. The bolus of adrenaline was then applied over about 20 
seconds amounting to a rate of 25μl/sec. Given that the rat ventricle has a volume of roughly 250μl, 
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a stroke volume of around 124 μl and a heart rate of 375bpm this should only increase the stroke 
volume by 3.2% and the ventricular volume by 1.6% over the course of the infusion. The volume of 
this infusion has been demonstrated to have no adverse effects in previous studies by our group 
(Paur et al, 2012- PBS was applied in isolation and echocardiographic parameters assessed over 60 
minutes as per the standard adrenaline protocol). As detailed in Chapter 2 the fractional shortening 
of each left ventricular segment was determined from the 1D M-Mode image as follows:  
Left ventricular fractional shortening = ((LVEDD-LVESD)/LVEDD) x100 
The Vevo 770 software can infer other measurements from this such as the volume of the ventricle 
and the % ejection fraction. Echocardiographic parameters were then observed over the specified 
time-frame of 60 minutes.  
6.2.4 MODIFIED BOLUS DOSE EXPERIMENTS 
As will be described in the results chapter ovariectomized females (OVX) suffered significant acute 
mortality following the adrenaline bolus. A decision was made post-hoc to test the effects of a lower 
dose of adrenaline on these animals to assess whether they would serve as an improved in vivo 
model of Takotsubo in comparison to male rats. Two separate sets of three ovariectomized animals 
were administered a half log or a log lower dose than the normal adrenaline bolus dose (as describe 
above and published for male rats in Paur et al, 2012). Echo-cardiographic and electrocardiographic 
parameters were recorded as usual.  ECG was recorded in the human lead II confirmation (-ve 
electrode placed at right forepaw and +ve electrode at the left leg.   
6.2.5 INITIAL ARRHYTHMIC PHASE FOLLOWING ADRENALINE INFUSION 
After infusion of the adrenaline a profound slowing of the heart presents most likely due to a vagal 
response countering the extreme adrenergic over stimulation present. Respiratory arrest is also 
observed. Following this phase as the heart begins to restore normal pumping function, an 
arrhythmic phase begins which presents ventricular ectopics and trains of ventricular tachycardia. In 
some cases this degrades to ventricular fibrillation (VF) which is marked by a loss of conduction and 
clear depolarizations of the atria and/or ventricles in the ECG recordings. The presence of VF in any 
case was terminal. The acute mortality of the adrenaline infusion was noted; much less frequently 
animals would die during the recording phase. In these cases electrocardiographic indices explaining 
the mortality would not be present. The arrhythmic phase which usually lasted for only 2-3 minutes 
was assessed by Matthew Tranter using a modified Lambeth Convention criterion. The animals were 
each placed in a single category of 0-5, 0 roughly equating to no arrhythmia and 5 being VF and 
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acute mortality. In some cases animals marked lower than 5 would subsequently die during the 60 
minute recording procedure. 
6.2.5.1 MODIFIED LAMBETH CONVENTION CRITERIA 
Scorings were applied hierarchically, i.e. if the animal exhibited 60 ventricular ectopics and a 
cumulative VT duration of >1 min, it would score 4, not 5 (4+1). 
Grade  
0  0-49 ventricular ectopics 
1  50-499 ventricular ectopics 
2 >500 ventricular ectopics or one brief period of non-sustained ventricular tachycardia (VT) 
3 <1 min of VT 
4 >1 min of VT, or  ventricular fibrillation (VF) occurring >10 minutes after treatment 
5 non-terminating VF 
6.2.6 ANIMAL NUMBERS FOR EACH TEST GROUP 
Animals from the four test groups were assessed to investigate the role of age, sex and oestrogen 
competency. Equally, the acute the cardio-protective effects of oestrogen were probed by infusion 
of Estradiol before administration of adrenaline as described above.  
Group + Weight Range Number 
Males (250-600g)  16 
Females (200-313g) 8 
Ovariectomized (OVX) Females (300-381g) 12 
OVX + estrogen infusion (311-390g) 12 
OVX + 0.5log dose 3 
OVX + 0.1log dose 3 
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6.2.7 STATISTICAL ANALYSIS  
Two-way ANOVA was utilized to test difference between baseline and measurements following 
treatment. One-Way ANOVA with Bonferroni post-test is used to establish differences in baseline 
parameters between groups. Fishers 2x2 exact test is used to test differences in mortality between 
groups.  Unpaired and Mann-Whitney t-tests are used to establish differences in baseline 
contractility and arrhythmia respectively between pairs of groups.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
214 
 
6.3 RESULTS 
6.3.1 BASELINE PARAMETERS OF GROUPS TESTED 
It was considered that baseline parameters relating to the physiology, separate to the modifications 
of physiology produced by adrenaline infusion may affect the cardiac response to adrenaline. The 
amount of adrenaline administered is corrected to the animal weight, so this should not impact too 
much upon the cardiac response as blood volume appears to scale linearly with rat body weight in 
this strain (Lee and Blaufox, 1985). This should mean that the weight corrected adrenaline dose 
should give equal plasma volumes of adrenaline which are presumed, equally, to be metabolised at 
similar rates within groups and between groups. 
 Male Female OVX 
N 16 8 30 
Weight (g) 394.5±24.3 253.4±12.1** 332.9±4.8 ~~## 
Left ventricular diastolic diameter at  MLV (mm) 7.11±0.16 6.11±0.25** 7.27±0.12 ~~~ 
Left ventricular systolic diameter at  MLV (mm) 3.89±0.20 2.86±0.35* 3.96±0.16 ~~ 
Left ventricular volume (μl) 267.1± 13.1 190.9± 16.5** 281.0± 10.8 ~~~ 
%Fractional Shortening MLV 44.80±2.42 54.12±4.52 44.49±1.61 ~ 
%Fractional Shortening Apex 48.38±2.48 52.68±2.81 47.70±1.59 
%Fractional Shortening Base 46.76±2.77 47.30±3.19 40.95±1.41 
Heart Rate bpm 363.8±13.30 359.3±19.79 362.9±5.13 
% Ejection Fraction 73.99±2.48 82.30±3.43 73.39±1.69 
Table 6.1 Table displaying the baseline echocardiographic parameters of rat groups before 
administration of adrenaline bolus. Values displayed are mean±sem, each parameter statistically 
tested for the three groups using an ANOVA with Bonferroni Post-Test (*,** p<0.05, p<0.01 vs. male) 
(~,~~,~~~p<0.05, p<0.01, p<0.001 vs. female)(## p<0.01male vs. OVX). MLV-Mid-left ventricle 
Male rats of between 2-3 months are heavier than females and ovariectomized females. The use of 
this species and strain in in vivo studies, when comparisons of gender are required, is complicated by 
the fact that male rats are almost twice as heavy as females for most of their lifecycle.  In this case 
ages are matched to within the month but male rats can gain >50g a week at this age. This weight 
difference may have some bearing upon arrhythmia. Interestingly, the ovariectomized females (OVX) 
are almost exactly in between the weights of males and normal females. This suggests that the 
215 
 
effects of ovariectomy result in the female rats gaining weight more rapidly. Male and OVX females 
have hearts which are identically wide (LVid MLV), which are almost a millimetre wider than female 
animals of the same age at diastole. They are equally wide at systole suggesting that this is not an 
artefact of contractility but is a true size difference between the male, OVX and female groups. In 
this respect it is possible to suggest that ovariectomy has resulted in a masculinisation of the female 
heart. This is shown by the diastolic volume of the OVX heart which is larger on average than both 
the male and female heart (although this only reaches statistical significance vs. female). The female 
heart appears to be more contractile than the other groups at the MLV and apex although this only 
reaches statistical significance for the MLV between Female and OVX groups. The heart rate and %EF 
are not significantly different between the groups, suggesting there are no further underlying 
differences in cardiac parameters which might affect the assessment of adrenergic overstimulation. 
It is not clear what effect the larger heart may have in the OVX females or if this is a sort of 
physiological or even pathological hypertrophy caused by the withdrawal of oestrogen upon 
ovariectomy.  
6.3.2 INCIDENCE OF MORTALITY IN THE GROUPS 
As mentioned previously there is a substantial level of acute mortality (around 50%) in this 
experimental model of Takotsubo (Paur et al, 2012). This is consistent with the syndrome of 
Takotsubo as being rare and sufferers showing plasma levels of catecholamine far in excess of those 
usually encountered in other forms of heart failure (Wittstein et al, 2005). The acute mortality levels 
in these groups may reveal the relative vulnerability of these different groups to adrenergic 
overstimulation.  
 Dead Alive Mortality 
(((((%) (%) 
((((((( (((0(5) 
Male 7 9 43.8% 
Female 0 8 0% 
OVX 9~~~ 3 75% 
OVX+E 6~ 6 50% 
 
Table 6.2 Table displaying mortality data for the four groups of rats, following the application of the 
adrenaline bolus. Statistical testing was performed by Fishers exact test 2x2 contingency table (~, ~~~ 
p<0.05, P<0.001 vs. female). 
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There appear to be differences in vulnerability between the groups. When analyzing the different 
groups using a Fisher’s exact test 2x2 the apparently very distinct difference between male and 
female borders on significance (p=0.0538) which is most likely due to lack of experimental power. 
Rates of mortality appear similar between male and OVX/OVX+E groups. OVX and OVX+ groups are 
significantly different from female, showing that sex and oestrogen competence appear to be a 
protective factors in this model. Ovariectomy appears to result in extreme vulnerability to the 
effects of the adrenaline bolus. Although it seems that acute oestrogen pre-treatment may have 
some ability to equalize the relative mortality of the OVX animals it does not restore the inherent 
protective effects displayed by healthy female animals and is not significantly different from the OVX 
group (p=0.4). Relatively there is a 50% reduction in deaths which would clinically be significant 
although the statistical analysis suggests this study is underpowered due to a low number of 
replicates. A post-hoc power calculation suggests that this dataset only has 20% power to detect a 
statistically significant difference of only 25% in the mortality rate. Thus a new set of studies should 
be undertaken to investigate the effect of estrogen on the acute mortality of ovariectomized female 
rats.  
6.3.3 THE ANALYSIS OF ARRHYTHMIA BETWEEN GROUPS 
The relative severity of the adrenaline bolus upon the electrocardiographic parameters of the 
individual animals was assessed. Arrhythmia was the cause of significant mortality within the 
protocol and consequently it was questioned whether the groups exhibited any intrinsic differences 
in their predilection for arrhythmias upon treatment. Male and OVX female animals had a higher 
frequency of mortality compared to female and oestrogen supplementation animals did not 
ameliorate this relationship. As shown in figure 6.1 control female animals had significantly lower 
arrhythmia scores than all other groups. On average the female animals would suffer less than 500 
ectopics and no sustained or non-sustained tachycardias. This is in contrast to cases in the three 
other groups which would suffer extended periods of sustained tachycardia over 1 minute or even 
ventricular fibrillation over 50% of the time. It appears that the unresponsiveness of the females to 
adrenergic stimulation is able to prevent arrhythmic death.  
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Figure 6.1 Chart displaying the arrhythmia grades for each individual animal from the male, female, 
OVX and OVX+ oestrogen supplementation rat groups. Graph shows groups’ medians with inter-
quartile ranges. Statistical testing by Mann-Whitney (## p<0.001 vs. all other groups), arrhythmia 
scoring performed by Matthew Tranter. 
Supplementation of the animals acutely with oestrogen did not ameliorate the effects of 
ovariectomy in this model. 
6.3.4 ANALYSIS OF REGIONAL CONTRACTILITY BETWEEN ‘SURVIVORS’ IN THE THREE 
GROUPS 
The production of ‘Takotsubo-like symptoms’ could be considered to be the results of hyper-
adrenergic overstimulation, which was not sufficient to cause sudden death. Ventricular fibrillation 
does not usually present with Takotsubo and cardiac arrest and the necessity for defibrillation is not 
widely reported. Takotsubo appears to be a result of pathological changes to cellular physiology 
which do not result in dysfunction severe enough to cause the death of the afflicted individual. As 
discussed above the in vivo model which was published presents with significant mortality in line 
with the hypothesis that this syndrome is due to a pathology, which results from cells being exposed 
to catecholamine concentrations which are just sub-lethal. It is clear that rather than being an 
improved in vivo model, OVX females are far more susceptible to adrenaline induced sudden death. 
In this respect the quantity of data on the contractile effects of the adrenaline bolus is very low. 
Enough data exists within the other groups with which to make a comparison. There is much inter-
individual variability between the cases within groups, this is a drawback of using an outbred rat 
model, but is clearly more concordant with what is found in the heterogeneous patient population. 
One OVX female was excluded from the study on the basis that it died following about 30 minutes of 
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an apparent respiratory arrest so one could not be sure that cardiac measurements were 
acceptable. Cardiac function may have been unduly affected by hypoxia as a result of the gradual 
respiratory failure. Male rats exhibit a slightly more contractile apex relative to base. This is not the 
case for female animals.  
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Figure 6.2 Graph showing a comparison of the baseline contractility (%Fractional shortening) of the 
male and female rat apical and basal myocardium determined by echocardiography. Statistical 
testing was performed using a Mann-Whitney test. 
The apical myocardium of male rats exhibits a significant reduction in contractility, which begins 
about 10 minutes after adrenaline infusion. This is apparent from data of raw contractility and after 
reanalyzing the effects of adrenaline as changes in fractional shortening from baseline (Figure 6.3 
and Figure 6.4). From these data it is apparent that adrenaline causes a transient reduction in the 
contractility of the apical myocardium by approximately 20-25% for the first 30 minutes of the 
protocol. Female animals do not exhibit a notable alteration of their baseline contractility in either 
the apical or myocardium following adrenaline infusion. When the data is corrected to baseline it is 
clear that neither the apical or basal myocardium is particularly affected by the adrenaline infusion 
beyond the initial arrhythmic phase. Analysis of the data from ovariectomized animals is complicated 
by the fact that so few of these animals survived beyond the initial phase of arrhythmia. This meant 
that only two surviving animals could be studied to 60 minutes. These individuals were strikingly 
different to each other suggesting that possibly the reason for their survival was due to some 
methodological factor or problem with the infusion of adrenaline. Even so it appeared that the 
fractional shortening of these animals was increased on average in both apical and basal regions 
especially the apex, but the variability with the data set made it impossible to deem whether this 
was a real effect, statistically. The ovariectomized females supplemented acutely with oestrogen 
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displayed the difference in contractility between the apex and base like the males.  However, their 
responses were strikingly different to that of the males. The apex of these animals was unaffected by 
the adrenaline bolus but the basal myocardium increased its fractional shortening significantly. This 
was by around 40% relative to baseline, this increase rapidly reversed to near baseline at 20 minutes 
but the shortening would on average increase again until it became statistically significant against 
the baseline again at 50 and 60 minutes. In this time the apex remained close to baseline 
contractility after an initial (non-significant) increase at 10 minutes.              
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Figure 6.3 Graphs showing the mean fractional shortening of the apical and basal regions of the 
hearts of a)male, b) female, c) OVX and d) OVX+E rats following application of adrenaline bolus. Data 
shows mean±sem at 10 minute time intervals over the course of an hour following the application of 
the adrenaline bolus for a, b and c. Data is shown before (-10 mins) and after oestrogen infusion (0) 
with 0 as the baseline in graph d. *p<0.05 statistical analysis was by Two-way repeated measures 
ANOVA against (0 minutes) 
 
220 
 
10 20 30 40 50 60 70
-40
-20
0
20
40
Apex
Base60
100
* **
Time (mins)
%
 C
h
a
n
g
e
 i
n
 F
S
 f
ro
m
b
a
s
e
li
n
e
10 20 30 40 50 60 70
-40
-20
0
20
40
Apex
Base60
100
Time (mins)%
 C
h
a
n
g
e
 i
n
 F
S
 f
ro
m
b
a
s
e
li
n
e
10 20 30 40 50 60 70
-40
-20
0
20
40
60
80
100 Apex
Base
Time (mins)%
 C
h
a
n
g
e
 i
n
 F
S
 f
ro
m
b
a
s
e
li
n
e
10 20 30 40 50 60 70
-40
-20
0
20
40
Apex
Base60
100
*
*
Time (mins)%
 C
h
a
n
g
e
 i
n
 F
S
 f
ro
m
b
a
s
e
li
n
e
A) B)
C) D)
Male Female
OVX OVX+E
 
Figure 6.4 Graphs showing the fractional shortening of the apical and basal regions of the hearts of 
a)male, b) female, c) OVX and d) OVX+E animals, as % of baseline shortening following the 
application of the adrenaline bolus. Data shows mean±sem at 10 minute time intervals over the 
course of an hour following the application of the adrenaline bolus for a, b, c and d in all cases 0 is 
used as the baseline (i.e. following oestrogen infusion for d). *p<0.05 Two-way repeated measures 
ANOVA against (0 minutes) 
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The heart rates of the animals were assessed, male but not female animals showed a significant 
decrease in heart rate following the adrenaline bolus, Figure 6.5. Only two OVX animals were 
analysed so much variability is present. After supplementation with oestrogen, there is no significant 
alteration in the animals’ heart rates, following the adrenaline bolus. Interestingly, in no case does 
adrenaline at this level increase heart rate which is suggestive of the intense cardio-depressive effect 
of adrenaline at these concentrations. These phenomena may be indicative of a bradycardia caused 
by a vagal reflex.  
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Figure 6.5 a) Graphs showing the heart rates of male and female animals at baseline and following 
the adrenaline bolus b) the same data is shown for the OVX and OVX+E cases. Mean±sem *p<0.05 
Statistical testing was by two-way repeated measures ANOVA against (0 minutes) 
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6.3.5 ANALYSIS OF REGIONAL CONTRACTILITY IN OVARIECTOMIZED FEMALES 
RECEIVING MODIFIED DOSES                 
When beginning the bolus studies upon ovariectomized animals it quickly became apparent that 
these animals were extremely sensitive to adrenaline and that they suffered severe mortality. For 
this reason it was questioned whether this extreme sensitivity to adrenaline would make the 
ovariectomized animals an improved model of Takotsubo compared to the male animals. This would 
have more physiological relevance to the disease as it presents in man. Given the hypothesis that 
Takotsubo results from adrenaline stimulation which is just sub-lethal, two doses were chosen to 
assess this, a half log or whole log lower bolus dose was applied. No animal died after being given 
either of these two doses. The apical region was not significantly depressed compared to the base at 
either dose.  Heart rates were not significantly altered and ther was no significant arrhythmic 
activity. 
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Figure 6.6 a) Graphs showing the Fractional shortening of OVX animals receiving a 0.5log dose of 
adrenaline b) shortening corrected to baseline. c) Fractional shortening of OVX animals receiving 
0.1log dose of adrenaline d) the same data corrected to baseline. Mean±sem *p<0.05 statistical 
testing was by two-way repeated measures ANOVA against (0 minutes) 
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Figure 6.7 a) Graphs showing the heart rate of OVX rats receiving the 0.5 and 0.1 dose of adrenaline 
monitored over 60 minutes. Mean±sem NS statistical testing was by two way repeated measures 
ANOVA against (0 minutes). b) Graph showing the arrhythmia scores of OVX rats. 
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6.4 DISCUSSION 
Female animals (as a model of pre-menopausal human) did not seem to have an apical 
hypocontractility which was present within the group of male animals following the adrenaline 
bolus.  This is concordant with the findings that female hearts are relatively less responsive to 
adrenergic stimulation in comparison to male (Lindheim et al., 1992). This suggestion was validated 
by the extreme phenotype displayed by OVX animals following the adrenaline infusion suggesting a 
role of the hormonal control supplied by the ovaries in modulating the effects of supra-physiological 
levels of adrenaline on cardiac responses. Indeed the effect on OVX animals was so extreme as to 
cast doubt on whether it could provide an improved in vivo model of Takotsubo. The high mortality 
prevented sufficient data collection to fully evaluate the effects of adrenaline between the 
application of adrenaline and 60 minutes post injection as is normal for this experimental protocol. 
As the protocol seems to take the animals to the extremes of cardiac physiology there was a notable 
amount of inter-individual variation within the study groups. This chapter demonstrates that the 
apical ballooning which piqued the interest in studying the apical and basal cardiomyocytes 
separately, is still justified in male animals (as cells in previous chapters were all male), as the 
findings of earlier work were replicated. Data from female animals showed them to be resistant to 
arrythmia; the data from OVX animals suggested that a radical overhaul of the bolus protocol may 
need to be made if this type of animal is to be used as a model of Takotsubo. This would allow 
further research to take advantage of the increased physiological relevance of this type of animal to 
human sufferers. This may also improve the modelling of Takotsubo within this species as the male 
apical depression is still somewhat transient. This should allow more accurate in vitro investigations 
of the pathways involved in these Takotsubo type symptoms and would possibly draw the role of the 
regionality of β2AR signalling into sharper relief. 
Multiple animal models of Takotsubo have been proposed with a view to uncovering the 
pathological basis of this syndrome. All animal models implicate the role of sympathetic and 
catecholamines as being the basis of this disease and inhibition of adrenoceptor responses remove 
cardiac symptoms. Although earlier studies demonstrated that apical ballooning could be produced 
by either emotional stress or catecholamine infusion they did not suggest any specific mechanisms 
by which this phenomenon occurs (Ueyama et al.,2002; Izumi et al., 2009). The centrality of the β2AR 
and β2AR-Gi signalling to apical ballooning has been demonstrated by a number of findings. 
Adrenaline but not noradrenaline (unable to produce β2AR-Gi signalling) is able to induce transient 
apical dysfunction in a rat model of TTC (Paur et al., 2012). The importance of β2AR-Gi is 
demonstrated by the loss of apical dysfunction after pre-treatment with pertussis toxin (ablating Gi) 
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suggesting that this is a Gi dependent effect. The efficacy of pertussis toxin treatment is shown in rat 
models of TTC using adrenaline and isoprenaline which are both β2AR-Gi agonists (Paur et al., 2012; 
Shao et al., 2013 A). The acute protective effect of β2AR and β2AR-Gi signalling was demonstrated by 
the increased mortality of rats in both models following PTX pre-treatment or blockade of the β2AR 
by the specific antagonist ICI 118,551 (Paur et al., 2012; Shao et al., 2013 A). ICI118, 551 pre-
treatment caused the adrenaline treatment to become 100% fatal for male rats (Paur et al., 2012). 
Although, the approaches of these models were quite different Paur et al. (2012) utilized an 
intravenous bolus of adrenaline whereas Shao et al. (2013 A, B) utilized an intraperitoneal bolus of 
isoprenaline. These treatments were both sufficient to cause apical ballooning and induced a similar 
amount of mortality; i.v adrenaline caused 50% mortality. Intraperitoneal isoprenaline caused >45% 
mortality at the lowest level required to induce apical dysfunction. The Shao study utilized a range of 
doses of isoprenaline and demonstrated interesting data concerning the incidence of mortality and 
the incidence of apical ballooning. At a 25mg/kg dose of isoprenaline there was both a zero 
incidence of mortality and no incidence of apical ballooning, at the next dose of 50mg/kg there was 
both a 50% incidence of mortality and a 60% incidence of apical ballooning. Interestingly, apical 
ballooning then decreases over the range of doses utilized (up to 300 and 450mg/kg) but mortality 
does not increase until reaching 90% for the 300 and 400mg/kg doses (Shao et al., 2013 A). This 
suggests that although the dose required for inducing arrhythmic death and apical ballooning for 
isoprenaline treatment superimpose upon one another there is a very specific window in which 
apical ballooning is induced beyond which mortality and ballooning incidence do not increase. This is 
not dissimilar to what was discovered with the studies in ovariectomized rats where sub-maximal 
doses of adrenaline were utilized. At these doses neither mortality or apical ballooning resulted, 
consistent, persistent apical ballooning and lower mortality may be possible with adrenaline doses 
given to the OVX females but within a narrow dosage window at some point between 0.5 and 1log 
dose. This will clearly require future study with larger sample sizes. The narrowness of the dose 
window required to produce apical ballooning (without sudden death) may account for the rarity of 
TTC within the patient population. The pathogenesis of TTC therefore involves an acutely high but 
non-fatal level of stimulation.  
The mortality of the isoprenaline-induced model was less acute than that observed in the adrenaline 
model. From the ECG data demonstrated in Shao et al. (2013 A) the arrhythmic activity before death 
does not show the same hallmarks of ventricular fibrillation observed before death in the adrenaline 
bolus model (as observed in this work and Paur et al. 2012). The dysrhythmic activity and 
progressive dysfunction leading to mortality may therefore have a different pathophysiological basis 
in comparison. TTC patients usually present with ST-segment elevation or T-wave inversion that are 
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indicative of an interference with ventricular repolarization (Bybee et al., 2004). ST-segment and or 
T-wave changes are not apparent following the adrenaline infusion but are produced by the i.p 
isoprenaline. Levels of both adrenaline and noradrenaline are elevated in the plasma of patients 
with TTC to a degree far higher than that observed for other cardiomyopathies (when measured 
within the first 24 hours) (Wittstein et al. , 2005). TTC patients’ apical dysfunction persists for several 
weeks following a severe episode, or resolves within hours in case of a milder episode. It may 
therefore be inferred that the isoprenaline model more accurately reflects the course of TTC in the 
patient. This may reflect differences in the pharmacokinetics of the drug/dose protocol used in the 
two studies. The metabolic half life of adrenaline in the blood plasma is less than 3 minutes whereas 
isoprenaline is over 2 hours. The adrenaline bolus is applied intravenously meaning the full dose is 
present in the plasma from t0 and the residual adrenaline level is possibly less than 1% at the onset 
of apical dysfunction. This demonstrates that these doses are sufficient to cause apical dysfunction 
(by a β2AR-Gi mechanism), but not a dysfunction that persists. It is suggested that isoprenaline 
allows this due to the greater persistence of the catecholamine within the blood plasma. The onset 
of apical ballooning is slower in this model not beginning until 40 minutes after injection and initially 
being much milder than the dysfunction observed with adrenaline i.v. Apical dysfunction reaches its 
nadir after 60 minutes in the isoprenaline model and persists for up to 10 days. The researchers 
show that factors such as glycogen depletion and lipid influx are decreased at this time point. 
However, it is not clear whether contractility was restored and histology still appears to show a large 
amount of cardiomyocyte dissarray in biopsies from rats 10 days after isoprenaline infusion. Patient 
biopsies show a loss of lipid influx and reduction of cardiomyocyte dissarray upon recovery (Nef et 
al., 2010). Consequently it is questioned whether the isoprenaline model accurately simulates TTC or 
simply causes a mild catecholamine cardiotoxicty of the variety discussed in the introduction (Rona 
et al., 1989). Recovery is an essential part of the diagnosis of TTC and whatever mechanisms underlie 
the syndrome must not cause grave persisting damage to the myocardium. Using isoprenaline in this 
way is not physiological and should be considered carefully as 15mg of isoprenaline given to a 300g 
rat, and which persists in the plasma, is required to produce the same effects as a 1mg dose of 
adrenaline given intra-muscularly to a 70kg human. There may be some aspect of the physiology of 
catecholamines which is different for conscious humans in comparison to unconscious rats. 
Potentially, more catecholamines are release due to the emotionally and physically stressful effects 
of catecholamine infusion. The suggestion is that although adrenaline can cause apical dysfunction 
this is not persistant in our current model of TTC. An improved model of TTC using the rat may be to 
provide a smaller bolus dose and then surgically implant a dosage form which elevates the 
adrenaline plasma level for a short period of time (48 hours). It should also be established how the 
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elevated adrenaline or noradrenaline levels in the patients persist over time and if this coincides 
with recovery, or as in the adrenaline model dysfunction persists beyond the elevated 
catecholamine level.  
Continuous adrenaline infusion induced apical ballooning in cynomologus monkeys (Izumi et al., 
2009) consisting of two, three hour infusions, separated by 24 hours, are sufficient to produce apical 
hypokinesis which persists for almost a month. Apical hypokinesis is present from three days after 
the second infusion. The timing of onset of this dysfunction was not clear, it reverses around 14 
days. This is quite similar to the situation in patients. Similarly to experiments involving rats around 
36% of the monkeys died during the adrenaline infusion, meaning mortality rates were almost alike. 
Similar to the experiments presented in this chapter Izumi et al. report that the monkeys died 
following ventricular arrhythmia and fibrillation ascribed to bundle branch type premature 
ventricular contraction. This phenomenon was observed in rat studies (especially those utilizing 
ovariectomized females). Usually, upon initial infusion of adrenaline, there was a profound reflex 
bradycardia followed by a tachycardia and polymorphic tachycardia. This may suggest that TTC 
sufferers may be survivors of a situation where life threatening ventricular fibrillation was narrowly 
averted. Izumi et al. (2009) report that the heart rate and blood pressure of the monkeys were 
elevated over the course of both adrenaline infusions with little apparent desensitization on day 
two. Interestingly this study once again hints at the cardio-protective but possibly negatively 
inotropic role of the β2AR. Metoprolol infusion ten minutes before beginning adrenaline infusion 
protects against the activation of genes and myocytolysis but does not particularly enhance 
contractility (as indexed by ejection fraction). Metoprolol shows a slight selectivity for the β1AR and 
as such may not block the effects of the β2AR. Metoprolol only slightly enhances the reversibility of 
the apical dysfunction. As an interesting aside the researchers show that expression of β2AR (ADRB2) 
is not enhanced at baseline in the apical myocardium and is unaffected by adrenaline or metoprolol 
infusion, suggesting that if β2AR signalling is involved it may not be the density of β2AR which is 
causative.  
The resistance of the young female, oestrogen competent, animals is concordant with a large body 
of research demonstrating the relative insensitivity of the female myocardium to adrenergic 
stimulation in comparison to the male. It may be the case that, as there is a hypothesized need to 
escape arrhythmic death whilst till providing sufficient stimulus to βAR, that persistent apical 
ballooning maybe more effectively induce in female rats at higher doses of adrenaline than the once 
utilized in the course of this work. It has been suggested that some persisting cardio-protective 
effects of oestrogen may still be present in the post-menopausal sufferers of TTC. Just enough SNS 
228 
 
activation and a reduction in the cardio-protection provided by oestrogen makes these women 
susceptible to TTC but not acute arrhythmic sudden death.      
Limitations and Further Work                  
Clearly future work should be focused upon enhancing the rat model so that the apical ballooning 
becomes persistent in the manner of the clinical presentation of TTC. This would probably be 
mosteffectively performed with adrenaline due to it being the physiological agent which is most 
likely to initiate TTC in vivo.  An infusion protocol analogous that utilized to produce a model of TTC 
in cynomolgous monkeys by Izumi et al. (2009). Equally, ovariectomized females should be 
reassessed using a dose response protocol to establish at which dose apical ballooning occurs, to 
establish that this is possible in this type of rat. Chronic oestrogen replacement may be more 
effective in preventing arrhythmic effects in the ovariectomized females, this was shown to be 
effective in the emotional stress induced TTC (Ueyama et al., 2003). Alongside improving these 
models and making them more relevant, the role of the β2AR should be more thoroughly 
investigated. This appears to present some issues as it appears that the β2AR is cardio-protective and 
any attempts to ablate its activity and equally that of downstream effectors such as Gi or p38MAPK 
(Paur et al., 2012; Shao et al. 2013A) results in increased mortality. It would be interesting to assess 
whether apical dysfunction occurs in the presence of a very selective β1AR antagonist such as 
CGP20712A.  
A mouse model of TTC has been demonstrated by Shao et al. (2013 B), although this relies on an 
extremely large dose of i.p isoprenaline (400mg/kg), it shows the importance of lipotoxicity. This 
facet should be assessed for the acute adrenaline stimulation, haematoxylin and eosin staining did 
not show any fibrosis or myofibrillar disorganization after the adrenaline shock. The mouse may be a 
useful model as the genetic tools which exist might be useful for exploring the pathogenesis of TTC. 
A mouse with ApoB overexpressed was demonstrated to be resistant to the isoprenaline induced 
akinesis. A mouse only expressing β2AR might reveal the true role of β1AR, it is questioned whether 
this molecule is a sensitizer or initiator of TTC in some way.  A transgenic mouse model has been 
created in which the scaffolding molecule Cav3 has been knocked out in all tissues; the effect of de-
compartmentalizing β2AR could be checked using this model. The effect may be an increased 
mortality as the ability for β2AR-Gi is prevented. It may be the case that the regional dysfunction 
becomes more generalized as β2AR becomes phosphorylated more rapidly due to increased PKA 
activity.                       
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7.0 FINAL DISCUSSION 
7.1 APICO-BASAL DIFFERENCES IN ΒAR RESPONSIVENESS  
Apical cells increase their contractility in response to both non-specific βAR and specific β2AR 
stimulation to a greater degree than basal cardiomyocytes. The difference in apical and basal β2AR 
contractile responses appears to be due to the increased influence of β2AR-cAMP on PKA 
compartments. There is an apparent increase in the density of βAR at the mammalian apical 
myocardium (Mori et al., 1993) and the ratio of β2AR to β1AR appears increased at the apex in rat 
(Paur et al., 2012). In this work the contribution of β2AR to the apical isoprenaline cAMP response 
appears greater than in the basal myocardium. These differences in the physiology of cAMP in the 
apex versus the base appear to be controlled by alterations in the membrane domains and 
phosphodiesterase activity. Basal cells demonstrate an increased number of membrane caveolae 
and have a denser and more regular t-tubular network. The differences between apical and basal 
cells are attributed to dynamic control of the cellular morphology which enhance the structural 
compartmentation of β2AR-cAMP within basal cardiomyocytes. This reduces the effect of β2AR-
cAMP on PKA and consequently reduces its control of cardiomyocyte contractility, via apparent 
effects on both inotropy and lusitropy.  Phosphodiesterase compartmentation of β2AR signalling is 
not dependent on caveolae or cholesterol dependent micro-domains as there appears to be free 
associations of phosphodiesterase sub-types and β2AR (Liu et al., 2012). Cholesterol-depletion does 
not enhance β2AR activity upon phosphodiesterase inhibition (MacDougall et al., 2012). Both 
inhibition of PDE and cholesterol depletion appear to equilibrate apical and basal responses. It is not 
clear which has the most important role in this scenario, as PDE inhibition would be hypothesised to 
increase the activity of any Gs- linked receptor and cholesterol depletion is widely reported to 
enhance cAMP responses (Pontier et al., 2008). This dynamic interplay must be investigated further 
to establish how this dichotomy is produced. In future, observations should be taken from systems 
where stimulation does not produce near maximal responses in contraction and cAMP output, as it 
is often not clear whether treatments are prevented from having effects because the system has 
reached its maximum amplitude, or whether factors are truly independent.  
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7.2 ARCHITECTURAL DIFFERENCES IN THE NEUROHORMONAL CONTROL OF THE HEART 
MAY ENSURE EFFICIENT FUNCTION DURING NORMAL PHYSIOLOGY 
Our laboratory proposed the hypothesis that the receptor densities and sub-type contributions of 
the apical and basal myocardium differ due to the differences in innervation of the myocardium 
(Lyon et al., 2008). The innervation is reduced at the apex in comparison to base (Kawano et al., 
2004). Sympathetic stimulation utilizes the neurotransmitter noradrenaline and this is less potent at 
the β2AR than adrenaline. Adrenaline is released systemically into the venous blood and therefore 
acts upon the myocardium via the plasma and microcirculation. This allows balanced contractility 
upon sympathetic stimulation. One wonders why this should be the case? What is the anatomical 
necessity for control of the basal myocardium by innervation and control of the apical myocardium 
by circulating factors?  The study by Kawano et al. (2003) elegantly demonstrates the differences not 
only in the sympathetic innervation of the heart but the parasympathetic innervation as well. The 
differences between the apical and basal innervations by sympathetic neurons are dwarfed by the 
differences in parasympathetic innervation with once more a far greater density of these neurones 
in the basal versus the apical myocardium. Approximately fives times more parasympathetic 
neurones are present in the atria versus the ventricles. Sympathetic stimulation is about 20% lower 
in the atria in comparison to the ventricles. The relative balance of sympathetic innervation means 
that it seems unlikely that innervation is being altered for anatomical reasons but due to the relative 
roles of different regions of the heart. PNS neurones are concentrated in the atria and run parallel to 
the conducting fibres (Loffelhog et al., 1985, Barbel et al., 1984). The effect of PNS activity is a 
slowing of the heart rate by changing the conduction and contraction of the atria. Aberrant 
conduction slowing is demonstrated to increase the likelihood of re-entry and fatal ventricular 
arrhythmias. It would therefore be extremely disruptive to have agents providing slowing of 
excitatory propagation or action potential at the ventricles as this can be altered by the effect of 
slowing of the atria with fewer pathological consequences. The apex which is the insertion point 
where the conduction system propagates the action potential via the bundle of His and up the 
ventricular walls could be a potential area of vulnerability if conduction velocity was slowed 
aberrantly through this area. The relative lack of PNS innervation toward the ventricular apex and an 
increased sensitivity to circulating catecholamines could be suggested to be a mechanism to prevent 
action potential slowing. These suggestions are further supported by the findings by Szentandrassy 
et al. (2005) where the ion channel expression profile of apically derived canine cardiomyocytes is 
appreciably different in comparison to basally derived cells. The apical potential duration is shorter 
at the apex and the speed of re-polarization is higher. These cells appear to need to conduct quicker 
to provide rapid depolarization to optimize ventricular emptying and hence synchronized 
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contractility to the entire ventricle. Apical and basal cells did not display differences in cell 
capacitance in the studies of Szentandrassy et al. (2005), suggesting the cells are of a similar size, a 
finding replicated in our study. One might have hypothesized the apical cells would have a lower 
capacitance as they have a less well defined t-tubular system. In the canine myocardium there 
appears to be an increased delayed rectifier K+ current in apical cells providing a shorter action 
potential. Inward rectifier, rapid delayed rectifier and LTCC are similar between apex and base. Ion 
channels contributing the transient outward K+ current and the slow delayed rectifier currents are 
more highly expressed in the apical myocardium (including Kv1.4, KChIP2, KvLQT1 and MaxiK) 
(Szentandrassy et al, 2005). Thus it appears rapid conductance through this region is required and 
increased levels of sympathetic activity will contribute to this, including the increased basal level of 
β2AR activity. This desirable characteristic must be balanced against the overall architecture of the 
heart.                   
7.3 DIFFERENCES IN THE MECHANICAL ENVIRONMENT OF APICAL AND BASAL CELLS 
The thickness of the ventricular wall varies from apex to base, with a thinner wall present at the 
apex this provides a conically shaped ventricle which can efficiently propel blood via the complex 3D 
contractile motion of the heart. The apical left ventricle has a smaller diameter and the wall is 
thinner which results in it being under greater tension than the basal myocardium (Seo et al., 2010). 
Myocardial stretch has been shown to decrease conduction velocity in both pathological and 
physiological scenarios (Mills et al., 2011). As the conduction is demonstrated to be quicker in the 
apical myocardium (and within the apical cells) some offsetting mechanisms must be occurring to 
prevent stretch from causing disruptive effects. Sub-membrane caveolae are recruited to the cell 
membrane upon stretching myocytes, in their role as membrane reserves. This possibly increases 
the capacitance of the cells and slows conduction (Kohl et al., 2003). Ablating caveolae via 
cholesterol depletion or knocking out Cav3 seems to completely remove the slowing effects on 
conduction in cardiomyocytes (Wright, et al., 2013). Apex cells are stretched so caveolae are more 
likely to be recruited to the membrane and cause slowing. The region may have adapted some 
mechanism to disassemble caveolae rapidly at the membrane to prevent slowing alongside the 
stated differences in ion channel expression. This would also have the effect of increasing adrenergic 
sensitivity as explored in this thesis. The increased activity of β2AR supports the rapid conduction of 
action potentials in normal physiology. Stretch dependent ion channels (MSC) appear to be 
regulated by caveolae, disrupting caveolae is demonstrated to increase the lusitropy of myocardial 
cells as demonstrated in this thesis and contributes to increased MSC currents (Huang et al., 2013). 
The lower strain upon the basal myocardium in contrast probably allows more caveolae to form and 
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this usefully controls the activity of the MSC from being evoked where it is not required. As a 
consequence caveolar localization becomes a mechanically sensitive method of signalling control 
within cells of the same type functioning in different mechanical environments.    
7.4 PATHOLOGICAL CONSEQUENCES OF REDUCED CAMP COMPARTMENTATION            
Although the increase in adrenergic sensitivity at the apical myocardium is useful to ensure the rapid 
conduction of the action potential around the heart it possibly has pathological consequences. 
Experimental reduction of the compartmentation of β2AR in healthy cells leads to signalling 
characteristics more similar to those of β1AR. Toxicity of β1AR signalling in comparison to β2AR has 
been explored widely and seems in most cases to be related to either the increased 
compartmentation of β2AR either by micro-domain localization or its biased agonism. The apical cells 
possibly represent a scenario where β2AR loses this capacity somewhat. This aspect of apical β2AR 
signalling has not been explored within this work. Future efforts could assess whether apical β2AR 
signalling can elicit pathological signalling like β1AR. For example β1AR but not β2AR is demonstrated 
to initiate sarcomeric Ca2+ leak via the cAMP effector Epac2 (Pereira et al., 2013). Equally, CamKII can 
be activated via β1AR mediated activity either via Gαs or cAMP activity inducing myocyte apoptosis. It 
should be established whether the apical β2AR responses demonstrates any of these characteristics 
in comparison to the basal β2AR response. These studies may establish whether the free signalling of 
the β2AR-cAMP in the apex might underlie the increased sensitivity of the apical myocardium to 
isoprenaline induced damage in chronic scenarios. In human patient syndromes involving chronic 
stress or heart failure and cardiomyopathies where SNS activity is higher may be contributed to by 
apical vulnerability, which serves to reduce cardiac function overall. It possibly contributes to 
pathological pro-arrhythmic mechanisms resulting in sudden death in sufferers.    
It may be the case that the high Gs activity in the apical cardiomyocytes could subsequently give rise 
to enhanced β2AR-Gi activity. β2AR-Gi signalling requires intial activation of PKA to produce 
phosphorylation of the β2AR allowing subsequent phosphorylation by GRK2/GRK5 to induce stimulus 
trafficking (Liu et al., 2008, Wang et al., 2007). The capacity of β2AR to signal through Gi has been 
demonstrated to underlie pathological effects of high catecholamines at the apical myocardium in 
animal models of TTC (Paur et al., 2012; Shao et al., 2013A). The restriction of cAMP in the base, 
following β2AR stimulation, may contribute to the prevention of β2AR-Gi-mediated akinesis in this 
region in TTC.     
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7.5 DECREASED APICAL CAMP COMPARTMENTATION AND CAVEOLAE NUMBER IN TTC 
The apical myocardium seems to be vulnerable to damage by acute or chronic adrenergic 
stimulation produced via pathological or physiological means. The apical hypo-contraction induced 
by adrenergic overstimulation appears to be contributed to by β2AR due to the inability of 
noradrenaline to produce the symptoms whereas adrenaline and isoprenaline can (Paur et al., 2012; 
Shao et al., 2013 A, B). The ability of β2AR to stimulus traffic to Gi also seems to play a role as PTX 
pre-treated animals do not present apical hypo-contraction. The irreversible toxicity of chronic 
isoprenaline stimulation is in contrast to the spontaneous recovery of acute hypo-contractility in 
animal models and in patients. Two broad pathways are presented which may result in the hypo-
contractility of the apical myocardium. The first is the non-specific cascade of catecholamine toxicity 
including fibrosis, apoptosis and lipotoxicity (Nef et al., 2010; Shao et al., 2013 B). The second is the 
cardio-protective but negatively inotropic effect of the β2AR-Gi pathway (Lyon et al., 2008). The 
decreased compartmentation could be hypothesised to enhance the likelyhood of apical hypo-
contractility in both ways. Following activation β2AR signalling may initially recapitulate a β1AR-like 
character causing enhanced toxicity within the region. However, the increased presence of β2AR in 
the apical region could be hypothesised to be a protective factor preventing the toxicity of β1AR 
signalling which is enhanced in the apex as well. Chronic animal models of catecholamine damage 
may have their effects due to the levels of catecholamine being just too low to fully activate β2AR 
stimulus trafficking which is shown to be a dose dependent phenomenon (Liu et al., 2009). PKA 
mediated phosphorylation of β2AR occurs at sub-nanomolar concentrations of catecholamine 
stimulation whereas the activation of GRK2 only occurs at saturating concentrations. It may also 
have the effect of decreasing the level at which stimulus trafficking of β2AR to Gi occurs as the 
receptor is phosphorylated by PKA at a lower level, thus more effectively inducing hypo-contractility 
in this segment. However, it is not clear how the main arbiter of stimulus trafficking via 
internalization, GRK2, would be affected by decreased compartmentation. It would appear that 
GRK2 binding to β2AR would be reduced by reduced compartmentation: as demonstrated, 
cholesterol depletion seems to prevent the adrenaline-mediated reductions in β2AR’s control of 
inotropy. Caveolin and caveolar domains appear to be important for receptor desensitization and 
also the normal function of GRKs as these proteins display binding motifs for caveolins (Carmen et 
al., 1999). Intriguingly, caveolin binding seems to down-regulate GRK activity, an up-regulation of 
GRK activity correlated with the loss of caveolin in senescent rats and implicated in their vasculature 
dysfunction (Schutzer et al., 2005).  This effect is relevant on a number of levels for the pathology of 
TTC. First, the caveolae deficient apical myocardium may be hypothesized to have enhanced GRK 
activity, although it is not clear to what degree GRK can freely associate with Cav-3, thus there may 
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be more β2AR-Gi activity within the apical myocardium. Secondly, the only genetic polymorphism 
implicated as increasing the likelyhood of TTC is the L41Q polymorphism of GRK5. This results in a 
constitutively active GRK (GRK5 plays the role of GRK2 in humans) so may result in an increased 
β2AR-Gi activity in these patients (Spinelli et al., 2010). Finally, TTC primarily afflicts post-menopausal 
women so senescence may result increased likelyhood of β2AR-Gi due to an increased activity of 
GRK5 and decreased caveolar compartmentation, and thus TTC. Gi expression also appears to 
increase with age (Bohm et al., 1993).       
7.6 IMPLICATIONS OF REGIONALITY FOR MYOCARDIAL PATHOLOGIES OTHER THAN TTC                                 
Increased SNS activity is present in cardiac pathology and situations of psychological stress. These 
two scenarios appear to regularly superimpose upon one another without a clear indication of which 
factor is truly causative (Dimsdale, 2008). The SNS activation in these situations is adaptive, being 
required in an evolutionary sense as a component of the ‘fight or flight’ response to enhance the 
performance and chances of survival of the individual during a stressful scenario, or in the case of 
acute heart failure to provide increased inotropic response. This allows the temporary increase in 
the contractility of surviving myocytes in the damaged myocardium. Unfortunately chronic 
activation of the SNS results in pathological adaptations of the heart itself, driving a worsening of the 
failure of the myocardium (Port and Bristow, 2001). This is the common end-stage of heart failure 
following MI or other cardiomyopathies which are caused by quite different initial stressors. 
Regionality may worsen MI-HF in a synergistic manner when part of the myocardium is lost and the 
apical myocardium is subsequently damaged by the SNS activation. Equally, an occlusion of the left 
anterior descending coronary artery such as that frequently utilized in animal models of MI causes 
an apical infarct (Lyon et al., 2008). The apoptosis and ischemic damage caused in this region is 
possibly enhanced by the increased adrenergic sensitivity of the apical myocardium. Restoring 
calcium handling through non-βAR means may provide protective effects (Lyon et al., 2008). In a 
model of mechanically induced hypertrophy, Engelhardt et al. (2004) demonstrated that 
overexpressing β1AR in mice resulted in a non-regional hypertrophy within the heart. By enhancing 
PLB activity the hypertrophy was averted showing the importance of βAR and aberrant Ca2+ handling 
within hypertrophic pathologies. Stabilizing the adrenergic response of the apex specifically may be 
a useful but as yet unexplored clinical pathway.               
7.7 FUTURE WORK 
This work has identified and confirmed an interesting aspect of βAR physiology and heart function. 
However, only two regions have been explored to properly assess what the role of regionality of βAR 
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function plays in cardiac physiology many regions both longitudinally and trans-murally should be 
studied. It would be interesting to establish whether these differences manifest as gradients much 
like differences in innervation (Kawano et al., 2003), or whether the apex is a special region separate 
to the other two thirds of the myocardium. Experiments to establish whether there is a role of 
enhanced β2AR signalling in lipotoxicity observed by some researchers should be conducted in 
isolated cardiomyocyte pre-stimulation induced by adrenaline and noradrenaline as presented 
above. Pertussis toxin has been used in many cases to remove the effects of Gi. This is rather a non-
specific tool as all aspects of Gi function are removed from the cell. A more effective approach might 
be to utilise βARKct peptide which specifically interrupts GRK2 activity. This may be more effective at 
probing Gi effects and may be able to demonstrate whether the increased GRK2 activity is greater in 
the apical myocardium. The FRET studies presented above could be extended by using the RII_Epac 
sensor as this is demonstrated to be a more effective predictor of effects of β2AR effects on cardiac 
inotropy and lusitropy, as opposed to the cEpac2 sensor. Imaging of calcium using Fluo-4 could be 
utilized to more effectively relate changes in myocytes contraction to effects of β2AR on excitation 
contraction coupling within different regions of the myocardium Biochemical studies could be 
undertaken to rapidly establish whether phosphorylation targets of β2AR-cAMP-PKA differ between 
cells from different regions of the myocardium. The relative expression of protein phosphatases (PP) 
could be explored as these are demonstrated to be important for the compartmentation of β2AR and 
is dependent upon cardiomyocyte caveolae (McDougall et al., 2012). These proteins rather than 
Cav3 and PDE4 may be arbiters of the apico-basal difference in β2AR signalling, whereby basal PP 
activity is more effective and thus β2AR has less effect on cardiomyocyte contractility. These 
biochemical analyses could also be undertaken in samples from the rapidly reversing rat adrenaline 
model of TTC, terminated at different time-points following the adrenaline bolus. This may allow 
analysis of the relative involvement of β2AR-Gs or Gi signalling. Equally an alternative model of TTC 
could be made by using an infusion type method employing adrenaline in rats in the manner of Izumi 
et al. (2009). This could establish whether the lipotoxic effects of isoprenaline at the myocardial apex 
can also be induced by adrenaline. The unreliability of the OVX model could be tackled by 
performing a small dose response type study to establish if TTC like symptoms result at a lower 
concentration of adrenaline stimulation. As a final point the apical basal differences should be 
explored in the young female animals where adrenaline did not induce TTC symptoms. It would be 
especially interesting to establish whether caveolae number is different between young female 
animals apical and basal myocardium. Caveolae have been widely investigated as the nexus of nitric 
oxide signalling within cardiomyocytes and the vasculature. This pathway is implicated in the vaso-
relaxant and cardio-protective effects of oestrogen.   
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7.8 CONCLUSION 
The thesis presents work demonstrating the increased sensitivity of the apical cardiomyocytes of rat 
and mouse myocardium to adrenergic stimulation and enhanced contractile and relaxant effects 
induced by β2AR stimulation. These studies show that these differences are due to the increased 
influence of β2AR-cAMP upon PKA-RII compartments. These compartments contain the PKA 
populations which define the phosphorylation of effectors of calcium handling within the excitation 
contraction coupling machinery. Differences between the membrane morphology of apical and basal 
cardiomyocytes are apparent with a decreased density of t-tubules and caveolae in apical 
cardiomyocytes which are proposed to curtail β2AR-cAMP signalling by both ‘PKA buffering’ and 
reducing cAMP influence on downstream effectors (Nikolaev et al., 2010; McDougall et al., 2012; 
Agarwal et al., 2011). β2AR-cAMP, appears to form a larger component of the cAMP response to 
isoprenaline stimulation in apical cardiomyocytes in comparison to  basal. This however is possibly 
distorted by the apparent increase in the rate of cAMP hydrolysis in basal cardiomyocytes due to an 
increased tone of PDE4 on β2AR-signalling in this cell type. Pre-stimulation of apical and basal 
cardiomyocytes with noradrenaline and adrenaline causes contractile dysfunction which seems to 
primarily affect apical cells upon re-stimulating β2AR. Adrenaline is implicated in the regional 
dysfunction present in TTC, and pre-stimulation by adrenaline causes reduction in the lusitropy of 
apical but not basal cardiomyocytes. Noradrenaline by comparison has no effect on apical 
cardiomyocyte lusitropy. The ability of β2AR to traffic to Gi is implicated in these effects as they are 
somewhat reversed by PTX removal of Gi effects. This recapitulates the findings of the animal model 
of TTC, which motivated this work, and where adrenaline but not noradrenaline caused apical 
dysfunction. To improve this model, female animals were investigated; oestrogen competent 
females were demonstrated to be resistant to TTC like symptoms following adrenaline bolus. 
Ovariectomized females were found to be highly vulnerable to adrenergic overload, suffering 
extreme mortality. This work highlighted the importance of the oestrogen axis as a protective 
system against adrenergic overstimulation. New avenues for improvement were suggested by this 
work. In conclusion the reduction of β2AR control within the apical myocardium makes this region 
vulnerable to catecholamine mediated damage and hypo-contractility induced in the syndrome of 
TTC and catecholamine damage in other myocardial pathologies.          
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Figure 9.1 A) FRET shifts in response to β2AR stimulation, B) responses stimulated by NKH477 and C) 
corrected β2AR responses for each sensor.  
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Figure 9.2 FRET data for apical and basal cells pre-stimulated with a) rolipram, b) Milrinone and c)IBMX 
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Figure 9.3 comparison of the survival of apical and basal cells following 24 and 48 hours in tissue 
culture   
Cardiomyocytes begin to degrade and undergo cell death at the point of isolation. Although they can 
be maintained in culture, optimally, they will not usually survive as rod-shaped cardiomyocytes 
beyond around 96 hours. Dead cardiomyocytes do not maintain their rod like structure and thus cell 
death is easily assessed in this cell type and can be assessed by optical inspection. There are 
differences in the expression of βAR sub-types between apical and basal populations. There is also 
the possibility of pre-existing but otherwise uncharacterized anatomical variation in the expression 
of other molecules governing cell survival. For these reasons, the stability of these differing cell types 
should be confirmed. In order to assess their relative stability samples of the cells were maintained 
in culture as per the protocol above. Following isolation the proportion of adherent rod-shaped cells 
to non-rod shaped was recorded in a sample of >35 apical or basal cells on three separate slips, after 
three separate isolations.  A one way ANOVA with Bonferroni’s post-test shows no significant 
difference between the mean proportions of apical or basal cells dead following 24 and 48 hours. 
This suggests no difference in the relative qualities of these cells would be responsible for observed 
differences in FRET responses.     
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Figure 9.4 Pharmacological Properties of Tool Compounds1 
 
 Log KD β2AR Log EC50 β2AR Efficacy Ratio (log)  β2AR Selectivity β2AR vs. β1AR 
Isoprenaline −6.64 −8.22 1.58 3.8 
Zinterol −8.04 −9.48 1.44 120.2 
Adrenaline -6.13 -7.93 1.80 9.55 
Noradrenaline −5.41 -6.36 0.95 0.47 
 
 Log KD β1AR pA2 β1AR Log KD β2AR pA2 β2AR Selectivity β2AR vs. β1AR 
CGP20712A -8.81 9.43-8.58 2,3 -6.11 - 0.002 
ICI 118551 -6.52 - -9.26 7.11-6.162,3 549.5 
 
 
 
 
 
Data:  
1. Baker, J.G. British Journal of Pharmacology (2005) 144, 317–322 and (2010) 160(5) 1048-1061 
2. Zwaveling, J., Winkler Prins, E.A., Pfatfendorf, M. and van Zwieten, P.A.  (1996). The influence of 
hyperthyroidism on β-adrenoceptor-mediated relaxation of isolated small mesenteric arteries. 
Naunyn-Schmiedeberg's Arch. Pharmacol. 353:438-444  
3. Horinouchi, T., Tanaka, Y. and Koike K. (2003). Function of h1-adrenoceptors and mRNA 
expression of h1- and h2-adrenoceptors in guinea-pig esophagus. European Journal of Pharmacology 
473, 79 – 82 
 
 
 
 
 
 
 
 
 Log KD β1AR Log EC50  β1AR Efficacy Ratio (log)   β1AR 
Isoprenaline −6.06 −8.59 2.53 
Zinterol −5.96 −7.23 1.27 
Adrenaline -5.15 −7.61 2.46 
Noradrenaline −5.74 −7.94 2.20 
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Equation 1: 
  
[ ]   
[ ]    [ ]   ⁄   ⁄
 
Receptor occupancy comparison in presence of inhibitors 
Agent + [Conc.] Inhibitor β1AR Occupancy β2AR Occupancy Relative Occupancy 
Ratio 
Isoprenaline 10-7M CGP20712A 
10-7M 
0.175% 28% 160 
Isoprenaline 10-6M CGP20712A 
3x10-7M 
0.59% 75.9% 129 
Zinterol 10-5M CGP20712A 
3x10-7M 
4.48% 99.9% 22.3 
 
Rolipram Efficacy for Different Phosphodiesterase Subtypes4 
Phosphodiesterase 4 Subtype IC50 (nM) 
PDE4A 1.1±0.3 
PDE4B 0.9±0.0 
PDE4C 324.6±27.4 
PDE4D 61.1±12.8 
Data:  
4. Wang, P., Myers, J.G., Wu, P., Cheewatrakoolpong, B., Egan, R.W. and Billah, 
M.M. (1997)  Expression, purification, and characterization of human cAMP-specific 
phosphodiesterase (PDE4) subtypes A, B, C, and D.  Biochem. Biophys. Res. 
Commun., 234 (2): 320-4. 
